SECURITIES AND EXCHANGE COMMISSION
                           Washington, D.C. 20549

                             AMENDMENT NO. 4 TO
                                FORM 10-SB

                 GENERAL FORM FOR REGISTRATION OF SECURITIES
                          OF SMALL BUSINESS ISSUERS
   Pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934



                    BION ENVIRONMENTAL TECHNOLOGIES, INC.
         (Name of small business issuer as specified in its charter)



             Colorado                                       84-1176672
(State or other jurisdiction of                          (I.R.S. Employer
 incorporation or organization)                         Identification No.)


     641 Lexington Avenue, 17th Floor
         New York, New York                                    10022
(Address of Principal Executive Offices)                     (Zip Code)


                Issuer's Telephone Number, including area code:
                                 212-758-6622


Securities to be registered under Section 12(b) of the Act:

                                     None


Securities to be registered under Section 12(g) of the Act:

                          Common Stock, no par value





                         Forward-Looking Statements

     This Report contains, in addition to historical information, forward-
looking statements regarding BION ENVIRONMENTAL TECHNOLOGIES, INC. (the
"Company"), which represent the Company's expectations or beliefs including,
but not limited to, statements concerning the Company's operations,
performance, financial condition, business strategies, and other information
and that involve substantial risks and uncertainties.  The Company's actual
results of operations, most of which are beyond the Company's control, could
differ materially.  For this purpose, any statements contained in this Report
that are not statements of historical fact may be deemed to be forward-
looking statements.  Without limiting the generality of the foregoing, words
such as "may," "will," "expect," "believe," "anticipate," "intend," "could,"
"estimate," "continue" or the negative or other variations thereof or
comparable terminology are intended to identify forward-looking statements.
Factors that could cause or contribute to such difference include, but are
not limited to, limited operating history; uncertain nature of environmental
regulation and operations; risks of development of first of their kind
Integrated Projects; need for additional financing; competition; dependence
on management; and other factors discussed herein.




































                                     2


                             TABLE OF CONTENTS

                                                                      Page

              INFORMATION REQUIRED IN REGISTRATION STATEMENT

ITEM 1.     DESCRIPTION OF BUSINESS ...............................     4

ITEM 2.     MANAGEMENT'S DISCUSSION AND ANALYSIS OR
            PLAN OF OPERATION .....................................    29

ITEM 3.     DESCRIPTION OF PROPERTY ...............................    45

ITEM 4.     SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
            AND MANAGEMENT ........................................    45

ITEM 5.     DIRECTORS AND EXECUTIVE OFFICERS, PROMOTERS AND
            CONTROL PERSONS .......................................    49

ITEM 6.     EXECUTIVE COMPENSATION ................................    55

ITEM 7.     CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS ........    60

ITEM 8.     DESCRIPTION OF REGISTRANT'S SECURITIES TO BE
            REGISTERED ............................................    61

                                    PART II

ITEM 1.     MARKET PRICE OF AND DIVIDENDS ON REGISTRANT'S
            COMMON STOCK AND RELATED STOCKHOLDER MATTERS ..........    61

ITEM 2.     LEGAL PROCEEDINGS .....................................    62

ITEM 3.     CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS .........    63

ITEM 4.     RECENT SALES OF UNREGISTERED SECURITIES ...............    63

ITEM 5.     INDEMNIFICATION OF DIRECTORS AND OFFICERS .............    64

                                   PART F/S

FINANCIAL STATEMENTS ..............................................    65

                                   PART III

ITEM 1.     INDEX TO EXHIBITS .....................................    65

ITEM 2.     DESCRIPTION OF EXHIBITS ...............................    65







                                     3


ITEM 1.   DESCRIPTION OF BUSINESS

General

     Bion Environmental Technologies, Inc.'s ("Bion," "Company," "We," "Us,"
or "Our") patented and proprietary technology provides a comprehensive
environmental solution to a significant source of pollution in US
agriculture, Confined Animal Feeding Operations ("CAFO's").  Bion's
technology is "comprehensive" in that it surpasses current environmental
regulations for both nutrient releases to water and air emissions from
livestock waste streams based upon our research to date. Because Bion's
technology reduces the harmful emissions from a CAFO on which it is utilized,
the CAFO can increase its herd concentration while lowering or maintaining
its level of nutrient releases and atmospheric emissions.  Additionally, we
believe that Bion's technology platform allows the integration of ethanol
production, renewable energy production and on-site energy utilization with
large-scale CAFO's (and their end-product users) in an environmentally and
economically sustainable manner while reducing the aggregate capital expense
and operating costs for the entire integrated complex. In the context of
Integrated Projects, Bion's waste treatment process, in addition to
mitigating polluting releases, generates renewable energy from portions of
the CAFO waste stream that can be used by ethanol plants or other users as a
natural gas replacement.  The ethanol plant's main by product, called
distillers grain, can be added to the feed of the animals in wet form thereby
lowering the capital expenditures and operating cost of the ethanol
production process.  The ethanol plant thereby acts as a feed mill for the
CAFO, thus reducing the CAFO's feeding costs and generating revenue to the
ethanol plant, and also provides a market for the renewable energy that
Bion's System produces from the CAFO waste stream. Bion, as developer of its
Integrated Projects, anticipates that it will share in the cost savings and
revenue generated from these activities.

     Since 2002, the Company has focused on completing development of its
technology platform and business model.  As such, we have not pursued near
term revenue opportunities such as retrofitting existing CAFO's with our
waste management solutions, because such efforts would have diverted scarce
management and financial resources and negatively impacted our ability to
complete development of an integrated technology platform in support of
large-scale sustainable Integrated Projects.  The Company now intends to
focus its efforts on development and operation of Integrated Projects based
on Bion's waste handling/renewable energy technology platform ("Bion Systems"
or "Systems") integrating large-scale CAFO's and ethanol production
("Projects" or "Integrated Projects").

     The financial statements for the years ended June 30, 2006 and 2005 and
for the periods ended December 31, 2006 and 2005 included in this
registration statement have been prepared assuming the Company will continue
as a going concern.  The Company has not recorded any revenue for either the
year ended June 30, 2006 or for the period ended December 31, 2006.  The
Company has incurred net losses of approximately $5,173,000 and $2,115,000
during the years ended June 30, 2006 and 2005, respectively, and has incurred
a net loss of approximately $1,800,000 (unaudited) for the six months ended
December 31, 2006.  The Company had a working capital deficiency and a
stockholders' deficit of approximately $1,000 and $3,278,000, respectively,
as of June 30, 2006, and $1,141,000 and $4,605,000, respectively, as of
December 31, 2006.

                                     4



The report of the independent registered public accounting firm on the
Company's financial statements as of and for the year ended June 30, 2006
includes a "going concern" explanatory paragraph which means that the
accounting firm has expressed substantial doubt about the Company's ability
to continue as a going concern.

Principal Products and Services

     Currently, Bion is focused on using applications of its patented waste
management technology to develop Integrated Projects which will include large
CAFOs, such as large dairies, beef cattle feed lots and hog farms, with Bion
waste treatment System modules processing the aggregate CAFO waste stream
from the equivalent of 20,000 to 40,000 or more dairy cows (or the waste
stream equivalent of other species) while producing solids to be utilized for
renewable energy production and to be marketed as feed and/or fertilizer,
integrated with an ethanol plant capable of producing 20 million to 40 (or
more) million gallons of ethanol per year. Such Integrated Projects will
involve multiple CAFO modules of 10,000 or more dairy cows (or waste stream
equivalent of other species) on a single site and/or within an approximately
30 mile radius.  Bion believes its technology platform will allow integration
of large-scale CAFO's with ethanol production, renewable energy production
from waste streams and on-site energy utilization in a manner that reduces
the capital expenditures and operating costs for the entire Integrated
Project and each component facility.

     Bion is currently working with local, state and federal officials and
with potential industry participants to evaluate sites in multiple states and
anticipates selecting a site for its initial Project during 2007. In
addition, Bion intends to choose sites for additional Projects from 2007
through 2008 to create a pipeline of Projects. Management has a 5-year
development target (through calendar year 2012) of approximately 12-25
Integrated Projects.  At the end of the 5-year period, Bion projects that 8-
16 of these Integrated Projects will be in full operation in 3-8 states, and
the balance would be in various stages ranging from partial operation to
early construction stage. No Integrated Project has been developed to date.

     Bion is presently establishing its implementation management team with
the intention of commencing development and construction of an initial
Project during 2007. In September 2006, Jeremy Rowland joined Bion Dairy as
its Chief Operating Officer and has served in the capacity since that time.
Mr. Rowland has further agreed to serve as the Company's Chief Operating
Officer once it has secured adequate director and officer liability insurance
coverage.  Mr. Rowland has eighteen years experience in multi-disciplinary
energy and environmental project development and management throughout the
U.S. and overseas. Mr. Rowland's areas of expertise include renewable energy
project development, distributed generation (mostly combined heat/power),
large-scale power plant developments, and strategic energy management.  In
addition, Sal Zizza, who rejoined Bion and Bion Dairy during 2005 on a
consulting basis, assumed the positions of Chairman and Director of Bion
Dairy on January 1, 2006 and Jeff Kapell, who became a consultant to Bion and
Bion Dairy in December 2003, joined the Bion management team on a full-time

                                     5



basis during April 2006 as Bion Dairy's Vice-President --Renewables.  Mr.
Zizza and Mr. Kapell have performed these services for Bion Dairy since
January 2006 and April 2006, respectively.  Mr. Zizza and Mr.Kapell have
further agreed to serve the Company in similar positions once it has secured
adequate director and officer liability insurance coverage. Bion will need to
continue to hire additional management and technical personnel as it moves
from the technology re-development phase to the implementation phase during
the 2007 calendar year.

     The Company's successful accomplishment of these activities is dependent
upon many factors including the following, neither of which can be assured at
this date:

     *  Successful development and completion of the first Project to
        demonstrate the operation of a fully integrated, environmentally
        compliant, Bion-based CAFO/ethanol Project at a profitable level; and

     *  Our ability to raise sufficient funds to allow us to finance our
        activities.

Industry Background

     The traditional business model for CAFO's, regardless of livestock type,
has relied on a combination of: 1) a passive environmental regulatory regime,
and 2) access to a relatively unlimited supply of cheap land and water to
serve as the basis for "environmental" treatment of animal waste.  Such land
and water resources have now become significantly more expensive while
ongoing consolidation of the CAFO industry has produced a substantially
increased and more concentrated waste streams.  At the same time, regulatory
scrutiny of, and public concern about, the environmental impact from CAFO's
has intensified greatly.

     Agricultural runoff is the largest water pollution problem in the United
States. Over-application of animal waste to cropland has resulted in manure
nutrients polluting surface and ground water systems, adversely impacting
water quality throughout the country.  Clean-up initiatives for the
Chesapeake Bay and the Great Lakes (and elsewhere) are requiring the
expenditure of substantial sums of money to reduce excess nutrient pollution.
In each such case, agriculture in general and CAFO's in particular have been
identified among the main contributors of pollution.  CAFO's are also
significant emitters of pollutants to air, with dairies having been
identified as the largest contributor to airborne ammonia and other polluting
gases in the San Joaquin Valley.

     We believe Bion's technology will enable increased CAFO herd
concentration that is economically and environmentally sustainable because
the technology removes nutrients from the waste streams generated by animal
operations while dramatically reducing atmospheric emissions.  The resulting
herd concentration potentially creates reduced marginal costs and results in
a core Bion technology platform that integrates environmental treatment and
renewable energy production and utilization with ethanol production.

                                      6




     Bion's technology platform and the resulting herd concentration, in
turn, potentially provide the opportunity to integrate a number of revenue
generating operations while maximizing the realized value of the renewable
energy production.  The Bion model will access diversified revenue streams
through a balanced integration of technologies to provide a hedge of the
commodity risks associated with any of the separate enterprises.  We believe
that the Bion's Integrated Projects will generate revenues and profits from:

     *  Waste processing and technology licensing fees;
     *  High-value organic fertilizer and/or high protein feed products;
     *  Fees related to permanently integrated utilization of the wet
        distiller grains, which are a by-product of ethanol production;
     *  Renewable energy production from the waste streams combined with
utilization of the energy produced within the Integrated Projects;
and
     *  Ethanol production.

     Exactly what fees and revenues accrue to Bion will depend on the nature
of Bion's participation in each Integrated Project and on negotiations with
other participants in such Projects.  If Bion is simply the operator of its
waste System within an Integrated Project that it develops, it would generate
revenue from: a) waste processing and technology licensing fees charged to
the CAFO, b) sales of the fertilizer and other products generated from the
waste treatment process, c) sales of energy to the ethanol plant, d) fees
related to the utilization of the wet distillers grain made possible by the
integration, and e) fees for its "developer" role.  If Bion also participates
in the ownership and/or operation of the ethanol plant, it would further
generate revenue from sales of ethanol and sales of feed products to the
CAFO.  Sales of wet distillers grain as feed products generally represent 14-
20% of the total revenues of an ethanol plant if there is an available market
for the wet distillers grain. If Bion also participates in ownership and/or
operation of the integrated CAFO (and its facilities), it would generate
revenues from the sale of the CAFO's end products.

     We believe that our technology platform and the proposed Projects do not
involve significant technology risk.  Our waste handling technology has been
utilized in the past efficiently and has been verified by peer-reviewed data.
The other Project components required for an integrated operation, such as
CAFO facilities, ethanol plants and solids drying and combustion equipment,
all consist of available and fully-tested processes and equipment that do not
pose any experimental challenges once properly sized, selected and installed.
It is Bion's ability to integrate the component parts in a balanced
proportion with large CAFO herds and ethanol production in an environmentally
sustainable manner that creates this unique economic opportunity. Bion has a
patent pending relating to the Bion integration model described herein.
Although we have developed the structure and basic design work related to
Integrated Projects, we have not yet actually constructed an Integrated
Project.  Further, we have not completed the development of all of the System
applications that will be necessary to address all targeted markets (such as
swine, poultry, etc.) and all geographic areas and we anticipate a continuing
need for the development of additional applications and more efficient
integration.

     The basic integration in a Project will include:

                                    7



     *  An ethanol plant and CAFO combination sized to balance the distillers
        grain by-product of the ethanol production with the feed requirements
        of the CAFO herd and the energy needs of the ethanol plant with the
        renewable energy produced by Bion from the CAFO waste stream.  Beyond
        the production of ethanol, the ethanol facility will function as a
        feed mill for the CAFO herd which will utilize the spent grain from
        ethanol production in its feed ration, materially reducing the
        operating expenses (energy and transportation) and capital
        expenditure requirements (for items such as dryers) and increasing
        the net energy efficiency of ethanol production;

     *  Additionally, the ethanol plant will be a source of waste heat
        (which, if not productively utilized, would increase ethanol
        production costs for required disposal) that will be used to pre-
        heat the CAFO waste stream to maintain temperatures throughout the
        co-located Bion System.  In colder climates, additional uses of this
        waste heat will potentially include heating some of the CAFO
        facilities;

     *  Drying and processing of the fine solids portion of the CAFO's waste
        stream into a value-added, marketable, organic fertilizer and/or
        high protein feed product ingredients; and

     *  Processing, drying and combusting the coarse solids portion of
        the CAFO's manure stream to produce heat used for solids drying and
        to replace natural gas usage by the ethanol production process.

     In order to implement this plan, Bion must work with both CAFO's and
ethanol producers to generate multi-party agreements pursuant to which the
Integrated Projects will be developed and which will provide that at least
the following take place: a) the CAFO and ethanol plant agree to locate in
geographic proximity to each other, b) Bion licenses, constructs and operates
its System to process the CAFO's waste stream and produce renewable energy
and other products therefrom, c) the CAFO agrees to purchase and utilize the
wet distillers grain by-product of the ethanol plant in its feed ration and
d)the ethanol plant agrees to purchase and utilize the renewable energy
produced by Bion from the CAFO waste stream in the place of natural gas or
other energy purchases.  These agreements could be in the form of joint
ventures, in which all parties share the cost of construction of all of
facilities in the Integrated Project (in negotiated uniform or varied manners
across the various facilities), or in other forms of multi-party agreements
including agreements pursuant to which Bion would bear the cost of
construction of its System and the owners of the CAFO and the ethanol plant
would bear the cost of construction of the CAFO facilities and ethanol plant,
respectively, and negotiated contractual arrangements would set forth the
terms of transfer of products (wet distillers grain, combustible dried
solids, etc.), energy and dollars among the parties.

Corporate Background

     The Company is a Colorado corporation organized on December 31, 1987.
Our principal executive offices are located at 641 Lexington Avenue, 17th
Floor, New York, New York 10022.  Our telephone number at that address is
212-758-6622. We have no additional offices at this time.

                                     8



Development of our Business

     Substantially all of our business and operations are conducted through
three wholly owned subsidiaries, Bion Technologies, Inc. (a Colorado
corporation organized September 20, 1989), BionSoil, Inc. (a Colorado
corporation organized June 3, 1996) and Bion Dairy Corporation ("Bion Dairy")
(formerly Bion Municipal, Inc., a Colorado corporation organized July 23,
1999). Bion is also the parent of Bion International, Inc. (a Colorado
corporation organized July 23, 1999), which is a wholly owned, presently
inactive subsidiary.  Bion is also the parent of Dairy Parks, LLC (an
inactive Delaware entity organized July 25, 2001). In January 2002, Bion
entered into a series of transactions whereby the Company became a 57.7%
owner of Centerpoint Corporation (a Delaware corporation organized August 9,
1995) ("Centerpoint").

     Although we have been conducting business since 1989, we determined that
we needed to redefine how we could best utilize our technology during fiscal
year 2002.  Since that time, we have been working on technology improvements
and applications and in furtherance of our business model of Integrated
Project development leading toward construction and operation of an initial
Integrated Project.

     Our original systems were wastewater treatment systems for dairy farms
and food processing plants.  The basic design was modified in late 1994 to
create Nutrient Management Systems ("NMS") that produced organic soil
products as a byproduct of remediation of the waste stream when installed on
large dairy or swine farms.  Through June 30, 2001, we sold and subsequently
installed, in the aggregate, 32 of these first generation systems in 7
states, of which we believe approximately 15 are still in operation in 3
states.  We discontinued marketing of our first generation NMS systems during
fiscal year 2002.  We were unable to produce a business model based on the
first generation technology that would generate sufficient revenues to create
a profitable business.  While continuing to market and operate the first
generation systems during the second half of calendar year 2000, we began to
focus our activities on developing the next generation of the Bion
technology. We no longer operate or own any of the first generation NMS
systems.

     As a result of our research and development efforts, the core of our
current technology was developed during fiscal years 2001-2003.  We have
designed and tested Systems that use state-of-the-art, computerized, real-
time monitoring and system control with the potential to be remotely accessed
for both reporting requirements and control functions.  These Systems are
smaller, faster and require less capital per animal than our first generation
NMS systems.  The new generation of Bion Systems is designed to harvest
solids used to produce our organic fertilizer and soil amendments or
additives(the "BionSoil(R) products") in a few weeks as compared to six to
twelve months with our first generation systems.



                                      9




     The first phase of this research and re-development, which was conducted
during the summer and fall of 2000 at DreamMaker Dairy, our former research
facility located outside Buffalo, New York, accelerated the speed at which we
could treat the CAFO waste stream and harvest the solids from the waste (the
"Bion Process") in a System which was substantially less than 20% of the size
of a comparable first generation system.  We began second phase testing and
development during the winter of 2000-2001, based on the faster, smaller
System design at the DreamMaker Dairy.  We placed the System into a
configuration of enclosed tanks that fully contained the process.  This
configuration allowed control and monitoring of the entire System from all
inputs through all outputs.  This closed tank system gave us the ability to
perform complete mass balance calculations (measuring all inputs of the
animal waste stream and all outputs from the System, including nitrogen and
phosphorus, which are the two elements of most critical concern from a
nutrient and water pollution control standpoint, and hydrogen sulfide and
ammonia, which are two of the main compounds of critical concern from an air
pollution control standpoint) on the System to produce the
scientific/technical data necessary to demonstrate definitively the
performance of our technology.  Essentially, the tank configuration enabled
our technical staff to measure the amount and manner of nitrogen and
phosphorous removed and the amount and manner of gaseous emissions from the
waste stream and compare such quantities to the inputs to the System
contained in the CAFO waste stream (also known as a "mass balance analysis").
Initial results of the mass balance analysis calculations demonstrated that
phosphorus and nitrogen removals from the total waste stream approximated
80%.  Additionally, measurements on the primary odor producing compounds
indicated levels low enough to essentially eliminate odor problems associated
with CAFO waste handling.  In January 2002, we announced results of testing
the fully contained Bion prototype at DreamMaker Dairy.  The goals of that
initiative (which were successfully reached) were to:

     *  Increase the efficiencies of the first generation system;
     *  Convert the core Bion technology into an operating System
        that could be integrated with complementary technologies; and
     *  Develop a computerized monitoring and control system capable of
        precise measurements and adjustments and remote reporting.

     During 2003 we designed, installed and began testing a commercial scale,
second generation Bion System as a modification or retrofit to a waste lagoon
on a 1,250 milking cow dairy farm in Texas known as the DeVries Dairy.  In
December 2004, Bion published an independently peer-reviewed report, a copy
of which may be found on our website, www.biontech.com, with data from the
DeVries project demonstrating a reduction in nutrients (nitrogen and
phosphorus) of approximately 75% and air emissions of approximately 95%.
More specifically, those published results indicated that on a whole farm
basis, the Bion System produced a 74% reduction of nitrogen and a 79%
reduction of phosphorus.  The air results show that the Bion System limited
emissions as follows: (in pounds per 1,400 pound dairy cow per year):



                                     10




     *  Ammonia                         0.20
     *  Hydrogen Sulfide                0.56
     *  Volatile Organic Compounds      0.08
     *  Nitrogen Oxides                 0.17

These emissions represented a reduction from published baselines of 95%-99%.

     The demonstration project at the DeVries Dairy in Texas (which remains
in operation) has also provided Bion with the opportunity to explore
mechanisms to best separate the processed manure into streams of coarse and
fine solids, with the coarse solids supporting generation of renewable energy
and the fine solids potentially becoming the basis of organic fertilizer
products and/or a high protein animal feed ingredients.

     For the past two years, Bion has focused on completing development of
its technology platform and business model.  As such, we have not pursued
near term revenue opportunities such as retrofitting existing CAFO's with our
waste management solutions, because such efforts would have diverted scarce
management and financial resources and negatively impacted our ability to
complete development of an integrated technology platform in support of
large-scale sustainable Integrated Projects. We believe significant retrofit
opportunities exist that may enable us to generate additional future revenue
streams from Bion's technology. However, Bion's management team remains
focused on implementation of its integrated technology platform as the basis
for development of its large-scale Projects, which represents our long-term
strategic goal.

     We currently anticipate that Bion will be the developer and manager of,
and a direct participant in and/or owner of components of, the Projects.  As
such, Bion will:

     *  Locate, secure and develop appropriate sites;

     *  Negotiate agreements with both input providers and in certain
        instances end-product users;

     *  Secure required permits based upon clear standards that establish
        acceptable environmental operating parameters for each component
        of the Integrated Projects;

     *  Manage construction and operation of the Projects; and

     *  Provide its waste treatment services to CAFO operators for a fee
        while producing renewable energy for on-site use (including sale to
        the ethanol plant) and fine solids products for sale.

     In turn, the CAFO operator will use the wet distiller grains from the
ethanol plant as a feed component for the herd at a long-term competitive
price.  The CAFO facilities, which will be subject to permits imposing
standards limiting their emissions and releases, can be owned either by the
CAFO operator or by an independent third party finance source and
subsequently leased to the CAFO operator.  The CAFO operator will be
responsible to provide its herd and operate the CAFO. In some instances, Bion

                                      11




will own direct interests in the CAFO herd, ethanol plant, end-product user
and/or the related facilities in addition to its ownership interest in the
Bion System.

     In June 2006, the Company entered into an agreement with Fair Oaks Dairy
Farm ("FODF") to construct a Bion research facility ("Stage I System") at
FODF.  Bion has been working with FODF since May 2005 for the purpose of
installing a waste treatment facility at FODF that could become the basis for
a future Integrated Project.  The June 2006 agreement contemplates expansion
beyond the initial waste treatment facility.  The Stage I System will
initially be used for testing necessary for: a) finalization of design
criteria for permitting and construction of, and b) optimization of renewable
energy production and utilization for, a full scale Integrated Projects.  We
are currently in negotiations toward an amended agreement with FODF pursuant
to which: a) the Company will construct a commercial scale Bion System
designed to handle the waste stream from approximately 3,500-6,200 milking
cows ("Initial System") at existing FODF facilities in Indiana which will
incorporate and expand the scope of the Stage I System; and b) when the
Initial System has completed start-up phase and demonstrated environmental
results consistent with the DeVries results set forth above, the Initial
System will become the basis of expansion into an Integrated Project at FODF
through development stages including dairy expansion, construction of
additional Bion System modules including renewable energy production and
solids processing facilities and construction of an ethanol plant. It is
anticipated that the amended agreement will be executed during fiscal 2007.
Preliminary engineering, design and site work at FODF has begun pursuant to
the existing agreement and we anticipate commencement of construction during
2007.  We anticipate completion of development of this Integrated Project
during 2008-9.

Acquisition of Centerpoint/Transactions with Centerpoint

     On January 15, 2002, Bion issued 1,900,000 shares of its restricted
common stock, valued at $7.50 per share, to Centerpoint, in exchange for
$8,500,000 in cash and the assignment of claims relating to Centerpoint's
transaction with Aprilia and other rights owned by Centerpoint for total
consideration of $14,250,000.  Immediately upon consummation of the
transaction with Centerpoint, Bion purchased a 57.7% majority interest in
Centerpoint from Centerpoint's Italian parent, OAM, S.p.A. ("OAM") by issuing
100,000 shares of our common stock to OAM, a warrant to purchase an
additional 100,000 shares of common stock valued at $380,000, $3,700,000 of
cash, assignment of a loan receivable valued at $3,263,000 and its rights
acquired under claims receivable acquired from Centerpoint valued at
$2,487,000.

     The agreements required additional Bion shares to be issued to
Centerpoint and OAM if the Company raised equity at a price less than $7.50
per share before the cumulative investment in the Company from unaffiliated
third parties, from the date of this transaction equaled $5 million.  The
number of additional shares to be issued would have been determined through a
formula calculating the additional number of shares Centerpoint and OAM would
have received if the transactions were consummated at the price per share of
the subsequent equity financing.  The Centerpoint transaction also required

                                    12



conversion of $14,256,779 of notes payable (including interest) into
1,900,911 shares of our common stock.  In addition, warrants to purchase
213,263 shares of our common stock had their exercise price decreased to
$7.50 and $6.00.  As described above, if the Company raised equity at a price
less than $7.50 per share, the Company would have needed to issue additional
shares to the former holders of the converted notes as if the notes were
converted into shares of the Company's common stock at the price per share of
the subsequent equity financing.

     The adjustment provisions in these agreements made it impossible for
Bion to raise additional needed funds from the middle of 2002 through
February 2003 (at which time Bion had run out of cash and liquid resources).
This resulted in the financial crisis (and subsequent management turnover and
curtailment of Bion's activities) described below.  These provisions were
finally amended in August 2003 as described below.

     In March 2002, the Company and Centerpoint entered into an agreement
effective January 15, 2002 whereby Centerpoint agreed to pay the Company
$12,000 per month and issued a warrant to purchase 1,000,000 shares of
Centerpoint's common stock at $3.00 per share exercisable until March 14,
2007 for management services, support staff and office space.  In addition,
the Company agreed to advance to Centerpoint funds needed to cure its
delinquencies with the SEC, distribute the Company's common shares to
Centerpoint shareholders, to locate and acquire new business opportunities
and for ongoing expenses.  The Company had no obligation to make any advances
in excess of $500,000.  All funds due the Company were evidenced by a
convertible revolving promissory note, which bore interest at 1% per month,
payable with accrued interest on March 15, 2003.  This date was extendable by
agreement between the Company and Centerpoint.  The Company had the right to
convert, at any time, all or a portion of the amount due under the promissory
note in shares of Centerpoint's common stock at a conversion price of $3.00
per share.

     During March 2003, the Company and Centerpoint entered into an agreement
(amended on April 23, 2003) which forgave sums due from Centerpoint to Bion
(approximately $450,000 at that time) and cancelled the warrants issued by
Centerpoint to Bion in consideration of amending the terms of the January
2002 agreement between Bion and Centerpoint to remove the adjustment
provisions (and other related provisions) described above. The shareholders
of Centerpoint ratified the agreement on August 25, 2003.  Such ratification
enabled Bion to complete an agreement with OAM, S.p.A. on August 27, 2003
that removed the balance of the adjustment provisions.

     Centerpoint delivered the shares of Bion it owned to its shareholders
during January 2004.  Centerpoint now has only nominal assets other than
631,528 Bion shares that it holds in anticipation of future delivery to its
shareholders, of which shares Bion is the "beneficial owner" of approximately
57.7% (approximately 399,011 shares) based on its ownership of Centerpoint.
Centerpoint has declared a dividend of these shares to be distributed if and
when a registration statement covering such shares is declared effective.
When and if Centerpoint delivers the Bion shares to its shareholders, the
Company will cancel the shares it receives and Centerpoint will effectively
be a publicly held shell corporation.

                                    13



Financial and Management Crisis (2003-2005)

     Bion suffered from severe financial difficulties commencing during the
fall of 2002 and, as a result, elected to cease being a reporting company
during January 2004 by filing a Form 15.  These financial difficulties
resulted in the resignation of nearly all of our officers and directors
during February and March of 2003, and the termination of most of our
employees. New management was able to retain our core technical staff, but we
had to drastically curtail our business activities to include only those
activities that were directly needed to complete development and testing of
our second-generation technology as described above. The Company's financial
difficulties resulted primarily from its inability to raise additional funds
due to:

     *  Contractual anti-dilution provisions that were contained in the
        agreements related to the Centerpoint transactions that were
        completed during January 2002, and

     *  Fiduciary breaches by prior control persons of Centerpoint related to
refusing to work with Bion to amend the anti-dilution provisions and
multiple other matters;

which combined to undermine the Company and to prevent any reasonable
financing from being completed by the Company.  See Description of Business,
Risk Factors, "We are currently involved in significant litigation."

     The Company became aware of the negative implications of these anti-
dilution provisions during the summer of 2002 while attempting to structure a
needed financing, which financing attempts ultimately failed in January of
2003.  Management attempted to either find alternative financing methods
which could be reasonably completed and/or negotiate an amendment to amend or
release such provisions. The inability to obtain an agreement to amend these
provisions from the late summer of 2002 through February/March 2003 (and
other related events) caused the Company's financial and management crisis.
After months of negotiations commencing during February 2003, new management
negotiated and executed agreements related to amending such provisions during
late May 2003 and the provisions were finally amended effective August 27,
2003.

      Thereafter, the Company was able to complete several relatively small
financing rounds through Bion Dairy, one of our subsidiaries, during August-
November of 2003 and May-June 2004. These financings enabled the Company to
continue development work on our technology, but our operations were severely
damaged during the period without financing.  Not only did we have to
terminate most of our activities and employees, but also we operated under
such dire financial constraints through 2004 that the Company lost
credibility with its historic vendors, creditors, the financial community and
its existing shareholders and investors.  As a result, the market price for
the Company's stock fell sharply. In order to continue with our business
activities and save the Company, we had to structure interim financing on
extremely dilutive terms which has negatively affected our shareholders and
will probably continue to negatively impact our ability to obtain future
financing on reasonable terms.

                                     14



     On September 30, 2005, the Company, through Bion Dairy, completed a
$1,917,500 placement of convertible debt that caused, in conjunction with the
Company's technical and financial progress, conversion of 100% of Bion
Dairy's convertible debt ($5,239,489, in aggregate, principal and accrued
interest) into 3,847,217 shares of Bion's restricted common stock on that
date.   This closing and conversion marked the completion of Bion's recovery
from the crisis it faced during 2003.

     While we no longer face a severe working capital shortage, we still have
no revenues. The Company will need to obtain additional capital to carry
forward its operations and technology development and to satisfy existing
creditors. There is no assurance the Company will be able to obtain the funds
that it needs to stay in business, complete its technology development or to
successfully develop its business.

Recent Financings

SERIES A, A*, B and B* NOTES OF BION DAIRY

     On August 25, 2003, Bion Dairy closed an initial stage of financing that
consisted entirely of 2003 Series A Secured Convertible Notes ("Series A
Notes") totaling $1,117,500 (including issuance of notes to Chris-Dan, LLC
("Chris-Dan") in consideration of cancellation/exchange of $600,000 of prior
advances from Bright Capital, Ltd. ("Brightcap") (Brightcap and Chris-Dan are
owned by Dominic Bassani, General Manager of Bion Dairy from April 2003
through September 2006 and a now full-time consultant to the Company) and of
$65,000 of prior advances from affiliates of David Mitchell, the former CEO
of Bion).  $65,000 of the Series A Notes were sold to Mark A. Smith, our
President. During November 2003, $400,000 of Series A* Notes were sold to our
affiliate Centerpoint. During April 2004, an additional $165,427.33 of Series
A* Notes were sold to Chris-Dan bringing the total issuance of Series A & A*
Notes to $1,747,927.30. The Series A & Series A* Notes are identical in all
material aspects.

     During the spring of 2004, Bion Dairy sold $785,000 of 2003 Series B
Secured Convertible Notes ("Series B Notes"), including $10,000 to Mark A.
Smith, our President.  On June 30, 2004, Bion Dairy sold $315,000 Series B*
Notes to Centerpoint and $59,172.18 to Chris-Dan (in exchange/cancellation of
prior advances from Brightcap) for a total issuance of $1,159,172.18 of
Series B & Series B* Notes. The Series B and Series B* Notes are identical in
all material aspects.

     At June 30, 2005, the largest holder of the Series A, A*, B and B* notes
was Chris-Dan which owned $974,599.51 original principal of the notes.  The
second largest note holder was Centerpoint which owned $715,000 principal
amount.  Bion owned $75,000 of the notes, which it received from Mark A.
Smith, our President, on May 31, 2004.

     All of these notes were converted as described below.

     Additionally, on May 31, 2004 Mark A. Smith, our President, purchased
$135,000 of convertible promissory notes from the Company for cash
(convertible into our common stock at $1.50 per share) and exchanged his Bion

                                     15




Dairy Series A & Series B Notes (described above) for convertible notes of
the Company with identical conversion prices. All of Mr. Smith's notes were
converted into restricted common stock of the Company (209,997 shares, in
aggregate) on December 31, 2005. Further, Mr. Smith converted $55,000 and
$60,000 of deferred compensation to 50,000 and 30,000 shares of the Company's
restricted common stock on December 31, 2004 and 2005, respectively.

SERIES C NOTES AND CONVERSION OF SERIES A, A*, B, B* & C NOTES OF BION DAIRY

     On September 30, 2005, the Company, through Bion Dairy, completed a
$1,917,500 placement of Series C Notes that caused, in conjunction with the
Company's technical progress and agreements with certain creditors,
conversion of 100% of Bion Dairy's convertible debt ($5,239,489, in
aggregate, principal and accrued interest) into the Company's restricted
common stock on that date according to their terms.  The Series C Notes were
identical to the other Notes in all material respects except for a $2.00
conversion price.

     In conversion of the Series A, A*, B, B*, & C Notes, respectively, the
Company issued 1,381,031, 645,753, 581,883, 274,434 and 964,117 shares of its
restricted common stock including issuance of:

     *  83,340 shares to Bion which have been cancelled as treasury stock
       (from the Series A & Series B Notes acquired from Mr. Smith as
        described above);

     *  691,528 shares to Centerpoint, of which shares Bion is the
        "beneficial owner" of 57.7% (approximately 399,011 shares) based
        on its ownership of Centerpoint.  Centerpoint has declared a
        dividend of these shares. When and if Centerpoint delivers shares
        to its shareholders, the Company will cancel the shares it
        receives upon receipt;

     *  1,005,692 shares to Chris-Dan, of which Dominic Bassani, former
        General Manager of Bion Dairy, is the owner.

DECEMBER 2005 PRIVATE PLACEMENT OF COMMON STOCK

     On December 23, 2005 Bion closed an offering of its restricted common
stock at a price of $4.00 per share that raised net proceeds of $1,136,500.
We also issued 3,750 shares of common stock as commissions in connection with
the financing.

2006 SERIES A CONVERTIBLE PROMISSORY NOTES

     On September 13, 2006, Bion closed an offering of its Series A
Convertible Promissory Notes in the principal amount of $700,000.  The notes
earn interest at the rate of 6%, payable on May 31, 2008, the maturity of the
notes.  All principal and accrued interest under the notes are required to be
converted into common shares of Bion at the rate of $6 per share if the
closing market price of Bion's common stock has been at or above $7.20 per
share for 10 consecutive trading days and the earlier to occur of (i) an
effective registration statement allowing public resale of the shares

                                     16




received upon conversion of the notes or (ii) one year after September 13,
2006.  No conversion may occur unless Bion is a "reporting company" with the
Securities and Exchange Commission pursuant to the Securities Exchange Act of
1934, as amended ("Exchange Act").  The notes may also be converted, in whole
or in part, at the election of the noteholders.

2007 SERIES A CONVERTIBLE PROMISSORY NOTES

     As of March 31, 2007, Bion has sold $700,000 of its 2007 Series A
Convertible Promissory Notes to existing investors.  The notes earn interest
at the rate of 6%, payable on July 1, 2008, the maturity date of the notes.
Principal and accrued interest under the notes is convertible at $4.00 per
share.  Additionally, Mark A. Smith, our President, agreed to accept $151,645
of the Company's 2007 Series A Convertible Notes in exchange for his deferred
compensation for the period from January 1, 2007 through March 31, 2007 and
the Company's promissory note issued on January 1, 2007 for Mr. Smith's
deferred compensation from April 1, 2006 through December 31, 2006.
Salvatore Zizza, Chairman and a Director of Bion's operating subsidiary, Bion
Dairy Corporation, and Bright Capital, Ltd. ("Brightcap"), which provide the
consulting services of Dominic Bassani to the Bion companies, agreed to
accept $379,389 and $455,486, respectively, of the Company's Series A Notes
in exchange for their respective deferred compensation for the period from
January 1, 2007 through March 31, 2007 and the Company's promissory notes
issued on January 1, 2007 for their respective deferred compensation owed by
Bion on December 31, 2006.

Competition

     There are a significant number of competitors in the waste treatment
industry who are working on animal related pollution issues. This competition
is increasing with the growing governmental and public concern focused on
pollution due to CAFO wastes.  Waste treatment lagoons which depend on
anaerobic microorganisms ("anaerobic lagoons")are the most common traditional
treatment process for animal waste on large farms within the swine and dairy
industries.  These lagoons are coming under increasing regulatory pressure
due to associated odor, nutrient management and water quality issues and are
facing possible phase-out in some states.  Although we believe that Bion has
the most economically and technologically viable solution for the current
problems, other alternative (though partial) solutions do exist including,
for example, synthetic lagoon covers (which are placed on the top of the
water in the lagoon to trap the gases), methane digesters (a tank which uses
anaerobic microorganisms to break down the waste to produce methane),
multistage anaerobic lagoons and solids separators (processes which separate
large solids from fine solids).  Additionally, many efforts are underway to
develop and test new technologies.

     Our ability to compete is dependent upon our ability to obtain required
approvals and permits from regulatory authorities and upon our ability to
introduce and market our Systems in the appropriate markets.


                                      17




     There is also extensive competition in the ethanol production, potting
soil, organic soil amendment, fertilizer and organic fertilizer and feed
ingredient markets.  There are many companies that are already selling
products to satisfy demand in the sectors of these markets we are trying to
enter.  Many of these companies have established marketing and sales
organizations and retail customer commitments, are supporting their products
with advertising, sometimes on a national basis, and have developed brand
name recognition and customer loyalty in many cases.

Dependence on One or a Few Major Customers

     We will be dependent upon one or a few major customers.  Our business
model is focused on development of Integrated Projects.  We anticipate
initially developing, owning interests in, and operating only one or a few
fully Integrated Projects commencing during fiscal 2007, and, thereafter,
developing a limited number of Projects at a time.  Thus, at least for the
near future, our revenues will be dependent on a few major Projects or
customers.

Patents

     We are the sole owner of eight United States patents, one Canadian
patent, one patent from Mexica and one New Zealand patent:

     *  U.S. Patent No. 4,721,569, Phosphorus Treatment Process,
        expires April 2007.
     *  U.S. Patent No. 5,078,882, Bioconversion Reactor and System,
        expires March 2010.
     *  U.S. Patent No. 5,472,472, Animal Waste Bioconversion System,
        expires September 2013.
     *  U.S. Patent No. 5,538,529, Bioconverted Nutrient Rich Humus,
        expires August 2014.
     *  U.S. Patent No. 5,626,644, Storm Water Remediatory Bioconversion
        System, expires October   2015.
     *  U.S. Patent No. 5,755,852, Bioconverted Nutrient Rich Humus,
        expires July 2016.
     *  U.S. Patent No. 6,689,274, Low Oxygen Waste Bioconversion System,
        expires November 2020.
     *  U.S. Patent No. 6,908,495, extension of Low Oxygen Waste
        Bioconversion System, expires June 2023.
     *  Canadian Patent No. 1,336,623, Aqueous Stream Treatment Process,
        expires August 2012.
     *  New Zealand Patent No. 526,342, Low Oxygen Organic Waste
        Bioconversion System, expires November 8, 2021.
     *  Mexican Patent No. 240,124, Low Oxygen Organic Waste Bioconversion
        System, expires November 8, 2021.

     On April 15, 2005, we filed a patent application titled "Low Oxygen
Biologically Mediated Nutrient Removal."  The application number is
11/106,751.

                                       18



     On November 3, 2006, we filed a patent application titled "Low Oxygen
Biologically Mediated Nutrient Removal."  The application number is
11/592,513.  On November 3, 2006, we also filed a patent application titled
"Environmentally Compatible Integrated Food and Energy Production System."
The application number is 11/592,511.

     In addition to such factors as innovation, technological expertise and
experienced personnel, we believe that a strong patent position is
increasingly important to compete effectively in the businesses on which we
are focused.  It is likely that we will file applications for additional
patents in the future. There is, however, no assurance that any such patents
will be granted.

     It may become necessary or desirable in the future for us to obtain
patent and technology licenses from other companies relating to technologies
that may be employed in future products or processes.  To date, we have not
received notices of claimed infringement of patents based on our existing
processes or products, but due to the nature of the industry, we may receive
such claims in the future.

     We generally require all of our employees and consultants, including our
management, to sign a non-disclosure and invention assignment agreement upon
employment with us.

Research and Development

     During the year ended June 30, 2006 we expended $3,809,716 (including
non-cash expenditures) and $1,030,717 during the six months ended December
31, 2006 (including non-cash expenditures) on undertaking research and
development related to our technology platform applications in support of
large-scale, economically and environmentally sustainable Integrated
Projects.  Bion's main efforts were directed at further development of our
technology and its applications based primarily on activities at the DeVries
Dairy. In addition, substantial research and development activity was focused
on design and refinement of all aspects of the technology and integration
engineering related to the energy balances, renewable energy production and
on-site utilization, related to Integrated Project issues and our business
model.  Research activities have focused on factors related to coarse solid
recovery, drying and use for renewable energy production, as well as fine
solids recovery, drying and utilization as fertilizer and/or animal feed.
On-going research related to reduction of nutrient releases and gaseous
emissions from CAFO waste streams also took place at the DeVries dairy
facility and elsewhere.

     During the year ended June 30, 2005, we expended $1,212,531 (including
non-cash expenditures) conducting research and development on similar matters
as described for the periods during 2006 above.

Environmental Protection/Regulation

     In regard to development of Projects, we will be subject to extensive
environmental regulations related to CAFO's and ethanol production.  To the
extent that we are a provider of systems and services to others that result

                                      19



in the reduction of pollution, we are not under direct enforcement or
regulatory pressure.  However, we are involved in CAFO waste treatment and
are impacted by environmental regulations in at least four different ways:

     *  Our marketing and sales success depends, to a substantial degree,
        on the pollution clean-up requirements of various governmental
        agencies, from the Environmental Protection Agency (EPA) at
        the federal level to state and local agencies;

     *  Our System design and performance criteria must be responsive to
        the changes in federal, state and local environmental agencies'
        effluent and emission standards and other requirements;

     *  Our System installations and operations require governmental permit
        approvals in many jurisdictions; and

     *  To the extent we own or operate Integrated Projects including
        CAFO facilities and ethanol plants, those facilities will be
        subject to environmental regulations.

Employees

     As of March 31, 2007, we had 11 employees and consultants, all of whom
are full-time except for Jere Northrop, our Senior Technology Director, who
works for the Company on a part-time basis.  Our future success depends in
significant part on the continued service of our key technical and senior
management personnel.  The competition for highly qualified personnel is
intense, and there can be no assurance that we will be able to retain our key
managerial and technical employees or that we will be able to attract and
retain additional highly qualified technical and managerial personnel in the
future.  None of our employees is represented by a labor union, and we
consider our relations with our employees to be good.  None of our employees
is covered by "key person" life insurance.

RISK FACTORS

WE ARE AN EARLY STAGE COMPANY.

     We have had no System sales since late 2001 when we ceased marketing our
first generation animal waste processing systems. Therefore, our Financial
Statements show no operating revenue for the relevant periods. Since 2001,
the Company has focused its activities on developing, testing and
demonstrating the next generation of its technology and developing its
business model.  Although the Company has developed its integration model, it
has not yet implemented its model by development, construction or operation
of an Integrated Project.  The Company has had no significant sales or
revenues while it has been in this technology re-development stage and has
accrued substantial losses to date.

     Further, potential investors should be aware of the difficulties faced
by a new enterprise, especially in view of the intense competition from
existing and more established companies in the wastewater, waste management,
environmental control, CAFO, alternative energy and soils products
industries. During the past several years we curtailed our commercial
operations to focus on research and development activities associated with

                                      20



our second-generation System and our potential development of Integrated
Projects. Consequently, we have very little relevant history of commercial
operations and we have never achieved any significant revenues.

     Additionally, potential investors should be aware that Bion has never
developed an Integrated Project and does not have the financial resources to
do so at this date.  Further, to the best of our knowledge no one has ever
developed and operated an economically and environmentally sustainable
CAFO/renewable energy/ethanol Integrated Project with either the size or
scope of integration contemplated by the Company.

WE HAVE INCURRED SUBSTANTIAL LOSSES AND MAY NEVER ACHIEVE PROFITABILITY.

     From inception to date, neither Bion nor its subsidiaries have sustained
any profitable operations. As set forth in the Financial Statements, during
the years ended June 30, 2006 and 2005, respectively, we had net losses of
$5,173,294 and $2,115,332. Our net loss for the six months ended December 31,
2006 was $1,799,944.  Through December 31, 2006 we have an accumulated
deficit of $71,814,345.

     We are in the process of completing development of applications of our
new generation of technology and expect to commence development of Projects
based on applications of this technology during fiscal 2007. Although we
expect to eventually generate revenues from the sale and/or operation of our
Systems and/or related Projects, the integration opportunities created by
these Systems and the related renewable energy and/or by-products, and
pollution reduction credits to pay our future operating expenses, there can
be no assurance that profitable operations will ever be achieved or
sustained. We are still dependent upon infusions of capital from investors
and proceeds from loans to enable us to continue in business. We believe that
we will not generate sufficient operating cash flow to meet our needs in the
near term without additional external financing. Although we have recently
signed an engagement letter with a securities firm to act as our financial
advisor and placement agent, there is no assurance that our efforts to obtain
such financing will be successful. Any failure on our part to do so will have
a material adverse impact on us and may cause us to cease operations. In the
event we are unable to achieve sustained profitable operations in the future,
it is likely that any investment in our shares or other securities will
ultimately be lost.

GOING CONCERN OPINION.

     Our financial statements have been prepared assuming that we will
continue in business as a going concern.  As discussed above, we have
previously suffered significant losses.  The report of our independent
registered public accounting firm on the Company's financial statements as of
and for the year ended June 30, 2006 includes a "going concern" explanatory
paragraph which means that the accounting firm expressed substantial doubt
about our ability to continue as a going concern.  Management's plans with
respect to these matters are described in Item 2 and in our financial
statements.  Our financial statements do not contain any adjustments that
might result from this uncertainty.


                                     21




OUR OPERATIONS WILL DEPEND ON THE EFFORTS OF OUR MANAGEMENT TEAM AND OUR
BUSINESS WILL SUFFER IF WE LOSE THE SERVICES OF ANY KEY EMPLOYEES.

     We are completely dependent upon the efforts and abilities of our team
of officers, directors, employees and consultants to manage and operate our
business. We do not currently carry any "key man" life insurance coverage on
any of our key personnel. Although none of our officers or directors has
experience in the management of any profitable entity that has engaged in our
area of business, the loss of the services of any of these persons could have
a material adverse impact on our business, results of operations and
financial condition.

WE NEED TO HIRE ADDITIONAL MANAGEMENT AND TECHNICAL PERSONNEL TO IMPLEMENT
OUR PLANS.

     As we move from the research and development of our technology to
implementation of our plans to develop Integrated Projects, we must continue
to hire operational management and technical personnel.  While we have hired
Mr. Sal Zizza as Chairman, Mr. Jeremy Rowland as our Chief Operations Officer
and Mr. Jeff Kappel as our Vice-President of Renewables, we must still hire
other management and technical personnel to implement our strategy.  If we
are unable to attract qualified personnel, we may be delayed in the
implementation of our business strategy or we may be unable to implement our
strategy.

WE HAVE NUMEROUS AGREEMENTS WITH RELATED PARTIES THAT COULD CREATE CONFLICTS
OF INTEREST.

     At present we have numerous agreements with related parties.  See Item
7.  Certain Relationships and Related Transactions.  Moreover, we have from
time-to-time entered into various employment, consulting and other agreements
with related parties pursuant to which we have paid these related parties in
cash, stock and/or options. See Item 6.  Executive Compensation.  We believe
that all of these agreements were negotiated on terms at least as favorable
to us as those which could have been obtained from unaffiliated persons;
however, our business, results of operations and financial condition could be
materially adversely affected by conflicts of interest.

OUR TECHNOLOGY HAS BEEN LIMITED TO A FEW POTENTIAL MARKETS AND MAY NOT
ATTRACT ENOUGH CUSTOMERS TO BE SUCCESSFUL.

     Our current generation technology platform to date has been re-developed
and tested only for dairy applications and has not yet been expanded into
other markets such as beef feedlots, hogs or poultry. We have not yet
completed the development of all of the System applications that will be
necessary to address targeted markets and geographic areas and we anticipate
a continuing need for the development of additional applications. Further,
there will be extensive design and planning work needed to implement the
integration opportunities created by our technology to successfully develop
Integrated Projects. During both our current and recent fiscal years, we have
continuously made a substantial investment in developing our new generation
technology and related integration business model.  Although we believe that

                                       22



our existing technology is sufficient to support development of the Projects
and additional commercial applications, no assurance can be given that new
applications can be developed or that existing or new applications will
achieve commercially viable sales levels.

     We have not conducted formal market studies with respect to our
technology and services. We anticipate that achieving any significant degree
of market acceptance for our Systems and products will require substantial
marketing efforts and significant expenditures to inform regulators,
potential customers, and potential industry partners of the distinctive
characteristics and benefits of our products and the Projects. We cannot give
any assurances that our targeted customers will accept our proposed products.
We also cannot give any assurance that we will ever realize substantial
revenues from the sale of our Systems or through development and operation of
Projects.

WE FACE INTENSE COMPETITION THAT COULD ADVERSELY AFFECT OUR FINANCIAL
PERFORMANCE.

     Although we believe that our technology offers many significant
advantages over other competing technologies and systems as to both
environmental clean-up of CAFO waste streams and the integration
opportunities it creates, competition in these industry sectors is intense.
We are in direct competition with local, regional and national engineering
and environmental consulting firms and soils products companies. Some of our
competitors may be capable of developing soils products or waste and
wastewater treatment systems similar to ours or based on other competitive
technologies. Many of our potential competitors are well established and have
much greater financial and other resources than we do.

OUR SYSTEMS COULD BECOME OBSOLETE AND WE MAY NOT BE ABLE TO KEEP UP WITH
CHANGES IN TECHNOLOGY.

     Our business is susceptible to changing technology. Although we intend
to continue to develop and improve our Systems, there is no assurance that
funds for such expenditures will be available or that our competitors will
not develop similar or superior capabilities.

OUR PATENT AND TRADE SECRET PROTECTION EFFORTS MAY NOT BE ADEQUATE TO PROTECT
OUR TECHNOLOGY.

     While we have protection from 8 U.S. patents, 3 foreign patents and 3
patents pending, and we intend to develop and file additional patent
applications and to obtain other appropriate protection for our technology,
including the use of nondisclosure contract provisions and license
arrangements which prohibit the disclosure of our proprietary processes,
there can be no assurance that we can effectively protect against
unauthorized duplication of our patents or the introduction of substantially
similar products. Our ability to compete with other companies is materially
dependent upon the proprietary nature of our patents and technologies. We
cannot give assurances that we will be able to obtain any additional key
patents or other protection for our technology. In addition, if any of our
key patents or proprietary rights were invalidated, there could be an adverse
effect on our business, results of operations and financial condition.

                                       23



OUR BUSINESS IS AFFECTED BY GOVERNMENT REGULATIONS THAT CHANGE.

     To date, we have been a provider of technology, Systems and services
that result in the reduction of pollution and, therefore, we have not been
under direct enforcement or regulatory pressure. However, if and when
Integrated Projects have been constructed and begin operation, we may be
under direct enforcement.

     We are involved in waste and wastewater treatment and are impacted by
environmental regulations in at least three different ways: (1) our marketing
and sales success depends, to a substantial degree, on the pollution clean-up
requirements of various governmental agencies, from the Environmental
Protection Agency at the federal level to state and local agencies; (2) our
System design and performance criteria must be responsive to the changes in
federal, state and local environmental agencies' effluent standards and other
requirements; and (3) our System installations and operations require
governmental permits or approvals in many jurisdictions. In addition, we
depend on the varying strictness of enforcement policies of various
governmental bodies.

     We also intend to manufacturer and provide soil amendments (soil
additives which are high in organic matter but low in nutrients) and
fertilizers. Some state and federal regulatory agencies have standards that
these products must meet to be sold as soil amendment or fertilizer products
in various markets. The production and sales of our fertilizer products will
need to meet relevant federal and state requirements. These regulations can
change which creates a level of unpredictability.

ADDITIONALLY, ETHANOL PRODUCTION IN PROJECTS WILL BE SUBJECT TO NUMEROUS
REGULATIONS.

     We are continually reviewing current regulations and potential changes
that may affect our business and are making necessary compliance efforts in
all jurisdictions in which we do business. We believe that Bion's technology
will allow compliance with both current and proposed federal, state and local
regulations. We are in the business of helping our customers (including
Projects and facilities in which we may become direct participants) solve
problems associated with their discharge of their waste streams into the
environment, and most of our Systems and services are subject to federal,
state and local government regulation, and many are subject to extensive
testing procedures. The effects of rulings of regulatory bodies and courts
could delay our marketing efforts for a long time and ultimately could
prevent the completion of Projects. The regulations pertaining to the
environment that may impact our Systems and Projects are continually
changing. While we believe that such regulatory changes are favorable to our
business since such regulations may require the use of our Systems, there can
be no assurance that, in the future, such regulations will not cause us
additional economic expense or have a materially adverse effect on our
business, results of operations and financial condition.





                                      24



WE ARE CURRENTLY INVOLVED IN SIGNIFICANT LITIGATION.

     Bion, our President Mark A. Smith and Bion Dairy are defendants in a
class action/derivative action lawsuit in Delaware Chancery Court (TCMP#3
Partners, LLP, et al v. Trident Rowan Group, Inc., et al, Civil Action No.
170-N).  The claims against the Company primarily relate to the January 2002
transaction with Centerpoint.  The Plaintiffs basically allege in multiple
claims denoted as fraudulent and negligent misrepresentation, promissory
estoppel, and corporate waste, that Bion breached its fiduciary duties to
Centerpoint and its shareholders and/or aided and abetted others in breaching
their duties and was unjustly enriched as a result of these actions.
Further, the plaintiffs allege that Bion, Bion Dairy and Mr. Smith breached
their duties to Centerpoint and its shareholders in connection with
Centerpoint's investments in Series A* and Series B* Notes of Dairy.  This
litigation is in the early stages of discovery and motion practice.
Settlement discussions are under way at the present time and the parties have
participated in voluntary, non-binding mediation to attempt to resolve the
disputed matters, which mediation has led to a contingent settlement
agreement.  This agreement is contingent on settlement of the matter
described in the paragraph below. If a reasonable settlement is not reached
in the matter described below and, if this contingent settlement is not
completed, the Company, Bion Dairy and Mr. Smith intend to vigorously defend
the claims against them.  Management believes that the claims against Bion,
Bion Dairy and Mr. Smith are without merit and that such parties will prevail
if the litigation eventually proceeds to trial.  However, litigation costs
(of which a substantial amount has already been expended) can have a material
adverse effect on companies the size of Bion and Bion Dairy.  Therefore, if a
reasonable settlement can be negotiated, Bion and Bion Dairy may enter into
such a resolution of the litigation.

     Additionally, the Company has drafted (on behalf of itself and
Centerpoint and Bion's shareholders) a complaint against the former
controlling shareholders and related persons of Centerpoint for damages
related to the Company's financial crisis, which were caused by their
breaches of their fiduciary duties to Bion, Centerpoint and their
shareholders.  The potential defendants have executed tolling agreements
through 30 days after the failure of the settlement in principle and the
litigation has not yet been commenced while the parties engage in settlement
discussions. Extended settlement discussions have taken place related to
these matters and agreements in principle have been reached (subject to due
diligence inquiries, drafting and execution of definitive agreements, and
court approvals).  If these settlements are concluded on terms similar to
those under discussion, Bion will be making no payments. Rather, Bion and
Centerpoint and the Bion shareholder class will be receiving substantial
asset transfers and Bion and Centerpoint will receive cash sufficient to
offset a large part of the portion their attorneys' fees expended to date (in
these two related matters) that have not been reimbursed by insurance
carriers. However, there is as yet no assurance that these settlements will
successfully be concluded.

     On May 6, 2002, Arab Commerce Bank Ltd. ("ACB"), an unaffiliated party,
filed a complaint against the Company in the Supreme Court of the State of
New York regarding $100,000 of the Company's convertible bridge notes ("ACB
Notes") that were purchased by ACB in March of 2000.  The complaint includes
a breach of contract claim asserting that the Company owes ACB $265,400 plus

                                      25



interest or $121,028 including interest based on ACB's interpretation of the
terms of the ACB Notes and subsequent amendments.  Effective June 30, 2001,
the Company issued ACB 5,034 shares of common stock in full payment of its
ACB Note based on the Company's interpretation of the ACB Note, as amended.
The Company has filed an answer to the complaint denying the allegations. No
activity has taken place in this lawsuit since 2002. The Company believes
that the ultimate resolution of this litigation will not have a material
adverse effect on the Company, its operations or its financial condition.

WE FACE RISKS OF LITIGATION RESULTING FROM IMPROPER OPERATION OF OUR SYSTEMS.

     In order for our waste and wastewater treatment Systems to function
properly, the Systems must be operated in accordance with our specifications.
In the event that our Systems are not operated properly and environmental
violations or other problems occur as a result, it is possible that we could
be named as a defendant in litigation brought by governmental agencies and/or
individuals. Such litigation could seek, among other things, damages,
equitable remedies, punitive damages and penalties. In fact, we were named as
a defendant, along with the owners of one of our first generation Systems, in
such an action filed by the Attorney General of the State of Illinois
alleging environmental violations associated with the operation of a hog
farm. While we were able to settle that litigation for approximately $9,000,
there can be no assurance that similar litigation will not occur in the
future. Litigation of this nature could damage our reputation.

     While it is our intention to operate or supervise operation of our
second-generation Systems in a manner that precludes such improper operation,
there is no assurance that we will be successful in this endeavor.

WE DO NOT CARRY ADEQUATE INSURANCE IN THE EVENT OF SIGNIFICANT ENVIRONMENTAL
LITIGATION.

     We do not have insurance coverage with respect to the risks of
litigation discussed above.  Presently we carry only nominal amounts of
insurance coverage to cover relatively standard business risks. Management
believes such coverage to be adequate for our current operations. It is
possible, however, that circumstances might potentially exist that could
cause us to be held liable for damage to the environment, such as the
negligent design of a System resulting in the aggravation of an existing
wastewater problem. We could also be subject to liabilities resulting from
other business risks in excess of our current policy amounts. Any such
liability, if imposed, could be substantial and would, in all likelihood,
have an adverse effect on our business, results of operations and financial
condition. Additionally we intend to participate as a principal in Integrated
Projects and, therefore, may be exposed to damages for which we do not have
adequate insurance in those activities.

RESALES OF OUR PREVIOUSLY RESTRICTED SECURITIES COULD HURT THE MARKET PRICE
OF OUR STOCK.

     Of our 8,757,904 shares of Common Stock currently outstanding, 5,960,286
shares are "restricted securities" which may in the future be sold upon
compliance with Rule 144 adopted under the Securities Act of 1933, as
amended. Generally, Rule 144 provides that a person holding restricted

                                     26



securities for a period of at least one year may sell every three months, in
brokerage transactions, an amount equal to the greater of one percent of our
outstanding shares of Common Stock or the average weekly reported volume of
trading for the securities provided the Company is current on its periodic
reports. There is no limitation on the amount of restricted securities that
may be sold by a person who has been the beneficial owner of such restricted
securities for more than two years, and has not been an "affiliate" for at
least 90 days prior to the date of such sales. Investors should be aware that
such sales under Rule 144 may cause the price of our Common Stock to drop in
the future.

CONVERSION OF OUTSTANDING CONVERTIBLE OBLIGATIONS, EXERCISE OF WARRANTS AND
OPTIONS AND CONTINGENT STOCK BONUSES WILL DILUTE OUR CURRENT SHAREHOLDERS.

     The future conversion to stock of outstanding obligations for
convertible debt and deferred compensation, possible future exercise of
warrants and options, and outstanding contingent stock bonuses will result in
a significant reduction in the respective percentage interests and voting
power held by our shareholders, other than those participating in the
conversions, exercises and bonuses. As of March 31, 2007 we are indebted to
Mark A. Smith, our President, in the amount of $396,094 (represented by a
promissory note) for deferred compensation, which amount is convertible into
our common stock at the lower of the current market value at the time of
conversion or $2.00 per share.  As of March 31, 2007, we are also indebted to
Bright Capital, Ltd. ("Brightcap") for services provided to the Company by
Dominic Bassani in the amount of $541,690 (represented by a promissory note)
with the same conversion feature.  Additionally, we are indebted to each of
Messrs. Smith and Zizza and Brightcap in the amounts of $151,646, $379,389
and $455,486 respectively pursuant to our 2007 Series A Promissory Notes,
which are convertible into our common stock at $4.00 per share.  In addition,
as of March 31, 2007 we have warrants outstanding to purchase 3,684,010
shares of our common stock at prices ranging from $1.00 to $5.00.  As of
March 31, 2006 we have also issued 1,745,833 options to purchase our common
stock, of which 1,089,167 are currently exercisable at prices ranging from
$2.00 to $7.50. Additionally, contingent stock grants have been made totaling
690,000 shares to employees of and consultants to the Company which vest if
and when the Company's stock price exceeds $10.00 (492,500 shares) and $20.00
(197,500 shares) per share if the grantee is still providing services to the
Company on such dates. Further, we expect to issue additional shares of our
Common Stock, warrants and options in connection with engaging further
employees or consultants and future financings.

OUR PRIOR FINANCINGS HAVE BEEN SUBSTANTIALLY DILUTIVE AND MAY CONTINUE TO
AFFECT OUR ABILITY TO RAISE CAPITAL.

     The Company was contractually obligated to respect significant anti-
dilution provisions during 2002 which limited its ability to obtain
financing.  We were unable to correct these anti-dilution provisions until
August 2003.  Thereafter, the Company was able to complete several relatively
small financing rounds through Bion Dairy, one of our subsidiaries, during
August-November of 2003 and May-June 2004. These financings enabled the
Company to continue development work on our technology, but our operations

                                      27



were severely damaged during the period without financing.  Not only did we
have to terminate most of our activities and employees, but also we operated
under such dire financial constraints through 2004 that the Company lost
credibility with its historic vendors, creditors, the financial community and
its existing shareholders and investors.  As a result, the market price for
the Company's stock fell sharply. In order to continue with our business
activities and save the Company, we had to structure interim financing on
extremely dilutive terms which has negatively affected our shareholders and
will probably continue to negatively impact our ability to obtain future
financing on reasonable terms.

WE DO NOT EXPECT TO PAY DIVIDENDS.

     We have never paid any cash dividends on any class of stock in the past.
Due to our present financial status and our contemplated financial
requirements, we do not anticipate paying any cash dividends upon any class
of stock in the immediately foreseeable future.

THE MARKET FOR OUR COMMON STOCK IS VERY LIMITED AND MAY NOT BE MAINTAINED.

     Our common stock currently trades "over-the-counter" on the "Pink
Sheets."  Upon our registration under the Exchange Act, we hope that our
stock will be traded over the counter on the OTC Bulletin Board.  However,
there is currently only an extremely limited and thin trading market in our
Common Stock, and there is no assurance that it will continue or that any
active trading market will develop or be sustained if developed.

THE MARKET FOR OUR COMMON STOCK IS ADVERSELY AFFECTED BY THE "PENNY STOCK"
RULES.

     Our Common Stock is currently defined as a "penny stock" under the
Exchange Act and rules of the SEC. The Exchange Act and such penny stock
rules generally impose additional sales practices and disclosure requirements
on broker-dealers who sell our securities to persons other than "accredited
investors" or in transactions not recommended by the broker-dealer. For
transactions covered by the penny stock rules, the broker-dealer must make a
written suitability determination for each purchaser and receive the
purchaser's written agreement prior to the sale. In addition, the broker-
dealer must make certain required disclosures in penny stock transactions,
including the actual sale or purchase price and actual bid and offer
quotations, and the compensation to be received by the broker-dealer and
certain associated persons, provide monthly account statements showing the
market value of each penny stock held in a customer's account, and deliver
certain standardized risk disclosures required by the SEC. Consequently, the
penny stock rules affect the ability of broker-dealers to make a market in or
trade our shares and may also affect the ability of purchasers of shares to
resell those shares in the public market.

NASD SALES PRACTICE REQUIREMENTS ADVERSELY AFFECT THE MARKET FOR OUR COMMON
STOCK.

     In addition to the "Penny Stock" rules described above, the NASD has
adopted rules that require that, in recommending an investment to a customer,
a broker-dealer have reasonable grounds for believing that the investment is

                                      28



suitable for that customer. Prior to recommending speculative low priced
securities to their non-institutional customers, broker-dealers must make
reasonable efforts to obtain information about the customers' financial
status, tax status, investment objectives and other information. Under
interpretations of these rules, the NASD believes that there is a high
probability that speculative low priced securities will not be suitable for
at least some customers. The NASD requirements make it more difficult for
broker-dealers to recommend that their customers buy our Common Stock, and
this has an adverse effect on the market for our shares.

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.

     Included in Part F/S are the audited Consolidated Financial Statements
for the fiscal years ended June 30, 2006 and 2005 and the unaudited
Consolidated Financial Statements of the Company for the three and nine
months ended March 31, 2007 ("Financial Statements").

     Statements made in this Amendment No. 4 to Form 10-SB that are not
historical or current facts, which represent the Company's expectations or
beliefs including, but not limited to, statements concerning the Company's
operations, performance, financial condition, business strategies, and other
information, involve substantial risks and uncertainties.  The Company's
actual results of operations, most of which are beyond the Company's control,
could differ materially.  These statements often can be identified by the use
of terms such as "may," "will," "expect," "believe," anticipate," "estimate,"
or "continue" or the negative thereof.  We wish to caution readers not to
place undue reliance on any such forward looking statements, which speak only
as of the date made.  Any forward looking statements represent management's
best judgment as to what may occur in the future.  However, forward looking
statements are subject to risks, uncertainties and important factors beyond
our control that could cause actual results and events to differ materially
from historical results of operations and events and those presently
anticipated or projected.

     These factors include adverse economic conditions, entry of new and
stronger competitors, inadequate capital, unexpected costs, failure to gain
product approval in the United States or foreign countries and failure to
capitalize upon access to new markets.  Additional risks and uncertainties
that may affect forward looking statements about Bion's business and
prospects include the possibility that a competitor will develop a more
comprehensive or less expensive environmental solution, delays in market
awareness of Bion and our Systems, or possible delays in Bion's development
of Projects and failure of marketing strategies, each of which could have an
immediate and material adverse effect by placing us behind our competitors.
Bion disclaims any obligation subsequently to revise any forward looking
statements to reflect events or circumstances after the date of such
statements or to reflect the occurrence of anticipated or unanticipated
events.

     The following discussion and analysis should be read in conjunction with
the Consolidated Financial Statements and Notes to Consolidated Financial
Statements filed with this Report.

                                      29




BUSINESS OVERVIEW

     The Company is currently focused on completion of the development of its
second-generation technology which provides solutions for environmentally
sound clean-up of the waste streams of large-scale CAFO's and creates
economic opportunities for integration of renewable energy production,
ethanol production, sustainable animal husbandry and organic soil/fertilizer
and feed production.  We believe our technology will also allow development
of Projects that can also directly integrate with dairy (and other CAFO) end-
users and that can potentially increase profitability and quality control of
each participant while mitigating the environmental impact of the entire
integrated complex.  The Company is in the process of finalizing engineering,
design and economic modeling for applications and Integrated Projects and
expects to select the site for and commence development of its initial
Integrated Project during its 2007 fiscal year.

     The financial statements for the years ended June 30, 2006 and 2005 have
been prepared assuming the Company will continue as a going concern.  The
Company has incurred net losses of approximately $5,173,000 and $2,115,000
during the years ended June 30, 2006 and 2005, respectively.  At June 30,
2006, the Company had a working capital deficiency and a stockholders'
deficit of approximately $1,000 and $3,278,000, respectively.  The financial
statements for the nine months ended March 31, 2007 and 2006 have also been
prepared assuming the Company will continue as a going concern.  The Company
has incurred net losses of approximately $1,884,000 and $3,565,000 during the
nine month periods ended March 31, 2007 and 2006, respectively.  At March 31,
2007, the Company has a working capital deficiency and a stockholders'
deficit of approximately $582,000 and $4,152,000, respectively.  The report
of the independent registered public accounting firm on the Company's
financial statements as of and for the year ended June 30, 2006 includes a
"going concern" explanatory paragraph which means that the accounting firm
has expressed substantial doubt about the Company's ability to continue as a
going concern.  Management's plans with respect to these matters are
described in this section and in our financial statements, and this material
does not include any adjustments that might result from the outcome of this
uncertainty.  There is no guarantee that we will be able to raise the funds
or raise further capital for the operations planned in the near future.

CRITICAL ACCOUNTING POLICIES

     Management has identified the following policies below as critical to
our business and results of operations.  Our reported results are impacted by
the application of the following accounting policies, certain of which
require management to make subjective or complex judgments.  These judgments
involve making estimates about the effect of matters that are inherently
uncertain and may significantly impact quarterly or annual results of
operations.  For all of these policies, management cautions that future
events rarely develop exactly as expected, and the best estimates routinely
require adjustment.   Specific risks associated with these critical
accounting policies are described in the paragraphs below.






                                       30




Revenue Recognition

     While the Company has not recognized any operating revenues for the past
two fiscal years, the Company anticipates that future revenues will be
generated from product sales, technology license fees, annual waste treatment
fees and direct ownership interests in Integrated Projects.  The Company
expects to recognize revenue from product sales when there is persuasive
evidence that an arrangement exists, when title has passed, the price is
fixed or determinable, and collection is reasonably assured.  The Company
expects that technology license fees will be generated from the licensing of
Bion's Systems.  The Company anticipates that it will charge its customers a
non-refundable up-front technology license fee, which will be recognized over
the estimated life of the customer relationship.  In addition, any on-going
technology license fees will be recognized as earned based upon the
performance requirements of the agreement. Annual waste treatment fees will
be recognized upon receipt. Revenues, if any, from the Company's interest in
Projects will be recognized when the entity in which the Project has been
developed recognizes such revenue.

Compensation Cost for Options with Service Conditions and Graded Vesting
Schedules

     The Company has issued non-employee options that include service
conditions and have graded vesting schedules.  Generally for these
arrangements, the measurement date of the services occurs when the options
vest.  In accordance with Emerging Issues Task Force Issue No. 96-18,
recognition of compensation cost for reporting periods prior to the
measurement date is based on the then current fair value of the options.
Fair value of the options is determined using a Black-Scholes option-pricing
model.  Any subsequent changes in fair value will be recorded on the
measurement date.  Compensation cost in connection with options that are not
fully vested is being recognized on a straight-line basis over the requisite
service period for the entire award.

Stock-based compensation

     On July 1, 2006, the Company adopted the provisions of Statement of
Financial Accounting Standards ("SFAS") No. 123 (Revised), "Share-Based
Payment" (SFAS 123(R)), which supercedes Accounting Principles Board Opinion
No. 25 ("APB 25"), and generally requires that share-based compensation
transactions be accounted and recognized in the statement of income based on
their fair values.  The Company adopted SFAS 123(R)using the modified
prospective application under which all share based awards granted on or
after the adoption date and  modifications, repurchases or cancellation of
prior awards made after the adoption date shall be accounted for under SFAS
123(R).  The modified prospective application does not require the Company to
restate prior period's financial results to reflect the adoption.  Pro forma
disclosure for prior period issuances of share based grants have been made in
the notes to the financial statements and the Company has used the Black-
Scholes option pricing model for determining fair value of stock options
granted.  As of March 31, 2007 the Company had $799,000 of unrecognized
compensation cost related to stock options that will be recorded over a
weighted average period of approximately 3 years.


                                      31



Cumulative Effect of Change in Accounting Principle

     In accordance with SFAF 123(R), outstanding instruments previously
classified as liabilities and measured at intrinsic values, are to be
measured initially at fair value with differences to be recorded as a
cumulative effect of a change in accounting principle.  The Company recorded
the cumulative effect of a change in accounting principle of $731,000 due to
the calculation of the fair value of convertible deferred compensation owed
Mark Smith ($1,522,000) and Brightcap ($2,081,475) as of July 1, 2006.  The
Company will re-measure the fair value of the convertible notes at each
reporting period after July 1, 2006, using a Black-Scholes model approach,
and record any adjustments as non-cash compensation expense in the re-
measurement period.  At March 31, 2007, the fair value of deferred
compensation owed Mark Smith and Brightcap was re-measured at $871,000 and
$1,192,000, respectively and resulted in a credit to earnings of $802,000 and
$1,580,000 for the three and nine months ended March 31, 2007, respectively.



RESULTS OF OPERATIONS - THREE MONTHS ENDED MARCH 31, 2007 COMPARED TO THREE
MONTHS ENDED MARCH 31, 2006

General and Administrative

     General and administrative expenses were ($59,000) for the three months
ended March 31, 2007 versus $348,000 for the three months ended March 31,
2006.  The decrease in general and administrative expenses of $407,000 was
partially due to a credit to non-cash compensation expense to re-measure the
President's convertible deferred compensation for the three months ended
March 31, 2007 of $(339,000) versus $234,000 to record the intrinsic value of
the liability for the three months ended March 31, 2006.  The decrease in
non-cash compensation was primarily due to: a) the Company's adoption of SFAS
123(R) which measures the fair value of the convertible feature of the
liability, versus valuing under the intrinsic value method, and b) the
decrease in the price of the Company's common stock from $5.75 to $3.90 per
share for the three months ended March 31, 2007 compared to an increase from
$4.00 to $4.75 per share for the three months ended March 31, 2006.
Offsetting the lower non-cash compensation costs during the three months
ended March 31, 2007, were higher rent costs of $33,000 due to the Company
obtaining office space in New York effective August 1, 2006.  Accounting and
tax expenditures were $44,000 higher during the three months ended March 31,
2007 due to income tax preparation, work performed for the December 31, 2006
10QSB and responses to a Securities and Exchange Commission comment letter on
the Company's Form 10-SB.  The Company also recorded non-cash compensation
expense relating to options for the three months ended March 31, 2007 of
$58,800.

Research and Development

     Research and development expenses decreased from $1,021,000 for the
three months ended March 31, 2006 to $104,000 for the three months ended
March 31, 2007.   Non-cash compensation (credit) expense of $(463,000) and
$206,000 for the three months ended March 31, 2007 and 2006, respectively,
was recorded to re-measure the fair value and to recognize the intrinsic
value of Brightcap's convertible deferred compensation at March 31, 2007 and
2006, respectively, due, in part, to the decrease in the price of the
Company's common stock from $5.75 to $3.90 per share for the three months
ended March 31, 2007 compared to the increase from $4.00 to $4.75 per share

                                   32


in the three months ended March 31, 2006.  With the Company's adoption of
SFAS 123R during its fiscal year 2007, other non-cash compensation expense of
$82,000 was recognized during the three months ended March 31, 2007 for
options issued to research and development employees, while no similar
expense was recognized during the same period in the prior year.  Salaries
and related payroll tax expense for the three months ended March 31, 2007 and
2006 was $198,000 and $128,000, respectively.  The increase in salaries and
payroll taxes was due to the addition of two members to the management team
in the three months ended March 31, 2007.  Bonuses of $170,000 to research
and development employees and a consultant were also recorded in the three
months ended March 31, 2007.

Loss from Operations

     As a result of the factors described above, the loss from operations for
the three months ended March 31, 2007 and 2006 was $45,000 and $1,369,000,
respectively.

Other Expense

     Other expense for the three months ended March 31, 2007 and 2006 was
$39,000 and $10,000, respectively.  Interest expense during the three months
ended March 31, 2007 was $44,000 compared to $21,000 for the same period in
the prior year.  The increase in interest expense is due to the 2006 Series A
notes and higher interest on deferred compensation balances during the three
months ended March 31, 2007.

Net Loss

     As a result of the factors described above, the net loss for the three
month period ended March 31, 2007 and 2006 was $84,000 and $1,379,000,
respectively, a decrease of $1,295,000.  The net loss per common share also
decreased by $0.15 from $0.16 for the three months ended March 31, 2006 to
$0.01 for the same period in 2007.

RESULTS OF OPERATIONS - NINE MONTHS ENDED MARCH 31, 2007 COMPARED TO NINE
MONTHS ENDED MARCH 31, 2006

General and Administrative

     General and administrative expenses were ($59,000) for the nine months
ended March 31, 2007 versus $873,000 for the nine months ended March 31,
2006.  The primary factor in the decrease in general and administrative
expenses is a decrease in non-cash compensation expense of $1,181,000
relating to the President's convertible deferred compensation resulting from
the adoption of SFAS 123(R) and the decrease in the price of the Company's
common stock from $6.40 to $3.90 per share for the nine months ended March
31, 2007 compared to the increase from the $2.00 per share floor to $4.75 per
share for the nine months ended March 31, 2006.  During the nine months ended
March 31, 2006, the Company recorded non-cash compensation of $514,000 to
record the intrinsic value of the liability.  During the nine months ended
March 31, 2007, the Company adopted SFAS 123(R) which re-measured the
convertible feature on the deferred compensation at fair value which resulted
in a $667,000 credit to non-cash compensation expense.  The remaining general
and administrative expenses not relating to adjustments for the fair value
and intrinsic value of the convertible deferred compensation are $608,000 and

                                      33



$360,000 for the nine months ended March 31, 2007 and 2006, respectively.
Rent expense was $107,000 higher for the nine month period ended March 31,
2007 due to the office lease in New York City which was entered into during
the first quarter of fiscal year 2007.  Accounting and tax services were
higher for the nine months ended March 31, 2007 over the similar period in
the prior year by $126,000 due to work performed on the 2006 fiscal year end
audit, the filing of the Company's Form 10-SB and Form 10QSB for the three
and six months ended December 31, 2006, and the preparation of federal and
state income tax returns for the Company for the 2002 through 2005 tax years.
The Company also recorded non-cash compensation expense of $75,000 relating
to options, due to the adoption of SFAS 123(R) during the nine months ended
March 31, 2007, while during the same period in fiscal year 2006 no expense
was required to be recorded.

     Research and development expenses decreased from $2,681,000 for the nine
months ended March 31, 2006 to $1,135,000 for the nine months ended March 31,
2007.   The majority of the decrease was attributable to a credit to non-cash
compensation expense of ($913,000) and $702,000 for the nine months ended
March 31, 2007 and 2006, respectively, which were recorded to re-measure the
fair value and recognize the intrinsic value of Brightcap's convertible
deferred compensation at March 31, 2007 and 2006, respectively.  The
decrease, in large part, is due to the decrease in the price of the Company's
common stock from $6.40 to $3.90 per share compared to the increase from the
$2.00 per share floor to $4.75 for the nine months ended March 31, 2007 and
2006, respectively.  Offsetting the decrease was other non-cash compensation
expense of $367,000 recognized during the nine months ended March 31, 2007
for options issued to research and development employees.  No similar expense
was recognized during the same period in the prior year, as the Company
adopted SFAS 123(R) as of July 1, 2007.  Legal expenses related to research
and development were $132,000 and $50,000 for the nine months ended March 31,
2007 and 2006, respectively, due to extensive patent work being performed
during the nine months ended March 31, 2007.  Salaries and related payroll
taxes increased $118,000 for the nine months ended March 31, 2007 over the
same period in the prior year due to the addition of two members to the
management team, one in April 2006 and one in September 2006, and overall pay
increases to employees.

Loss from operations

     As a result of the factors described above, the loss from operations for
the nine months ended March 31, 2007 decreased $2,478,000, from $3,554,000 to
$1,076,000 for the nine months ended March 31, 2006 and 2007, respectively.

Other Expense

     Other expense was $77,000 and $11,000 the nine months ended March 31,
2007 and 2006, respectively.  Interest expense decreased from $113,000 to
$105,000 for the nine month period ended March 31, 2006 and 2007,
respectively, due to the absence of interest expense on the Dairy notes and
the Series A, B and C notes which were converted during the six months ended
December 31, 2005, which was offset by the interest on the 2006 Series A
Promissory notes during the nine months ended March 31, 2007.  Meanwhile
interest income increased $18,000 during the nine months ended March 31, 2007
compared to the same period in the prior year due to higher average cash
balances.  During the nine months ended March 31, 2006, the Company had other
income of approximately $91,000 from the settlement of debt with third party
vendors.

                                     34



Cumulative Effect of Change in Accounting Principle

     During the nine months ended March 31, 2007, the Company recorded the
cumulative effect of a change in accounting principle of $731,000.

     On July 1, 2006, the Company adopted the provisions of Statement of
Financial Accounting Standards ("SFAS") No. 123 (Revised), "Share-Based
Payment" (SFAS 123(R)), which supersedes APB 25, using the modified
prospective application.  In accordance with SFAF 123(R), outstanding
instruments previously classified as liabilities and measured at intrinsic
values, are to be measured initially at fair value with differences to be
recorded as a cumulative effect of a change in accounting principle.  The
Company recorded the cumulative effect of a change in accounting principle of
$731,000 due to the calculation of the fair value of convertible deferred
compensation owed Mark Smith and Brightcap as of July 1, 2006.  The
cumulative effect of change in accounting principle resulted in a net loss
per common share of $0.08 for the nine months ended March 31, 2007.

Net Loss

     As a result of the factors described above, the net loss was $1,884,000
and $3,565,000 for the nine months ended March 31, 2007 and 2006,
respectively, representing a $0.21 decrease in the net loss per common share
from $0.43 for the nine months ended March 31, 2006 to $0.22 for the same
period in 2007.

LIQUIDITY AND CAPITAL RESOURCES

     As of March 31, 2007, the Company had cash and cash equivalents equal to
$843,264.  During the nine months ended March 31, 2007, net cash used in
operating activities was $1,303,367.  As previously noted, the Company is
currently not generating revenue and accordingly has not generated cash flows
from operations.  The Company does not anticipate generating sufficient
revenues to offset operating and capital costs for a minimum of two to five
years.  While there are no assurances that the Company will be successful in
its efforts to develop and construct its Projects and market its Systems, it
is certain that the Company will require significant funding from external
sources.

Investing Activities

     During the nine months ended March 31, 2007 the Company used $78,623 of
cash for investing activities to purchase property and equipment for the New
York office. In addition, the Company used $171,945 of cash to secure a
guarantee for the office lease obligation.

Financing Activities

     During the nine months ended March 31, 2007, $545,000 and $700,000 of
cash was provided by financing activities resulting from the sale of the 2006
Series A and 2007 Series A convertible promissory notes, respectively.





                                     35



     As of March 31, 2007 the Company has significant debt obligations
consisting primarily of mandatorily convertible notes - affiliates of
$2,063,123, 2006 Series A convertible promissory notes - current of $727,243,
2007 Series A convertible promissory notes - affiliates of $986,521 and 2007
Series A convertible promissory notes of $700,000.  The Company has entered
into an 88-month operating lease for office space in New York, with an
average monthly lease expense of $15,820.

Convertible Notes

     Under the terms of a convertible deferred compensation agreement with
our President that was exchanged for a promissory note and conversion
agreement on April 4, 2006, sums accrued through March 31, 2006 accrue
interest at 6% per annum and are convertible into the Company's common stock
at the lower of the current market value at the time of conversion, or $2.00
per share.  Through July 1, 2007, conversions may occur by mutual agreement
between the Company and the President.  The Company may convert the
promissory note, in whole or part, at any date after July 1, 2007 and the
convertible note owned by the President is mandatorily converted to common
stock of the Company on July 1, 2009. Through June 30, 2006, the Company
accounted for this employee stock-based compensation agreement under APB 25
and recorded the intrinsic value of the deferred compensation agreement at
each reporting date.  On July 1, 2006, the Company adopted the provisions of
SFAS 123(R), which supersedes APB 25.  In accordance with SFAS 123(R),
outstanding instruments previously classified as liabilities and measured at
intrinsic values, are to be measured initially at fair value with differences
to be recorded as the cumulative effect of a change in accounting principle.
The fair value of deferred compensation owed to Mark A. Smith on July 1, 2006
was $1,521,609, and the cumulative effect of the change in accounting
principle of $308,870 was recorded.  Fair value at July 1, 2006 was
calculated using a Black-Scholes option pricing model with the following
assumptions: a dividend yield of zero, a risk-free interest rate of 5.13%,
volatility of 181%,  a remaining contractual life of 3 years and a stock
price of $6.40 per share.  At March 31, 2007 the fair value of deferred
compensation owed to Mark A. Smith was re-measured as $871,405 and resulted
in a credit to earnings of $338,634 and $667,315 for the three and nine
months ended March 31, 2007, respectively.  Fair value at March 31, 2007 was
calculated utilizing the following assumptions: a dividend yield of zero, a
risk-free interest rate of 4.58%, volatility of 66%, a remaining contractual
life of 2.25 years and a stock price of $3.90 per share.  Sums accrued after
April 1, 2006, ($150,000 through March 31, 2007), were converted as of March
31, 2007 into the Company's 2007 Series A convertible promissory notes.  The
President earns compensation of $150,000 annually.  All these sums related to
Mr. Smith's deferred compensation are net of $55,000 and $60,000 of deferred
compensation that was converted to 50,000 and 30,000 shares of the Company's
restricted common stock on December 31, 2004 and 2005, respectively.

     On December 31, 2005, convertible deferred compensation payable to
Brightcap for services provided to the Company by the former general manager
of Bion Dairy between April 1, 2003 and September 30, 2005 was exchanged for
a promissory note which note bears interest at 6% per annum and conversion
agreement pursuant to which all sums accrued through September 30, 2005 are
convertible into the Company's common stock at the lower of the current
market value at the time of conversion or $2.00 per share.  Through January
1, 2007 conversion may occur by mutual agreement between the Company and
Brightcap.  The Company may convert the promissory note, in whole or in part,
at any date after January 1, 2007 and, on July 1, 2009, the promissory note

                                     36


is mandatorily convertible to common stock of the Company. Through June 30,
2006, the Company accounted for this employee stock-based compensation
agreement under APB 25 and recorded the intrinsic value of the deferred
compensation agreement at each reporting date.  On July 1, 2006, the Company
adopted the provisions of SFAS 123(R), which supersedes APB 25.  The fair
value of deferred compensation owed to Brightcap on July 1, 2006 was
$2,081,475, and the cumulative effect of the change in accounting principle
of $422,516 was recorded.  Fair value at July 1, 2006 was calculated using a
Black-Scholes option pricing model with the following assumptions: a dividend
yield of zero, a risk-free interest rate of 5.13%, volatility of 181%, a
remaining contractual life of 3 years and a stock price of $6.40 per share.
At March 31, 2007 the fair value of deferred compensation owed to Brightcap
was re-measured as $1,191,717 and resulted in a credit to earnings of
$463,110 and $913,023 for the three and nine months ended March 31, 2007,
respectively.  Fair value at March 31, 2007 was calculated utilizing the
following assumptions: a dividend yield of zero, a risk-free interest rate of
4.58%, volatility of 66%, a remaining contractual life of 2.25 years and a
stock price of $3.90 per share. Brightcap receives annual compensation of
$300,000 for the full time consulting services of Dominic Bassani with
payment deferred. Sums accrued after October 1, 2005 ($450,000 as of March
31, 2007) were converted into the Company's 2007 Series A convertible
promissory notes as of March 31, 2007.

Deferred Compensation

     Prior to March 31, 2003, the Company incurred management fees under
various management agreements for management and consulting services.  The
fees totaled $607,629 including interest at 6%, as of March 31, 2007.  It was
agreed in March 2003 that payment would be made on March 31, 2007 by
conversion of the deferred compensation into common stock of the Company at
the higher of the average price of the Company's common stock during the ten
trading days ending March 27, 2007 or $4.00 per share.  The Company issued
151,908 shares of common stock on March 31, 2007 to satisfy its obligation.

Convertible Promissory Notes

2006 Series A Convertible Promissory Notes:

     On September 13, 2006, the Company closed the offering of its 2006
Series A Convertible Promissory Notes (the "Notes"), by issuing Notes
totaling $700,000.  The holders of the Notes earn interest on the unpaid
principal balance of the Notes at 6%, payable on May 31, 2008, the maturity
date of the Notes.  All of the principal and accrued interest under the Notes
shall be converted into common shares of the Company at the conversion rate
of one share for each $6.00 that is owed under the terms of the Notes if the
following conditions are met:

          A)  The closing market price of the Company's shares has been at or
above $7.20 per share for 10 consecutive trading days, and

          B)  The earliest of the following events:

              1)  An effective registration allowing public resale of the
shares to be received by the Note holders upon conversion, or
              2)  One year after the initial closing date of the offering,
and

                                     37



              3)  No conversion without an effective registration statement
shall take place until the Company has become a "reporting company" with the
Securities and Exchange Commission pursuant to the Securities Exchange Act of
1934, as amended, which occurred on January 13, 2007.

     The Notes may also be convertible, in whole or in part, into the
Company's common shares at any time at the election of the Note holders at a
conversion rate of $6.00 per share, which was above the approximate market
price of the Company's common shares at the commitment date of the offering.
For the three and nine months ended March 31, 2007 the notes accrued interest
of $10,489 and $27,243, respectively.

     2007 Series A Convertible Promissory Notes:

     On March 31, 2007, the Company sold $700,000 of its 2007 Series A
Convertible Notes (the "2007 Notes"). In addition the Company issued 2007
Notes totaling $986,521 in exchange for promissory notes with convertible
features, and deferred compensation.  The 2007 Notes are convertible into
shares of the Company's common stock at $4.00 per share until maturity on
July 1, 2008, at the election of the 2007 Note holder, and will accrue
interest at 6% per annum.  The note holders will have the option to exchange
the 2007 Notes, plus interest, into securities substantially identical to
securities the Company sells in any subsequent offering of up to $3,000,000.
The Company has the right to require the 2007 Notes (principal plus interest)
be converted into its common shares at the lesser of $4.00 per share or the
price of an offering in which the Company raises $3,000,000 or more.  The
conversion price of the 2007 Notes of $4.00 per share was above the
approximate market price of the Company's common shares at the commitment
date of the offering.

Plan of Operations and Outlook

     As of March 31, 2007 the Company had cash and cash equivalents of
$843,264.   Based on our operating plan, management believes that existing
cash on hand will be sufficient to fund the Company's basic overhead through
the end of the 2007 calendar year.  However, the Company will need to raise
additional capital to execute our business plan discussed below.

     The Company currently intends to seek financing of between $5,000,000
and $50,000,000 during 2007 in the form of equity and/or debt.  The proceeds
would be used to expand and accelerate the development activities of Bion's
initial Integrated Projects and for general corporate purposes.  If we do not
receive sufficient funding on a timely basis, it could have a material
adverse effect on our liquidity, financial condition and business prospects.
Additionally, in the event that we receive funding, it may be on terms that
are not favorable to the Company and its shareholders.  There is no assurance
that the Company will successfully complete any financings.

     Currently, Bion is focused on using applications of its patented waste
management technology to develop Integrated Projects which will include large
CAFOs, such as large dairies, beef cattle feed lots and hog farms, with Bion
waste treatment System modules processing the aggregate CAFO waste stream
from the equivalent of 20,000 to 40,000 or more dairy cows (or the waste
stream equivalent of other species) while producing solids to be utilized for
renewable energy production and to be marketed as feed and/or fertilizer,
integrated with an ethanol plant capable of producing 20 million to 40 (or
more) million gallons of ethanol per year.

                                     38



     In June 2006, the Company entered into an agreement with Fair Oaks Dairy
Farm ("FODF") to construct a Bion facility ("Stage I System") at FODF.  Bion
has been working with FODF since May 2005 for the purpose of installing a
waste treatment facility at FODF that could become the basis for a future
Integrated Project.  The June 2006 agreement contemplates expansion beyond
the initial waste treatment facility.    The Stage I System will initially be
used for testing necessary for: a) finalization of design criteria for
permitting and construction of, and b) optimization of renewable energy
production and utilization for the full scale Integrated Projects.  We are
currently in negotiations toward an amended agreement with FODF pursuant to
which: a) the Company will construct a commercial scale Bion System designed
to handle the waste stream from approximately 3500-6200 milking cows
("Initial System") at existing FODF facilities in Indiana which will
incorporate and expand the scope of the Stage I System; and b) when the
Initial System has completed start-up phase and demonstrated environmental
results consistent with the published results achieved at Bion's Derives
research facility, the Initial System will become the basis of expansion into
an Integrated Project at FODF through development stages including dairy
expansion, construction of additional Bion System modules including renewable
energy production and solids processing facilities and construction of an
ethanol plant.  It is anticipated that the amended agreement will be executed
during fiscal 2007.  Preliminary engineering, design and site work at FODF
has begun pursuant to the existing agreement and we anticipate completion of
development of this Integrated Project during 2008-2009.

     Bion is currently working with local, state and federal officials and
with potential industry participants to evaluate sites in multiple states and
anticipates selecting a site for its initial Project during the 2007. In
addition, Bion intends to choose sites for additional Projects during 2007
and 2008 to create a pipeline of Projects. Management has a 5-year
development target (through calendar year 2013) of approximately 12-25
Integrated Projects.  At the end of the 5-year period, Bion projects that 8-
16 of these Integrated Projects will be in full operation in 3-8 states, and
the balance would be in various stages ranging from partial operation to
early construction stage. No Integrated Project has been developed to date.

     Bion is presently establishing its implementation management team with
the intention of commencing development and construction of an initial
Project during 2007. Bion will need to continue to hire additional management
and technical personnel as it moves from the technology re-development phase
to the implementation phase during the 2007 calendar year.

YEAR ENDED JUNE 30, 2006 COMPARED TO YEAR ENDED JUNE 30, 2005

General and Administrative

     General and administrative expenses increased by $702,466 or 110% for
the year ended June 30, 2006 compared to the prior year.  The increase in
general and administrative expenses is primarily due to an increase of non-
cash compensation charges of approximately $834,000 to record the intrinsic
value of the President's convertible deferred compensation as of June 30,
2006, and financial accounting and audit costs of $67,000 associated with the
preparation of the December 31, 2005 balance sheet audit and the June 30,
2006 audit, which were not performed during the fiscal year ended June 30,
2005.  The increases in general and administrative expenses were partially
offset by lower legal fees during the fiscal year ended June 30, 2006 of
approximately $218,000 due to decreased litigation expense and partial
reimbursement of prior legal expenses.

                                    39



Research and Development

     Research and development expenses increased by $2,597,185 or 214% for
the year ended June 30, 2006 compared to the prior year.  The increase in
research and development expenses was primarily due to increased consulting
expenses and salaries and related payroll taxes.  Consulting expenses
increased due to the addition of several key consultants in order to further
the development of the Company's second generation technology and integration
applications.  Also during the year ended June 30, 2006, $790,000 in non-cash
charges were recorded to recognize consulting expense related to the issuance
and vesting of the Company's stock options to non-employees and $1,140,000 of
non-cash charges were recorded to recognize the intrinsic value of
Brightcap's convertible deferred compensation as of June 30, 2006 compared to
$21,000 and $0, respectively, in fiscal 2005.   Salaries and related payroll
taxes increased during the year ended June 30, 2006 due to pay raises and a
discretionary payment of bonuses to compensate certain employees for pay
reductions in prior years.

Loss from Operations

     As a result of the factors described above, the loss from operations for
the year ended June 30, 2006 increased by $3,299,651 from the prior year of
which $2,756,000 represented the increase in non-cash expenses.

Other Expense

     Other expense decreased by $241,689 for the year ended June 30, 2006
compared to the prior year.  The decrease in other expenses is primarily due
to the decrease in interest expense of $155,408 and an increase in other
income of $65,298.  Interest expense decreased during the year ended June 30,
2006 due to the conversion of the interest bearing Bion Dairy notes and
interest bearing notes held by the Company's president into the Company's
common stock during September and December 2005, respectively.  Other income
increased during the year ended June 30, 2006 due to the settlement of
creditor liabilities during the year.

Net Loss

     As a result of the factors described above, the net loss increased by
$3,057,962 for the year ended June 30, 2006 (an increased net loss of $0.20
per common share) compared to the prior year of which $2,756,000 represents
the increase in non-cash items.

LIQUIDITY AND CAPITAL RESOURCES

     As of June 30, 2006, the Company had cash and cash equivalents equal to
$1,152,199.  During the year ended June 30, 2006, net cash used in operating
activities was $2,040,708, primarily consisting of cash operating expenses.
As previously noted, the Company is currently not generating revenue and
accordingly has not generated cash flows from operations.  The Company does
not anticipate generating sufficient revenues to offset operating and capital
costs for a minimum of two to five years.  While there are no assurances that
the Company will be successful in its efforts to develop and construct its
Projects and market its Systems, it is certain that the Company will require
significant funding from external sources.

                                      40



Investing Activities

     During the year ended June 30, 2006 the Company used $9,166 of cash for
investing activities to purchase property and equipment.

Financing Activities

     During the year ended June 30, 2006, $3,194,821 of cash was provided by
financing activities primarily resulting from $1,870,821 received from the
sale of convertible debt and $1,136,500 received from the sale of common
stock.

     As of June 30, 2006 the Company has significant debt obligations
consisting primarily of mandatorily convertible notes - affiliates
($2,871,698) and deferred compensation, of which $581,344 is mandatorily
convertible.

Convertible Notes

     Under the terms of a convertible deferred compensation agreement with
our President that was exchanged for a promissory note and conversion
agreement on April 4, 2006, sums accrued through March 31, 2006 accrue
interest at 6% per annum and are convertible into the Company's common stock
at the lower of the current market value at the time of conversion, or $2.00
per share.  Through July 1, 2007, conversions may occur by mutual agreement
between the Company and the President.  The Company may convert the
promissory note, in whole or part, at any date after July 1, 2007 and the
convertible note owned by the President is mandatorily converted to common
stock of the Company on July 1, 2009. The Company is accounting for this
employee stock-based agreement under APB 25.  At June 30, 2006, the note
balance (principal and accrued interest) due to the President was $378,981,
and the market price of the Company's common stock was $6.40 per share.
Therefore the Company has recorded the intrinsic value of the deferred
compensation agreement at $1,212,739 as of June 30, 2006.  The President
earns compensation of $150,000 annually, all of which has been deferred from
April 1, 2006 ($37,500 as of June 30, 2006) on a non-convertible and non-
interest bearing basis. All these sums related to Mr. Smith's deferred
compensation are net of $55,000 and $60,000 of deferred compensation that was
converted to 50,000 and 30,000 shares of the Company's restricted common
stock on December 31, 2004 and 2005, respectively.

     On December 31, 2005, convertible deferred compensation payable to
Brightcap for services provided to the Company by the former general manager
of Bion Dairy between April 1, 2003 and September 30, 2005 was exchanged for
a promissory note which note bears interest at 6% per annum and conversion
agreement pursuant to which all sums accrued through September 30, 2005  are
convertible into the Company's common stock at the lower of the current
market value at the time of conversion or $2.00 per share.  Through January
1, 2007 conversion may occur by mutual agreement between the Company and
Brightcap.  The Company may convert the promissory note, in whole or in part,
at any date after January 1, 2007 and, on July 1, 2009, the promissory note
is mandatorily convertible to common stock of the Company. At June 30, 2006,
the note balance (principal and accrued interest) due Brightcap was $518,425
and the market price of the Company's common stock was $6.40 per share.
Therefore the Company has recorded the intrinsic value of the deferred
compensation agreement at $1,658,959.  Brightcap receives annual compensation

                                    41



of $300,000 for the full time consulting services of Dominic Bassani with
payment deferred. Sums accrued after October 1, 2005 total $225,000 as of
June 30, 2006, and accrue on a non-convertible and non-interest bearing
basis.

Deferred Compensation

     Prior to March 31, 2003, the Company incurred management fees under
various management agreements for management and consulting services.  The
fees totaled $581,344 including interest at 6%, as of June 30, 2006.  It was
agreed in March 2003 that payment would be made on March 31, 2007 by
conversion of the deferred compensation into common stock of the Company at
the higher of the average price of the Company's common stock during the ten
trading days ending March 27, 2007 or $4.00 per share.

     The Company has aggregate deferred compensation liabilities of $412,500
and $600,000 for three of its officers/directors/consultants as of June 30,
2006 and September 30, 2006, respectively.  This deferred compensation does
not accrue interest and is not convertible.  Payment is to be made at the
earliest date that the Company has in excess of $2,000,000 in cash and cash
equivalents or as decided by the Board of Directors or by December 31, 2007.

Plan of Operations and Outlook

     As of June 30, 2006 the Company had cash and cash equivalents of
$1,152,199.  In addition, subsequent to yearend and through the date of this
report, the Company received $545,000 in proceeds from the sale of its 2006
Series A Convertible Promissory Notes that closed on September 13, 2006.
Based on our operating plan, management believes that existing cash on hand
will be sufficient to fund the Company's basic overhead through the end of
the 2007 fiscal year.  However, the Company will need to raise additional
capital to execute our business plan discussed below.

     The Company currently intends to seek financing of between $5,000,000
and $50,000,000 during fiscal year 2007 in the form of equity and/or debt.
The proceeds would be used to expand and accelerate the development
activities of Bion's initial Integrated Projects and for general corporate
purposes.  If we do not receive sufficient funding on a timely basis, it
could have a material adverse effect on our liquidity, financial condition
and business prospects.  Additionally, in the event that we receive funding,
it may be on terms that are not favorable to the Company and its
shareholders.  We have engaged a New York City based investment banking firm
to act as our placement agent, financial advisor and arranger for equity and
Project financings, although no specific financing has yet been arranged.
There is no assurance that the Company will successfully complete any
financings.

     Currently, Bion is focused on using applications of its patented waste
management technology to develop Integrated Projects which will include large
CAFOs, such as large dairies, beef cattle feed lots and hog farms, with Bion
waste treatment System modules processing the aggregate CAFO waste stream
from the equivalent of 20,000 to 40,000 or more dairy cows (or the waste
stream equivalent of other species) while producing solids to be utilized for
renewable energy production and to be marketed as feed and/or fertilizer,
integrated with an ethanol plant capable of producing 20 million to 40 (or
more) million gallons of ethanol per year.

                                     42



     In June 2006, the Company entered into an agreement with Fair Oaks Dairy
Farm ("FODF") to construct a Bion facility ("Stage I System") at FODF.  Bion
has been working with FODF since May 2005 for the purpose of installing a
waste treatment facility at FODF that could become the basis for a future
Integrated Project.  The June 2006 agreement contemplates expansion beyond
the initial waste treatment facility.    The Stage I System will initially be
used for testing necessary for: a) finalization of design criteria for
permitting and construction of, and b) optimization of renewable energy
production and utilization for the full scale Integrated Projects.  We are
currently in negotiations toward an amended agreement with FODF pursuant to
which: a) the Company will construct a commercial scale Bion System designed
to handle the waste stream from approximately 3500-6200 milking cows
("Initial System") at existing FODF facilities in Indiana which will
incorporate and expand the scope of the Stage I System; and b) when the
Initial System has completed start-up phase and demonstrated environmental
results consistent with the published results achieved at Bion's DeVries
research facility, the Initial System will become the basis of expansion into
an Integrated Project at FODF through development stages including dairy
expansion, construction of additional Bion System modules including renewable
energy production and solids processing facilities and construction of an
ethanol plant.  It is anticipated that the amended agreement will be executed
during early 2007.  Preliminary engineering, design and site work at FODF has
begun pursuant to the existing agreement and we anticipate completion of
development of this Integrated Project during 2008.

     Bion is currently working with local, state and federal officials and
with potential industry participants to evaluate sites in multiple states and
anticipates selecting a site for its initial Project during the 2007 fiscal
year. In addition, Bion intends to choose sites for additional Projects from
during 2007 and 2008 to create a pipeline of Projects. Management has a 5-
year development target (through calendar year 2011) of approximately 12-25
Integrated Projects.  At the end of the 5-year period, Bion projects that 8-
16 of these Integrated Projects will be in full operation in 3-8 states, and
the balance would be in various stages ranging from partial operation to
early construction stage. No Integrated Project has been developed to date.

     Bion is presently establishing its implementation management team with
the intention of commencing development and construction of an initial
Project during 2007. Bion will need to continue to hire additional management
and technical personnel as it moves from the technology re-development phase
to the implementation phase during the 2007 calendar year.

CONTRACTUAL OBLIGATIONS

     We have the following material contractual obligations (in addition to
employment and consulting agreements with management and employees):

     1) The Company executed a non-cancelable operating lease for office
space in New York City effective August 1, 2006 and extending to November 30,
2013. The average monthly rent under the lease is $15,820.  The Company has
provided the lessor with a letter of credit in the amount of $171,945 in
connection with the lease.  The Company's obligations under the lease are
partially guaranteed by Salvatore Zizza, Chairman of Bion Dairy.  The Company
has entered into sub-leases with non-affiliated parties for approximately 28%
of the obligations under the lease.

                                     43



     2) In June 2006, the Company entered into an agreement with Fair Oaks
Dairy Farm ("FODF") to construct a Bion  facility ("Stage I System") at FODF.
Bion has been working with FODF since May 2005 for the purpose of installing
a waste treatment facility at FODF that could become the basis for a future
Integrate Project.  The June 2006 agreement comtemplates expansion beyond the
initial waste treatment facility.  The Stage I System will initially be used
for testing necessary for: a) finalization of design criteria for permitting
and construction of, and b) optimization of renewable energy production and
utilization for, full scale Integrated Projects. We are currently in
negotiations toward an amended agreement with FODF pursuant to which: a) the
Company will construct a commercial scale Bion optimization System designed
to handle the waste stream from approximately 6200 milking cows ("Initial
System") at existing FODF facilities in Indiana which will incorporate and
expand the scope of the Stage I System; and b) when the Initial System has
completed start-up phase and demonstrated environmental results consistent
with the DeVries results set forth above, the Initial System will become the
basis of expansion into an Integrated Project at FODF through development
stages including dairy expansion, construction of additional Bion System
modules including renewable energy production and solids processing
facilities and construction of an ethanol plant. It is anticipated that the
amended agreement will be executed during early 2007. Preliminary
engineering, design and site work at FODF has begun pursuant to the existing
agreement and we anticipate commencement of construction during the first
half of 2007.  We anticipate completion of development of this Integrated
Project during 2008.  The estimated cost of Stage I under the June 2006
agreement, including Stage I System construction and testing operations, is
$750,000, which Bion and FODF have agreed to split equally net of any grants.
However, as indicated above, we believe that an amended agreement will
supersede the June 2006 agreement which new agreement will require larger
expenditures.

OFF-BALANCE SHEET ARRANGEMENTS

     We do not have any off-balance sheet arrangements (as that term is
defined in Item 303 of Regulation S-K) that are reasonably likely to have a
current or future material effect on our financial condition, revenue or
expenses, results of operations, liquidity, capital expenditures or capital
resources.

RECENT ACCOUNTING PRONOUNCEMENTS

     In December 2004, the Financial Accounting Standards Board ("FASB")
issued SFAS No. 123(R) Share Based Payment, which addresses the accounting
for share-based payment transactions.  SFAS No. 123(R) eliminates the ability
to account for share-based compensation transactions using APB No. 25, and
generally requires instead that such transactions be accounted and recognized
in the statement of income based upon their fair values.  SFAS No. 123(R)
will be effective for the Company beginning on July 1, 2006.  Depending upon
the number and terms of options that may be granted in future periods,
management believes that the implementation of this standard could have a
material impact on the Company's financial statements.





                                      44



ITEM 3.  DESCRIPTION OF PROPERTY.

     The Company maintains its offices at 641 Lexington Avenue, 17th Floor,
New York, New York 10022, telephone number (212) 758-6622.  These offices are
leased pursuant to a non-cancellable operating lease that became effective on
August 1, 2006 and expires on November 30, 2013.  The average monthly rental
under the terms of the lease is $15,820. The Company has entered into sub-
leases with non-affiliated parties for approximately thirty-two per cent
(32%) of its obligations under this lease.

     The Company holds eight United States patents, one Canadian patent, one
patent from Mexicao  and one New Zealand patent as described above.  Three
patent applications have been filed and are pending.

ITEM 4.  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.

     At March 31 31, 2007, the Company had issued 8,757,904 shares of its
common stock, of which 8,064,105 are outstanding (the balance of 693,799
shares are owned by Centerpoint, the Company's majority owned subsidiary).

     The following table sets forth certain information regarding the
beneficial ownership of our common stock as of March 31, 2007 by:

     *  each person that is known by us to beneficially own more than
        5% of our common stock;
     *  each of our directors;
     *  each of our executive officers and significant employees; and
     *  all our executive officers, directors and significant employees
        as a group.

     Under the rules of the Securities and Exchange Commission, beneficial
ownership includes voting or investment power with respect to securities and
includes the shares issuable under stock options that are exercisable within
sixty (60) days of December 31, 2006.  Those shares issuable under stock
options are deemed outstanding for computing the percentage of each person
holding options but are not deemed outstanding for computing the percentage
of any other person.  The percentage of beneficial ownership schedule is
based upon 8,605,996 shares outstanding as of December 31, 2006.  The address
for those individuals for which an address is not otherwise provided is c/o
Bion Environmental Technologies, 641 Lexington Avenue, 17th Floor, New York,
New York 10022.  To our knowledge, except as indicated in the footnotes to
this table and pursuant to applicable community property laws, the persons
named in the table have sole voting power and investment power with respect
to all shares of common stock listed as owned by them.













                                     45






                                                      Shares of Common Stock
                                                        Beneficially Owned
                                                 ----------------------------------
                                                             Percent of
                                                                Class      Entitled
Name and Address                                  Number     Outstanding   to Vote
----------------                                 ---------   -----------   --------
                                                                  

Centerpoint Corporation (1)                        693,799       7.9%          -
641 Lexington Avenue, 17th Floor
New York, NY  10022

Dominic Bassani/Chris-Dan, LLC (2)                2,766,395      26.9%       28.9%
64 Village Hills Drive
Dix Hills, NY  11746

Anthony Orphanos (3)                              1,548,228      16.1%       17.4%
c/o Austin Investments Management
520 Madison Avenue, 28th Floor
New York, NY  10022

Donald Codignotto (4)                               811,409       8.5%        9.2%
4 Keenan Drive
Garden City, NY 11530

The Danielle Christine Bassani Trust (5)            566,000       6.1%        6.6%
 Anthony Orphanos and
 Donald Codignotto, Trustees
4 Keenan Drive
Garden City, NY  11530

Mark A. Smith (6)                                 1,078,950      11.7%       12.6%

Jere Northrop (7)                                   256,248       2.9%        3.1%

Jon Northrop (8)                                    198,710       2.3%        2.4%

Salvatore Zizza (9)                                 744,259       7.9%        8.5%

Jeremy Rowland (10)                                 150,000       1.7%        1.8%

James Morris (11)                                   200,000       2.2%        2.4%

George Bloom (12)                                   202,112       2.3%        2.4%

David Mager  (13)                                   194,209       2.2%        2.4%

Jeff Kapell (14)                                    100,000       1.1%        1.2%

Richard Berman (15)                                  73,601        *          *

Bart Chilton (16)                                    28,000        *           *

Charles Millard (17)                                 30,000        *           *

All executive officers, directors
and significant employees as
a group ( 13 persons)                             6,022,484      48.5%       51.4%

                                     46



___________________

* Less than 1%

(1)  Centerpoint Corporation is currently majority owned by the Company.
Under Colorado law, Centerpoint Corporation is not entitled to vote these
shares unless otherwise ordered by a court.  These shares of common stock may
be distributed to the shareholders of Centerpoint Corporation at a future
date pursuant to a dividend declared during July 2004.  The shares
distributed to Bion, if any, will be cancelled immediately upon receipt.

(2)   Includes 64,612 shares and 600,000 shares underlying warrants held
directly by Mr. Bassani; 3,981 shares and 500,000 shares underlying warrants
held by Brightcap Capital, Ltd. ("Brightcap") of which Mr. Bassani is the
owner; 1,055,692 shares held by Chris-Dan, LLC of which Mr. Bassani is owner;
30,432 shares and 25,000 shares underlying warrants held by Mr. Bassani's
wife; 101,961 shares which represents 50% of the shares held by D2 Trust, of
which he is 50% beneficial owner; and 270,845 shares that Brightcap may
receive pursuant to conversion of an outstanding note of the Company
calculated at March 31, 2007 at the $2.00 maximum conversion price and
113,872 shares that Bright Capital, Ltd. may receive pursuant to conversion
of an outstanding note of the Company at $4.00 per share.  Mr. Bassani has
also been granted 250,000 shares of contingent stock bonuses that are not
included in this calculation.  Mr. Bassani disclaims ownership of 566,000
shares underlying warrants held by The Danielle Christine Bassani Trust,
which is separately itemized herein. Mr. Bassani's adult daughter, who lives
with him, is the beneficiary of the Danielle Christine Bassani Trust.  Mr.
Bassani further disclaims beneficial ownership of shares and warrants owned
by various family members, none of whom live with him or are his dependents,
and such shares are not included in this calculation.

(3)  Includes 315,529 shares and 10,000 shares underlying options held
directly by Mr. Orphanos; 130,263 shares held jointly with his wife; and
260,904 shares held in an IRA.   Also includes 150,000 shares that Mr.
Orphanos may receive pursuant to conversion of an outstanding note of the
Company at a $4.00 per share conversion price. Also includes 566,000 shares
underlying warrants held by the Danielle Christine Bassani Trust, of which
Mr. Orphanos is a co-trustee and 92,500 common shares and 23,032 common
shares underlying conversion of promissory notes owned by certain clients of
Mr. Orphanos, over which Mr. Orphanos exercises discretionary authority.

(4)  Includes 11,409 shares held directly by Mr. Codignotto; 566,000 shares
underlying warrants held by The Danielle Christine Bassani Trust of which Mr.
Codignotto serves as co-Trustee (see note 5); and 234,000 shares underlying
warrants held by The Christopher Parlow Trust of which Mr. Codignotto serves
as co-Trustee.

(5)  Represents shares underlying warrants held by the The Danielle Christine
Bassani Trust, Anthony Orphanos and Donald Codignotto, trustees.

(6)  Includes 359,582 shares held directly by Mark A. Smith; 205,000 shares
underlying options and 35,000 shares underlying warrants held directly by Mr.
Smith; 20,334 shares held jointly with his wife; 66,145 shares held by his
wife; and 156,931 shares of common stock held by LoTayLingKyur Foundation
which is controlled by Mr. Smith.  Also includes 198,047 shares that Mr.
Smith may receive pursuant to conversion of an outstanding note of the

                                     47



Company calculated at March 31, 2007 at the $2.00 maximum conversion price,
and 37,911 shares that Mr. Smith may receive pursuant to conversion of an
outstanding note of the Company at a $4.00 per share conversion price.  Does
not include shares and warrants owned by various family members of which Mr.
Smith disclaims beneficial ownership.  Mr. Smith is also the President of
Centerpoint, although shares owned by Centerpoint are not entitled to a vote
while held by Centerpoint.

(7)  Includes 67,401 shares held by Jere Northrop's wife; 3,549 shares held
by a family trust; 62,598 shares and 122,500 shares underlying options held
by Jere Northrop; and 200 shares owned jointly by Jere Northrop and his wife.
Does not include 12,608 shares owned by the Jere and Lynn Northrop Family
Foundation, 7,906 shares owned by the Jere Northrop Family trust and 805
shares owned by the Harley Northrop Charitable Trust, for each of which Mr.
Northrop disclaims beneficial ownership.  Jere Northrop has also been granted
22,500 shares of contingent stock bonus that are not included in this
calculation.

(8)  Includes 108,466 shares held directly by Jon Northrop; 16,464 shares
owned by Jon Northrop's wife; 4,100 shares owned jointly by Jon Northrop and
his wife; options to purchase 50,000 shares held by Jon Northrop; and 19,680
shares owned by a family trust.  Does not include shares owned by the adult
children of Jon Northrop or 2,007 shares owned by the Harley Northrop Family
Foundation.

(9)  Includes 41,912 shares held by Mr. Zizza; 7,500 shares underlying
options and 600,000 shares underlying warrants held by him, 94,847 shares
that Mr. Zizza may receive pursuant to conversion of an outstanding note of
the Company at a $4.00 per share conversion price. Mr. Zizza has also been
granted 150,000 shares of contingent stock bonus that are not included in
this calculation.

(10) Mr. Rowland holds warrants to purchase 150,000 shares.

(11) Mr. Morris holds options to purchase 200,000 shares. Mr. Morris has also
been granted 75,000 shares of contingent stock bonus that are not included in
this calculation.

(12) Mr. Bloom holds 2,112 shares and options to purchase 200,000 shares. Mr.
Bloom has also been granted 75,000 shares of contingent stock bonus that are
not included in this calculation.

(13) Mr. Mager holds 40,876 shares and  warrants to purchase 153,333 shares.
Mr. Mager has also been granted 37,500 shares of contingent stock bonus that
are not included in this calculation.

(14) Mr. Kapell holds warrants to purchase 100,000 shares.  Mr. Kapell has
also been granted 37,500 shares of contingent stock bonus that are not
included in this calculation.

(15) Mr. Berman holds 3,928 shares and options to purchase 35,000 shares.
Also includes 34,133 shares into which a $200,000 (initial principal amount)
2006 Series A Convertible Note held by Mr. Berman s (including accrued
interest) were convertible as of December 31, 2006.


                                     48


(16) Mr. Chilton holds options to purchase 28,000 shares.

(17) Mr. Millard holds options to purchase 30,000 shares.

ITEM 5.  DIRECTORS AND EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS.

     Our directors, executive officers and significant employees/consultants,
along with their respective ages and positions are as follows:

Name                       Age     Position
----                       ---     --------

Director and Officers:

  Mark A. Smith            57      President, General Counsel, Interim Chief
                                   Financial Officer and Director

  Jere Northrop            64      Senior Technology Director and Director

  Jon Northrop             63      Secretary and Director

  Salvatore J. Zizza       60      Chairman and Director of Bion Dairy

  George W. Bloom          51      Chief Operating Officer of Bion
                                   Technologies

  Jeremy Rowland           43      Chief Operating Officer of Bion Dairy

Significant Employees:

  James W. Morris          56      Chief Technology Officer of Bion
                                   Technologies

  Jeff Kapell              60      V.P. for Renewables of Bion Dairy

  David Mager              53      V.P. for Public Policy of Bion Dairy

  Dominic Bassani          61      Full Time Consultant to Bion and Bion
                                   Dairy

     Mark A. Smith (57) has been President, General Counsel, interim Chief
Financial Officer and a director of Bion Environmental Technologies, Inc.
since late March 2003.  Since that time, he has also served as sole director,
President and General Counsel of Bion's wholly-owned subsidiaries including
Bion Dairy Corporation.  Since mid-February 2003, Mr. Smith has served as
sole director and President and General Counsel of Bion's majority-owned
subsidiary, Centerpoint Corporation. Previously, from May 21, 1999 through
January 31, 2002, Mr. Smith served as a director of Bion. From July 23, 1999,
when he became President of Bion, until mid-2001 when he ceased to be
Chairman, Mr. Smith served in senior positions with Bion on a consulting
basis.  Additionally, Mr. Smith was the president of RSTS Corporation prior
to its acquisition of Bion Technologies, Inc. in 1992.  Mr. Smith received a
Juris Doctor Degree from the University of Colorado School of Law, Boulder,
Colorado  (1980) and a BS from Amherst College, Amherst, Massachusetts
(1971).  Mr. Smith has engaged in the private practice of law in Colorado
since 1980.  In addition, Mr. Smith has been active in running private family
companies, Stonehenge Corporation (until 1994) and LoTayLingKyur, Inc. (1994-
2002). Until returning to Bion during March 2003, Mr. Smith had been in
retirement with focus on charitable work and spiritual retreat.

                                     49

     Jere Northrop (64) is the founder of Bion and developed its technology.
He has served as the Company's Senior Technology Director since 1999 and has
been a Board of Directors member since April 9, 1992.  Dr. Northrop is a
founder of Bion Technologies, Inc. and was its President from October 1989 to
July 23, 1999. Since 2003, Dr. Northrop has served as a director of As It Is,
Inc., a private company of which he is a cofounder.  Prior to founding Bion,
he had ten years experience in the management of operations and process
control at a large municipal advanced wastewater treatment plant in Amherst,
New York (1979-1989).  He also has twenty-five years of experimental research
on both individual and complex systems of microorganisms.  Dr. Northrop has a
BS degree in biology from Amherst College, Amherst, Massachusetts (1964), a
PhD in biophysics from Syracuse University, Syracuse, New York, (1969), and
has done post doctoral work at the University of California at Davis, Davis,
California and The Center for Theoretical Biology, State University of New
York at Buffalo, Buffalo, New York.

     Jon Northrop (63) has served as our Secretary and a Director since March
of 2003.  Since September 2001 he has been self employed as a consultant with
a practice focused on business buyer advocacy.  Mr. Northrop is one of our
founders and served as our Chief Executive Officer and a Director from our
inception in September 1989 until August 2001.  Before founding Bion
Technologies, Inc., he served in a wide variety of managerial and executive
positions. He was most recently the Executive Director of Davis, Graham &
Stubbs, one of Denver's largest law firms, from 1981 to 1989. Prior to his
law firm experience, Mr. Northrop worked at Samsonite Corporation's Luggage
Division in Denver, Colorado, for over 12 years.  His experience was in all
aspects of manufacturing, systems design and implementation, and planning and
finance, ending with three years as the Division's Vice President, Finance.
Mr. Northrop has a bachelor's degree in Physics from Amherst College,
Amherst, Massachusetts (1965), an MBA in Finance from the University of
Chicago, Chicago, Illinois (1969), and spent several years conducting post
graduate research in low energy particle physics at Case Institute of
Technology, Cleveland, Ohio. Jon Northrop is the brother of Jere Northrop.

     Salvatore J. Zizza (60) recently rejoined Bion and Dairy during 2005 on
a consulting basis and assumed the positions of Chairman and Director of Bion
Dairy Corporation on January 1, 2006.  Mr. Zizza served as a Director of Bion
from December 1999 through February 2003.  Mr. Zizza has agreed to join
Bion's Board of Directors and serve as Bion's Chairman once Bion has
commenced Exchange Act reporting with Securities and Exchange Commission and
has secured adequate director and officer liability insurance coverage. From
2003 to 2005, Mr. Zizza was self employed providing consulting services as
well as his board of director duties as described below. He served as
Chairman of the Board, President and Treasurer from 1992 through 1997 of
Hollis Eden Pharmaceuticals (HEPH) (f/k/a IAC) and has served as a Director
since 1998. Mr. Zizza served as Chairman of the Board of Directors of The
Lehigh Group, Inc. (f/k/a The LVI Group Inc.) ("LHG") beginning in 1991, and
was President and Chief Financial Officer of The Lehigh Group, Inc. from 1985
to 1991.  LHG, a New York Stock Exchange listed company, was engaged, through
its subsidiary, in the distribution of electrical products, and from 1985
until 1991 was one of the largest interior construction and asbestos
abatement firms in the United States.  Mr. Zizza was Chief Operating and
Chief Financial Officer of NICO, Inc., an interior construction firm, from

                                      50



1978 until its acquisition in 1985 by LHG.  Mr. Zizza is a director of The
Gabelli Equity Trust, The Gabelli Asset Fund, The Gabelli Growth Fund and The
Gabelli Convertible Securities Fund and other funds in the Gabelli Fund
family. Mr. Zizza is presently Chairman of Hallmark Electrical Supplies Corp,
a distributor of electrical products, Bethlehem Advanced Metals which designs
and manufactures high-temperature furnaces for sale and for its own use in
the processing of specialty carbon, graphite and ceramic materials for
semiconductor and aerospace applications, and Chairman of Metropolitan Paper
Recycling, the largest independent recycler in New York.

     George W. Bloom (51) has been with Bion Technologies, Inc. since
December 2000 and has served as Chief Operating Officer since January 15,
2002.  From 1986 through December 2000, Mr. Bloom was employed by Woodard &
Curran, Inc., an environmental engineering and science-consulting firm, where
he held the position of Chief Engineer of the Municipal Business Center at
the time of his departure.  Mr. Bloom is a registered professional engineer
with over twenty years environmental engineering and consulting experience
specializing in the planning, design, construction and operation of waste
treatment facilities.  Mr. Bloom is responsible at Bion for oversight of the
planning, design and construction of waste treatment systems and solids
processing facilities. He has his BS in Environmental Science from Cornell
University.

     Jeremy Rowland  (43) joined Bion Dairy on September 18, 2006 as its
Chief Operating Officer. Mr. Rowland has agreed to serve as Chief Operating
Officer of Bion once Bion has commenced reporting with the Securities &
Exchange Commission and has secured adequate director and officer liability
insurance coverage. Prior to joining Bion, he worked for URS Corporation, a
major national engineering/consulting firm, for 16 years where he developed
and lead URS's efforts in the renewable energy marketplace. Mr. Rowland has
eighteen years experience in multi-disciplinary energy and environmental
project development and management throughout the U.S. and overseas. Mr.
Rowland's areas of expertise include renewable energy project development,
distributed generation (mostly combined heat/power), large-scale power plant
developments, and strategic energy management. Mr. Rowland earned his MS in
Environmental Science in 1987 and his BS in Forest Ecology in 1985 from
Southern Illinois University, School of Agriculture Science.

     James W. Morris (56) has served as Chief Technology Officer of Bion
Technologies, Inc. since February 2002 and is co-inventor of portions of the
Bion Process.  Prior to joining Bion, Dr. Morris provided the Company with
technical assistance and technical advice for over two years as a consultant.
Other consulting work included eight years acting as the Senior Technical
Consultant for a large environmental consulting firm and the formation of
James W. Morris & Associates, Inc. that allowed him to serve clients ranging
from small commercial establishments, to municipalities and corporations, as
well as a sub consultant to several larger engineering firms. Dr. Morris is a
licensed professional engineer in Maine and Vermont with more than 30 years
of engineering experience.  Over a twelve-year period he performed research
and taught graduate and undergraduate engineering as a member of the
faculties of Cornell University, the University of Manitoba and the
University of Vermont.  He earned his BSCE and MSCE at Tennessee

                                      51




Technological University and a Ph.D. in Environmental Quality/Agricultural
Engineering from Cornell University.  He is a member of the American Society
of Civil Engineers, Water Environment Federation, Institute of Food
Technologists, American Society of Agricultural Engineers, Agricultural
Engineering Society, Aquacultural Engineering Society and American Water
Works Association, Tau Beta Phi (Engineering honor society), Chi Epsolon
(Civil Engineering honor society) and is a member of Sigma Xi, The Scientific
Research Society of North America.

     Jeff Kapell (60) became a consultant to Bion and Bion Dairy in December
2003 and joined the Bion management team on a full-time basis during April
2006 as Bion Dairy's Vice-President -- Renewables. Previously, Mr. Kapell was
Associate Principal at SJH & Company, a strategic management-consulting group
serving the global agri-food industry.  Mr. Kapell served SJH & Company from
2000 to 2005.  While at SJH, he led the firm's development of a practice area
in "renewables" and has become recognized throughout the industry as a sector
expert at the intersection of agriculture and renewable energy.  Commencing
in mid-2005, Mr. Kapell provided consulting services to Bion and Bion Dairy
as Principal of Kapell Consulting.  Mr. Kapell has also been a cranberry
grower for the past twenty-five years and has served on the Board of Ocean
Spray Cranberries, Inc., as president of The Cape Cod Cranberry Growers
Association, and is currently Vice-Chairman of the Board of the Cranberry
Institute.  Mr. Kapell is an engineer by training, having performed systems
analysis for several firms prior to launching his farming and consulting
ventures.  Mr. Kapell is a graduate of Lehigh University.

     David Mager (53) became a consultant on a full time basis to Bion and
Bion Dairy in June 2003 and serves as Bion Dairy's Vice President for Public
Policy. He is a scientist, inventor and consultant whose specialty is helping
companies serve a "dual bottom line" of being profitable while being
environmentally and socially responsible. Prior to joining Bion, Mr. Mager
wasemployed for over 20 years  providing environmental consulting to
companies such as  Amoco, General Electric, General Motors, Coca Cola, IBM,
Unilever, Aveda, Tommy Boy Records, Rhino Records, Eileen Fisher, Stonyfield
Farm Yogurt, Kozy Shack, Gaiam and ABC Home.  He has focused on helping his
clients continuously improve their environmental footprints.   Since 2001, he
has been a  principal of Meadowbrook Lane Capital, LLC, an investment bank,
through which he provides his services to Bion and Bion Dairy. Mr. Mager has
a BS in biology from the State University of New York at Stony Brook (1975).

     Dominic Bassani (60) served as the General Manager of Bion Dairy from
April 2003 through September 2006.  He now serves Bion (and its subsidiaries)
as a consultant (through Bright Capital, Ltd. ("Brightcap")) on a full-time
basis with focus on strategic planning and special projects.  He has been an
investor in and consultant to Bion since December 1999. He is an independent
investor and since 1990 has owned and operated Brightcap, a management
consulting company that provides management services to early stage
technology companies. He was a founding investor in 1993 in Initial
Acquisition Corp. that subsequently merged in 1995 with Hollis Eden Corp.
(HEPH), a biotech company specializing in immune response drugs. From early

                                     52



1998 until June 1999 he was a consultant to Internet Commerce Corp. (ICCA), a
leader in business-to-business transactions using the Internet. He is
presently an investor in numerous private and public companies primarily in
technology related businesses. From 1980 till 1986, Mr. Bassani focused
primarily on providing management reorganization services to manufacturing
companies and in particular to generic pharmaceutical manufacturers and their
financial sponsors.

     In addition, the following persons became directors of Bion Dairy
effective October 15, 2006 and have agreed to become directors of Bion upon
effectiveness of this Form 10-SB registration statement and the Company's
acquisition of director and officer liability insurance:

     Richard Berman (64) has a business career that spans over 35 years of
venture capital, management and merger & acquisitions experience. Since 1982,
Richard Berman has mainly been active as an investor, advisor, manager,
director, and financier to over 100 public and private companies, with
emphasis on biotech, internet, and other technology sectors.  In the last
five years, Mr. Berman has served as a director and/or officer of
approximately a dozen public and private companies.  He is currently CEO of
Nexmed, a small public biotech company; Chairman of National Investment
Managers, a public company in pension administration and investment
management; and Chairman of Candidate Resources, a private company delivering
human resources services over the web, and Chairman of Fortress Technology
Systems (homeland security).  Mr. Berman is a director of seven public
companies: Dyadic International, Inc., Broadcaster, Inc., Internet Commerce
Corporation, MediaBay, Inc., NexMed, Inc., National Investment Managers, and
Advaxis, Inc.  From 1998-2000, Mr. Berman was employed by Internet Commerce
Corporation as Chairman and CEO.  From 1975-1982 Mr. Berman served Banker
Trust Company, New York with a final position of Senior Vice President where
he was Head of Mergers & Acquisitions and Leverage Buyout Departments. Mr.
Berman is active in real estate and venture capital investing.  He is a past
Director of the Stern School of Business of NYU where he obtained his BS
(1964) and MBA (1973).  He also has US and foreign law degrees from Boston
College (1969) and The Hague Academy of International Law, respectively.

     Bart Chilton (46) has held the position of Chief of Staff, Vice
President for Strategic Development & Government Relations, National Farmers
Union since June 2006.  From February 2005 - May 2006 he has served as
Executive Assistant to the Farm Credit Administration Board. From 2001 -
2005, Mr. Chilton served as Senior Advisor to Senator Daschle, the Majority
and Minority Leader, United States Senate.  From 1998-2000 he served as
Deputy Chief of Staff to the U.S. Secretary of Agriculture and from 1995-1998
he served as Senior Policy Director for Rural Development to the U.S.
Secretary of Agriculture.  From 1985-1995, Mr. Chilton served as Legislative
Director for four different members of the U.S. House of Representative's.
Mr. Chilton attended Purdue University from 1978-1983.

     Charles Millard (49) has served as President and Managing Director of BP
Direct Securities, affiliate of Broadway Real Estate Partners since July
2004. From May 2001 though June 2004 he served at Lehman Brothers as Managing
Director/Head of Wealth Management Services and from May 1999 - April 2000 he
worked at Prudential Securities, Inc., as Group Head/Managing Director, NY
Internet Group.  From December 1995 to May 1999, Mr. Millard served as

                                      53



President of the New York City Economic Development Corporation and Chairman
of the New York City Industrial Development Agency.  From 1991 to 1995, Mr.
Millard served as Councilman, Upper East Side, Manhattan, New York City
Council and from 1986 to 1991, he worked as an attorney at the law firm of
Davis, Polk & Wardell, NYC.  Mr. Millard received a J.D. from Columbia
University School of Law (1985) and a B.A. from Holy Cross College (1979).

Family Relationships

     There are currently no family relationships among our Directors and
Executive Officers except that Jon Northrop and Jere Northrop are brothers.

Compliance with Section 16(a) of the Exchange Act

     Section 16(a) of the Exchange Act requires our officers and directors,
and stockholders owning more than ten percent of a registered class of our
equity securities, to file reports of ownership and changes in ownership with
the Securities and Exchange Commission.  Upon effectiveness of our Form 10-
SB, executive officers, directors and such stockholders will be required by
SEC regulations to furnish us with copies of all forms they file pursuant to
these requirements.

Involvement in Legal Proceedings

     To the best of our knowledge, during the past five years, none of the
following occurred with respect to our directors or executive officers:

     (1)  any bankruptcy petition filed by or against any business of which
one of them was a general partner or executive officer either  at the time of
the bankruptcy or within two years prior to that time;

     (2)  any conviction in a criminal proceeding or being subject to a
pending criminal proceeding (excluding traffic violations and other minor
offenses).

     (3)  being subject to any order, judgment or decree of any court of
competent jurisdiction, permanently or temporarily inquiring, barring,
suspending or otherwise limiting involvement in any type of business,
securities or otherwise limiting involvement in any type of business,
securities or banking activities, and

     (4)  being found by a court of competent jurisdiction, the SEC or the
CFTC to have violated Federal or state securities or commodities laws.

Audit Committee

     The Company has no audit committee and is not now required to have one,
or an audit committee financial expert.

Code of Ethics

     To date, the Company has not adopted a code of business conduct and
ethics applicable to its officers, directors or accounting officer.

                                      54



ITEM 6.  EXECUTIVE COMPENSATION.

     The following table sets forth the compensation paid to, or accrued for,
each of our current and former executive officers during each of our last
three fiscal years and the compensation paid to, or accrued for, each of our
significant employees and consultants for the same period.






                                               Summary Compensation Table

                                          Annual Compensation                   Long-Term Compensation
                                      --------------------------    -------------------------------------------
                                                                                Securi-
                                                                                ties
                                                                                Under-
                                                         Other      Restricted  lying              All Other
                              Fiscal                     Compen-    Stock       Options/  LTIP     Compensation
Name and Principal Position   Year    Salary(1)  Bonus   sation     Awards      SARs      Payouts  (2)(3)
---------------------------   ------  ---------  ------  -------    ----------  --------  -------  ------------
                                                                           
Mark A. Smith (2),            2006    150,000    12,500  20,569 (5)     -       121,875     -          833,758
 President and Interim Chief  2005    150,000      -     19,908 (5)     -        25,000     -             -
 Financial Officer since      2004    150,000      -     10,910 (5)     -       290,000     -             -
 March 25, 2003, Director

Jere Northrop,                2006     57,999    12,000    -            -       118,750     -             -
 Senior Technology Officer,   2005     63,000      -       -            -       112,500     -             -
 Director                     2004     81,466      -       -            -          -        -             -

Jon Northrop,                 2006       -         -       -            -        68,750     -             -
 Secretary, Director          2005       -         -       -            -          -        -             -
                              2004       -         -       -            -        65,000     -             -

Brightcap/
 Dominic Bassani (3),         2006    300,000      -     44,719 (5)      -         -        -        1,140,535
 General Manager of Dairy     2005    195,000      -     41,405 (5)      -         -        -             -
                              2004    230,000      -     18,224 (5)      -         -        -             -


Salvatore J. Zizza, (4)       2006    210,000      -       -             -         -        -             -
 Chairman and Director        2005       -         -       -             -         -        -             -
 of Bion Dairy                2004       -         -       -             -       37,500     -             -

George W. Bloom,              2006    142,500    30,000    -             -         -        -             -
 Chief Operating Officer      2005    120,000      -       -             -      197,500     -             -
 Bion Technologies            2004    120,000      -       -             -      332,500     -             -

James W. Morris,              2006    142,500    30,000    -             -         -        -             -
 Chief Technology Officer     2005    120,000      -       -             -       40,000     -             -
 Bion Technologies            2004    120,000      -       -             -      490,000     -             -

David Mager,                  2006    150,000      -       -             -         -        -             -
 Vice President for Public    2005    150,000      -       -             -      124,999     -             -
 Policy Bion Dairy            2004    137,500      -       -             -      325,000     -             -
______________________________




(1)  Includes compensation paid by Bion Technologies, Inc. and Bion Dairy, our wholly
owned subsidiaries.

(2)  Mr. Smith has agreed to provide services to Bion and Dairy through December 31,
2007 at a salary of $150,000 all of which has been deferred to date. On April 4, 2006,
Mr. Smith's accrued deferred compensation was exchanged for a promissory note and
conversion agreement.  Through June 30, 2006, $378,981 had been accrued on the note,


                                            55



including interest at the rate of 6% per annum.  The note is convertible into our
common stock at the lower of current market value at the time of conversion or $2.00
per share.  We may convert the note, in whole or in part, at any date after July 1,
2007 and the note is mandatorily converted to common stock on July 1, 2009.
Compensation deferred after April 1, 2006 of $37,500 through June 30, 2006 is non-
interest bearing and non-convertible.  The "Other Compensation" represents the
difference between the intrinsic value of Mr. Smith's deferred compensation recorded
as an expense of the Company as of June 30, 2006 ($1,212,739) and the note balance due
to Mr. Smith of $378,981.  On March 31, 2007, Mr. Smith agreed to accept $151,645 of
the Company's 2007 Series A Convertible Notes in exchange for his deferred
compensation for the period from January 1, 2007 through March 31, 2007 and the
Company's promissory note issued on January 1, 2007 for Mr. Smith's deferred
compensation from April 1, 2006 through December 31, 2006.

(3)  On December 31, 2005, convertible deferred compensation payable to Brightcap for
services provided to the Company by Dominic Bassani between April 2, 2003 and
September 30, 2005 was exchanged for a promissory note and conversion agreement upon
the same terms as Mr. Smith's note.  At June 30, 2006, the note balance (including
accrued interest at a rate of 6% per annum) due to Brightcap was $518,425.  Effective
March 31, 2005, Brightcap entered into an agreement to provide Mr. Bassani's services
to the Company through March 31, 2009, with annual compensation in the amount of
$300,000. Compensation deferred commencing October 1, 2005 ($225,000 at June 30, 2006)
is non-convertible and non-interest bearing.  The "Other Compensation" represents the
difference between the intrinsic value of Brightcap's deferred compensation recorded
as an expense of the Company as of June 30, 2006 ($1,658,959) and the note balance due
to Brightcap of $518,425.  On March 31, 2007 Brightcap agreed to accept $455,486 of
the Company's Series A Notes in exchange for its deferred compensation for the period
from January 1, 2007 through March 31, 2007 and the Company's promissory notes issued
on January 1, 2007 for its deferred compensation owed by Bion on December 31, 2006.

(4)  Mr. Zizza is working for the Company at an annual compensation rate of $300,000
per annum.  All of Mr. Zizza's compensation since January 1, 2006 has been deferred on
a non-convertible and non-interest bearing basis ($150,000 at June 30, 2006). On March
31, 2007 Mr. Zizza agreed to accept $379,389 of the Company's Series A Notes in
exchange for his deferred compensation for the period from January 1, 2007 through
March 31, 2007 and the Company's promissory notes issued on January 1, 2007 for his
deferred compensation owed by Bion on December 31, 2006.  Mr. Zizza received a fee of
$60,000 for his service to the Company through December 31, 2005.

(5)  Represents interest accruals on deferrals and related notes.



     The following table sets forth the options that were granted during the
fiscal years ended June 30, 2006 and 2005 respectively to Executive Officers
and Significant Employees and Consultants:










                                      56





                   Number of
                   Securities   Percent of
                   Underlying   Total Options
                   Options      Granted to      Exercise
                   Granted      Employees in    Price       Expiration
Name               2006         Fiscal 2006     Per Share   Date
----               ----------   -------------   ---------   ----------

Mark A. Smith        12,500         13.23%        $5.50     12/31/2010
                     12,500         13.23%        $4.25     12/31/2010

Jere Northrop        12,500         13.23%        $5.50     12/31/2010
                     20,000         21.16%        $2.50     5/1/2005

Jon Northrop         12,500         13.23%        $5.50     12/31/2010


                   Number of
                   Securities   Percent of
                   Underlying   Total Options
                   Options      Granted to      Exercise
                   Granted      Employees in    Price       Expiration
Name               2005         Fiscal 2005     Per Share   Date
----               ----------   -------------   ---------   ----------

Mark A. Smith        10,000          1.50%        $2.50     5/1/2015

Jere Northrop        10,000          1.50%        $2.50     5/1/2005
                     22,500          3.38%        $3.00     7/31/2008
                     10,000          1.50%        $2.00     3/8/2009

George W. Bloom      75,000         11.28%        $2.50     5/1/2015
                      5,000          0.75%        $2.00     3/8/2009

James W. Morris      20,000          3.01%        $2.00     3/8/2009

David Mager          10,000          1.50%        $2.50     5/1/2015
                     33,333          5.01%        $3.00     7/31/2008


Aggregated Option Exercises and Option Value Table as of June 30, 2006

     The following table sets forth the options exercises during the fiscal
year ended June 30, 2006 and the value of exercisable and unexercisable
options outstanding as of June 30, 2006.








                                     57






                                              Number of
                                              Securities
                                              Underlying         Value of
                                              Unexercised        Unexercised
                                              Options at         In-the-Money
                     Shares                   June 30, 2006      Options at FYE
                     Acquired      Value      Exercisable/       Exercisable/
Name                 on Exercise   Realized   Unexercisable      Unexercisable
---------------      -----------   --------   -------------      ---------------
                                                     
Mark A. Smith             -           -       105,000 / 0        $235,125 / $0
Jere Northrop             -           -       122,500 / 0        $384,000 / $0
Jon Northrop              -           -        37,500 / 0        $106,250 / $0
George W. Bloom           -           -       150,000 / 50,000   $555,000 / $195,000
James W. Morris           -           -       150,000 / 50,000   $555,000 / $195,000
Salvatore J. Zizza        -           -         7,500 / 0        $ 10,500 / $0
David Mager               -           -       143,333 / 10,000   $492,332 / $ 39,000


Employment Agreements

     Effective March 31, 2007 Mark A. Smith, our President, agreed to serve
as President, General Counsel and as a Director of the Company and its
subsidiaries until December 31, 2007 for compensation of $150,000. The amount
deferred through June 30, 2006 and September 30, 2006 under this arrangement
(as in existence at such dates) are $37,500 and $75,000, respectively.
Compensation accrued after April 1, 2006 is non-convertible and non-interest
bearing.  Amounts accrued prior to April 1, 2006 in the amount of $378,981
(principal and accrued interest) are represented by a convertible promissory
note bearing interest at the rate of 6% per annum and convertible after July
1, 2007 into the Company's common stock at the lower of the current market
value at the time of conversion, or $2.00 per share.  The note is mandatorily
convertible on July 1, 2009.  On March 31, 2007, Mr. Smith agreed to accept
$151,645 of the Company's 2007 Series A Convertible Notes ("Series A Notes")
in exchange for his deferred compensation for the period from January 1, 2007
through March 31, 2007 and the Company's promissory note issued on January 1,
2007 for Mr. Smith's deferred compensation from April 1, 2006 through
December 31, 2006.

     Effective May 1, 2005, the Company entered into a four-year
consulting/employment agreement with a former officer and director of the
Company, Salvatore Zizza.  Mr. Zizza received $60,000 for his services to the
Company through December 31, 2005 which sum he used to purchase 600,000
warrants. As of January 1, 2006, the former officer and director assumed the
position of Chairman and Director of Bion Dairy, with an annual salary of
$300,000, all of which has been deferred to date. The amounts deferred
through June 30, 2006 and September 30, 2006 under this arrangement are
$150,000 and $225,000, respectively.  Compensation accrued after January 1,
2006 is non-convertible and non-interest bearing. To the extent that such
compensation is deferred, the deferred amount shall be payable at the
earliest of the date on which the Company has $2,000,000 cash, December 31,

                                     58




2007 or at the discretion of the Company's Board of Directors.  On March 31,
2007 Mr. Zizza agreed to accept $379,389 of the Company's Series A Notes in
exchange for his deferred compensation for the period from January 1, 2007
through March 31, 2007 and the Company's promissory notes issued on January
1, 2007 for his deferred compensation owed by Bion on December 31, 2006.

     Dominic Bassani, former General Manager of Dairy, has agreed, through
Brightcap, to serve as a consultant to Bion and Bion Dairy until March 31,
2009 for compensation of $300,000 per year.  Amounts accrued prior to
September 30, 2005 in the amount of $518,425 (principal and accrued interest)
are represented by a convertible promissory note bearing interest at the rate
of 6% per annum and convertible after July 1, 2007 into the Company's common
stock at the lower of the current market value at the time of conversion or
$2.00 per share.  The note is mandatorily convertible on July 1, 2009.  To
the extent that such compensation accrued after September 30, 2005 is
deferred, the deferred amount shall be payable at the earliest of the date on
which the Company has $2,000,000 cash, December 31, 2007 or at the discretion
of the Company's Board of Directors. The amounts deferred through June 30,
2006 and September 30, 2006 under this arrangement are $225,000 and $300,000,
respectively.  Compensation accrued after October 1, 2005 is non-convertible
and non-interest bearing.  On March 31, 2007 Brightcap agreed to accept
$455,486 of the Company's Series A Notes in exchange for its deferred
compensation for the period from January 1, 2007 through March 31, 2007 and
the Company's promissory notes issued on January 1, 2007 for its deferred
compensation owed by Bion on December 31, 2006.

     Effective May 1, 2005, Bion entered into a four-year consulting/
employment agreement with Jeff Kapell.  Under the terms of the agreement, Mr.
Kapell provided part-time consulting services to Bion through March 2006.  In
April 2006, Mr. Kapell was appointed as Bion Dairy's Vice-President -
Renewables at a salary of $120,000 per year.

     Effective September 18, 2006, Bion entered into a four-year employment
agreement with Jeremy Rowland.  Under the terms of the agreement, Mr. Rowland
was appointed as Bion Dairy's Chief Operating Officer at a salary of $150,000
per year.

Other Agreements

     In May 2005, Bion declared contingent Stock Bonuses of 690,000 shares,
in aggregate, to its key employees and consultants.  Stock bonuses of 492,500
and 197,500 shares are contingent upon the Company's stock price exceeding
$10.00 and $20.00 per share, respectively, and the grantees still being
employed by or providing services to the Company at the time the target
prices are reached.

Director Compensation

     Members of the Board of Directors do not currently receive any cash
compensation for their services as Directors, but are entitled to be
reimbursed for their reasonable expenses in attending meetings of the Board.
However, it is the Company's intention to begin to pay cash compensation to
Board members at some date after the effectiveness of this Form 10-SB
registration statement.

                                      59



Stock Option Plans

     During June 2006 the Company adopted its 2006 Consolidated Incentive
Plan ("Plan") which terminated all prior plans and merged them into the Plan.
The Plan was ratified by the Company's shareholders in October 2006.  Under
the Plan, Directors may grant Options, Stand Alone SARs, shares of Restricted
Stock, shares of Phantom Stock and Stock Bonuses with respect to a number of
Common Shares that in the aggregate does not exceed 3,200,000 shares. The
maximum number of Common Shares for which Incentive Awards, including
Incentive Stock Options, may be granted to any one Participant shall not
exceed 500,000 shares in any one calendar year; and the total of all cash
payments to any one participant pursuant to the Plan in any calendar year
shall not exceed $500,000.  1,663,333 Options have been granted under the
Plan (as amended), including all options granted under prior merged plans.
Additionally, 690,000 shares of contingent Stock Bonuses have been granted
under the Plan.

ITEM 7.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.

     Other than the employment/consulting agreements, deferred compensation
arrangements and conversions of debt described above in Item 1 Business and
Item 6 Executive Compensation, there are no related party transactions except
that:

     1)   Bion has accrued a payable of $41,647 to a company controlled by
Salvatore Zizza for rental of office space in 2003.

     2)   The Company executed a non-cancellable operating lease for office
space in New York City effective August 1, 2006 and extending to November 30,
2013.  The average monthly rent under the lease is $15,820.  The Company has
provided the lessor with a letter of credit in the amount of $171,945 in
connection with the lease.  The Company's obligations under the lease are
partially guaranteed by Salvatore Zizza, Chairman of Bion Dairy. The Company
has entered into sub-leases with non-affiliated parties for approximately 30%
of the obligations under the lease.

     3)   On June 2006, the Company entered into an agreement with Fair Oaks
Dairy Farm ("FODF") to construct a Bion  facility ("Stage I System") at FODF.
Bion has been working with FODF since May 2005 for the purpose of installing
a waste treatment facility at FODF that could become the basis for a future
Integrated Project.  The June 2006 agreement comtemplates expansion beyond
the initial waste treatment facility.  The Stage I System will initially be
used for testing necessary for: a) finalization of design criteria for
permitting and construction of, and b) optimization of renewable energy
production and utilization for, full scale Integrated Projects. We are
currently in negotiations toward an amended agreement with FODF pursuant to
which: a) the Company will construct a commercial scale Bion System designed
to handle the waste stream from approximately 6200 milking cows ("Initial
System") at existing FODF facilities in Indiana which will incorporate and
expand the scope of the Stage I System; and b) when the Initial System has
completed start-up phase and demonstrated environmental results consistent
with the DeVries results set forth above, the Initial System will become the
basis of expansion into an Integrated Project at FODF through development
stages including dairy expansion, construction of additional Bion System
modules including renewable energy production and solids processing
facilities and construction of an ethanol plant. It is anticipated that the
amended agreement will be executed during fiscal 2007. Preliminary

                                      60



engineering, design and site work at FODF has begun pursuant to the existing
agreement and we anticipate commencement of construction during 2007.  We
anticipate completion of development of this Integrated Project during 2008.
FODF is owned and controlled by Michael McCloskey and Timothy Den Dulk who
have served as consultants to the Company since May 2005.

ITEM 8.  DESCRIPTION OF REGISTRANT's SECURITIES TO BE REGISTERED.

     The class of securities to be registered is the Company's common stock,
no par value per share, of which 100,000,000 shares are authorized and
8,625,996 are outstanding.  Except as otherwise set forth in our Articles of
Incorporation, the holders of common stock are entitled to one vote per share
on all matters to be voted upon by the stockholders.  The holders of common
stock are entitled to share ratably in dividends, if any, as may be declared
from time to time by the board of directors out of funds legally available
for that purpose.  In the event of our liquidation, dissolution or winding
up, the holders of common stock are entitled to share ratably in all assets
remaining after payment of liabilities.  Holder of common stock have no
preemptive or conversion rights or other subscription rights.


                                   PART II

ITEM 1.  MARKET PRICE OF AND DIVIDENDS ON REGISTRANT's COMMON STOCK AND
RELATED STOCKHOLDER MATTERS.

     (a)  Market Information

     During the past two years, we have had only limited volumes of trading
in our common stock in the over the counter pink sheets market, and there is
no assurance that such trading will expand or even continue.

     Our common stock is quoted in the Pink Sheets under the symbol "BNET."
The following quotations reflect inter dealer prices, without retail mark up,
markdown or commission and may not represent actual transactions.

                                            2005            2006
Fiscal Year Ending June 30,            High     Low     High     Low
---------------------------            ----     -----   -----    -----

First Fiscal Quarter                   $2.00    $1.01   $2.75    $1.15
Second Fiscal Quarter                  $1.35    $1.05   $6.00    $2.40
Third Fiscal Quarter                   $1.35    $1.20   $9.50    $4.00
Fourth Fiscal Quarter                  $1.30    $1.15   $7.00    $4.16

     (b)  Holders

     The number of holders of record of our common stock at September 30,
2006 was approximately 742.  Many of our shares of common stock are held by
brokers and other institutions on behalf of stockholders, so we are unable to
estimate the number of stockholders represented by these record holders.

     The transfer agent for our common stock is Corporate Stock Transfer,
Inc., 3200 Cherry Creek Drive South, Suite 430, Denver, Colorado 80209.


                                      61




     (c)  Dividends

     We have never paid any cash dividends on our common stock.  Our board of
directors does not intend to declare any cash dividends in the foreseeable
future, but instead intends to retain earnings, if any, for use in our
business operations.  The payment of dividends, if any, in the future is
within the discretion of the board of directors and will depend on our future
earnings, if any, our capital requirements and financial condition, and other
relevant factors

ITEM 2.  LEGAL PROCEEDINGS.

     Bion, our President Mark A. Smith and Bion Dairy are defendants in a
class action/derivative action lawsuit in Delaware Chancery Court (TCMP#3
Partners, LLP, et al v. Trident Rowan Group, Inc., et al, Civil Action No.
170-N).  The claims against the Company primarily relate to the January 2002
transaction with Centerpoint.  The Plaintiffs basically allege in multiple
claims denoted as fraudulent and negligent misrepresentation, promissory
estoppel, and corporate waste, that Bion breached its fiduciary duties to
Centerpoint and its shareholders and/or aided and abetted others in breaching
their duties and was unjustly enriched as a result of these actions.
Further, the plaintiffs allege that Bion, Bion Dairy and Mr. Smith breached
their duties to Centerpoint and its shareholders in connection with
Centerpoint's investments in Series A* and Series B* Notes of Dairy.  This
litigation is in the early stages of discovery and motion practice.
Settlement discussions are under way at the present time and the parties have
participated in voluntary, non-binding mediation to attempt to resolve the
disputed matters, which mediation has led to a contingent settlement
agreement.  This agreement is contingent on settlement of the matter
described in the paragraph below. If a reasonable settlement is not reached
in the matter described below and, if this contingent settlement is not
completed, the Company (and Bion Dairy and Mr. Smith) intends to vigorously
defend the claims against them.  Management believes that the claims against
Bion, Bion Dairy and Mr. Smith are without merit and that such parties will
prevail if the litigation eventually proceeds to trial.  However, litigation
costs (of which a substantial amount has already been expended) can have a
material adverse effect on companies the size of Bion and Bion Dairy.
Therefore, if a reasonable settlement can be negotiated, Bion and/or Bion
Dairy may enter into such a resolution of the litigation.

     Additionally, the Company has drafted (on behalf of itself and
Centerpoint and Bion's shareholders) a complaint against the former
controlling shareholders (and related persons) of Centerpoint for damages
related to the Company's financial crisis, which were caused by their
breaches of their fiduciary duties to Bion, Centerpoint and their
shareholders.  The potential defendants have executed tolling agreements
through 30 days after the failure of the settlement in principle and the
litigation has not yet been commenced while the parties engage in settlement
discussions. Extended settlement discussions have taken place related to
these matters and agreements in principle have been reached (subject to due
diligence inquiries, drafting and execution of definitive agreements, and
court approvals).  If these settlements are concluded on terms similar to
those under discussion, Bion will be making no payments. Rather, Bion and
Centerpoint and the Bion shareholder class will be receiving substantial
asset transfers and Bion and Centerpoint will receive cash sufficient to

                                      62



offset a large part of the portion their attorneys' fees expended to date (in
these two related matters) that have not been reimbursed by insurance
carriers. However, there is as yet no assurance that these settlements will
successfully be concluded.

     On May 6, 2002, Arab Commerce Bank Ltd. ("ACB"), an unaffiliated party,
filed a complaint against the Company in the Supreme Court of the State of
New York regarding $100,000 of the Company's convertible bridge notes ("ACB
Notes") that were purchased by ACB in March of 2000.  The complaint includes
breach of contract claim asserting that the Company owes ACB $265,400 plus
interest or $121,028 including interest based on ACB's interpretation of the
terms of the ACB Notes and subsequent amendments.  Effective June 30, 2001,
the Company issued ACB 5,034 shares of common stock on conversion in full
payment of its ACB Note based on the Company's interpretation of the ACB
Note, as amended.  The Company has filed an answer to the complaint denying
the allegations. No activity has taken place in this lawsuit since 2002. The
Company does not believe that the ultimate resolution of this litigation will
have a material adverse effect on the Company, its operations or its
financial condition.

ITEM 3.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS.

     On December 8, 2005, we engaged GHP Horwath, P.C. to serve as our
independent registered public accounting firm.

     During the two most recent fiscal years, and through September 6, 2006,
the Company did not consult with GHP regarding any of the matters or events
set forth in Item 304(a)(2)(i) and (ii) of Regulation S-B.

ITEM 4.  RECENT SALES OF UNREGISTERED SECURITIES.

     On September 30, 2005, the Company, through Bion Dairy, completed a
$1,917,500 placement of Series C Notes to accredited individuals and
institutions in compliance with Regulation D of the rules of the SEC and
Section 4(2) of the 1933 Act.  The offering was conducted by the Company
without the aid of a placement agent, although the Company paid commissions
to participating dealers of $46,679, resulting in net proceeds of $1,870,821.
Completion of the offering caused, in conjunction with the Company's
technical progress and agreements with certain creditors, conversion of 100%
of Dairy's convertible A, B and C debt ($5,239,489, in aggregate, principal
and accrued interest) into 3,847,217 shares of Bion's restricted common
stock.

      In conversion of the Series A, A*, B, B*, & C Notes of Bion Dairy,
respectively, the Company issued 1,381,031, 645,753, 581,883, 274,434 and
964,117 shares of its restricted common stock including issuance of:

     *  83,340 shares to Bion which have been cancelled as treasury stock;
     *  693,799 shares to Centerpoint, of which shares Bion is the
        "beneficial owner" of 57.7% (approximately 399,011 shares) based on
        its ownership of Centerpoint.  Centerpoint has declared a dividend
        of these shares. When and if Centerpoint delivers shares to its
        shareholders, the Company will cancel these shares upon receipt;
     *  1,005,692 shares to Chris-Dan, of which, Dominic Bassani, former
        General Manager of Bion Dairy, is the owner.


                                     63




     On December 23, 2005 Bion closed an offering of 291,750 shares of its
restricted common stock at a price of $4.00 per share to accredited
individuals and institutions in compliance with Regulation D of the rules of
the SEC and Section 4(2) of the 1933 Act resulting in gross proceeds of
$1,167,000.  The offering was conducted by the Company without the aid of a
placement agent, although the Company paid commissions to participating
dealers of $30,500, resulting in net proceeds of $1,036,500.  We also issued
3,750 shares of common stock as commissions in connection with the financing.

     On May 31, 2004 Mark A. Smith, our President, purchased $135,000 of
convertible promissory notes from the Company for cash (convertible into our
common stock at $1.50 per share) and exchanged his Bion Dairy Series A &
Series B Notes (described above) for convertible notes of the Company with
identical conversion terms. All of Mr. Smith's notes were converted into
restricted common stock of the Company (209,997 shares, in aggregate) on
December 31, 2005. Further, Mr. Smith's converted $55,000 and $60,000 of
deferred compensation to 50,000 and 30,000 shares of the Company's restricted
common stock on December 31, 2004 and 2005, respectively.

     On September 13, 2006, Bion closed an offering of its Series A
Convertible Promissory Notes in the principal amount of $700,000 to
accredited individuals and institutions in compliance with Regulation D of
rules of the SEC and Section 4(2) of the 1933 Act.  The offering was
conducted by the Company without the aid of a placement agent and no
commissions or discount were paid.  The notes earn interest at the rate of
6%, payable on May 31, 2008, the maturity of the notes.  All principal and
accrued interest under the notes are required to be converted into common
shares of Bion at the rate of $6 per share if the closing market price of
Bion's common stock has been at or above $7.20 per share for 10 consecutive
trading day and the earlier to occur of (i) an effective registration
statement allowing public resale of the shares received upon conversion of
the notes or (ii) one year after September 13, 2006.  No such conversion may
occur unless Bion is a "reporting company" with the Securities and Exchange
Commission pursuant to the Securities Exchange Act of 1934, as amended.  The
notes may also be converted, in whole or in part, at the election of the
noteholders.

     As of March 31, 2007, Bion has sold $700,000 of its 2007 Series A
Convertible Promissory Notes to existing investors.  The notes earn interest
at the rate of 6%, payable on July 1, 2008, the maturity of the notes.
Principal and accrued interest under the notes is convertible at $4.00 per
share.

ITEM 5.  INDEMNIFICATION OF DIRECTORS AND OFFICERS.

     The Articles of Incorporation and the Bylaws provide that we may
indemnify our officers and directors for costs and expenses incurred in
connection with the defense of actions, suits, or proceedings where the
officer or director acted in good faith and in a manner he reasonably
believed to be in our best interest and is a party to such actions by reason
of his status as an officer or director.  To date, we have never provided
such indemnification.

     Insofar as indemnification for liabilities arising under the Securities
Act of 1933 (the "Act") may be permitted to directors, officers and
controlling persons pursuant to the foregoing provisions or otherwise, we
have been advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as expressed in the
Act and is, therefore, unenforceable.

                                     64




                                   PART F/S

     The Company's Consolidated Financial Statements for the years ended June
30, 2006 and 2005 and the three and six months ended December 31, 2006 and
2005 (unaudited) are attached hereto.

                                   PART III

ITEM 1. INDEX TO EXHIBITS; ITEM 2. DESCRIPTION OF EXHIBITS.

Exhibit
Number     Description

   3.1     Articles of Incorporation.*

   3.2     Bylaws.*

  10.1     Subscription Agreement dated January 10, 2002 between Bion
           Environmental Technologies, Inc and Centerpoint Corporation
           regarding issuance of stock in exchange for cash and claims
           regarding Aprilia.*

  10.2     Agreement dated March 15, 2002 and effective January 15, 2002
           between Bion Environmental Technologies, Inc. and Centerpoint
           Corporation regarding purchase of warrant and management
           agreement.*

  10.3     Agreement dated February 12, 2003 between Bion Environmental
           Technologies, Inc. and Centerpoint Corporation canceling
           provisions of the Subscription Agreement by and between Bion
           Environmental Technologies, Inc. and Centerpoint Corporation.*

  10.4     Promissory Note and Security Agreement between Bion
           Environmental Technologies, Inc. and Bright Capital, LLC.*

  10.5     First Amendment to Lease between Bion Environmental
           Technologies, Inc. and Pan Am Equities Corp.*

  10.6     Agreement between Bion Environmental Technologies, Inc. and
           Bergen Cove.*

  10.7     Agreement between Bion Environmental Technologies, Inc. and
           David Mitchell dated April 7, 2003.*

  10.8     Letter Agreement with Bright Capital, Ltd.*

  10.9     Agreement with OAM, S.p.A. dated May 2003.*

  10.10    Amended Agreement with Centerpoint Corporation dated
           April 23, 2003. *

  10.11    Form of Series A Secured Convertible Notes issued in August 2003.*

  10.12    Financing Documents for Bion Dairy Corporation.*

                                      65




  10.13    Form of Class SV/DB Warrant.*

  10.14    Form of Class SV/DM Warrant.*

  10.15    Form of Series A* Secured Convertible Notes issued in April 2004.*

  10.16    Form of Series B Secured Convertible Notes issued in Spring 2004.*

  10.17    Form of Series B* Secured Convertible Notes issued in June 2004.*

  10.18    Form of Series C Notes issued in September 2005.*

  10.19    Form of 2006 Series A Convertible Promissory Notes issued in
           September 2006.*

  10.20    Form of Non-Disclosure Agreement used by the Company.*

  10.21    Promissory Note and Conversion Agreement between Bion
           Environmental Technologies, Inc. and Mark A. Smith related to
           deferred compensation.*

  10.22    Promissory Note and Conversion Agreement between Bion
           Environmental Technologies, Inc. and Bright Capital, Ltd.
           related to deferred compensation.*

  10.23    Employment agreement with Mark A. Smith.*

  10.24    Employment agreement with Salvatore Zizza.*

  10.25    Employment agreement with Bright Capital, Ltd.*

  10.26    Employment agreement with Jeff Kapell.*

  10.27    Employment agreement with Jeremy Rowland.*

  10.28    Office lease at 641 Lexington Avenue, 17th Floor, New York.*

  10.29    2006 Consolidated Incentive Plan.*

  10.30    Memo to Dominic Bassani & Bright Capital, Ltd. dated October 16,
           2006 regarding Change in Title/Status of DB/Amendment to
           Brightcap Agreement.*

  10.31    Letter Agreement between Bion Dairy Corporation and Fair Oaks
           Dairy Farms dated June 19, 2006.**

  10.32    Waiver and Release Agreement with Ardour Capital Investments,
           LLC.**

  10.33    Promissory Note and Conversion Agreement for Mark Smith, dated
           January 1, 2007.**

  10.34    Promissory Note and Conversion Agreement for Salvatore Zizza,
           dated January 1, 2007.**

  10.35    Promissory Note and Conversion Agreement for Bright Capital,
           Ltd., dated January 1, 2007.**

                                      66



  10.36    Extension Agreement dated March 31, 2007 between the Company
           and Mark A Smith.***

  10.37    Form of Note dated March 31, 2007 in the amount of $151,645.89
           in favor of Mark A. Smith.***

  10.38    Form of Note dated March 31, 2007 in the amount of $379,389.04
           in favor of Salvatore Zizza.***

  10.39    Form of Note dated March 31, 2007 in the amount of $455.486.30
           in favor of Bright Capital, Ltd.***

  21       Subsidiaries of the Registrant.*
____________

*   Filed with Form 10SB12G on November 14, 2006.
**  Filed with Form 10SB12G/A on February 1, 2007.
*** Filed with Form 8-K on April 3, 2007.





































                                      67



                                 SIGNATURES

     Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereunto duly authorized.

                                     BION ENVIRONMENTAL TECHNOLOGIES, INC.


Date:  May 11, 2007                  By:/s/ Mark A. Smith
                                        Mark A. Smith, President









































                                       68

















           BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

                      CONSOLIDATED FINANCIAL STATEMENTS

                     YEARS ENDED JUNE 30, 2006 AND 2005




                                   CONTENTS

                                                                     Page
                                                                     ----

Report of independent registered public accounting firm .......      F-1

Consolidated financial statements:

  Balance sheet ...............................................      F-2

  Statements of operations ....................................      F-3

  Statements of changes in stockholders' equity deficit .......      F-4

  Statements of cash flows ....................................      F-5

  Notes to consolidated financial statements ..................   F-6 - F-19















                                    69


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


Board of Directors
Bion Environmental Technologies, Inc.


We have audited the accompanying consolidated balance sheet of Bion
Environmental Technologies, Inc. and subsidiaries as of June 30, 2006, and
the related consolidated statements of operations, stockholders' equity
deficit and cash flows for each of the two years in the period ended June 30,
2006. These consolidated financial statements are the responsibility of the
Company's management. Our responsibility is to express an opinion on these
consolidated financial statements based on our audit.

We conducted our audits in accordance with the standards of the Public
Company Accounting Oversight Board (United States). Those standards require
that we plan and perform the audit to obtain reasonable assurance about
whether the financial statements are free of material misstatement. An audit
includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by management, as
well as evaluating the overall financial statement presentation. We believe
that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above
present fairly, in all material respects, the financial position of Bion
Environmental Technologies, Inc. and its subsidiaries as of June 30, 2006,
and the results of their operations and cash flows for each of the two years
in the period ended June 30, 2006, in conformity with accounting principles
generally accepted in the United States of America.

The accompanying consolidated financial statements have been prepared
assuming that the Company will continue as a going concern.  As discussed in
Note 1 to the consolidated financial statements, the Company has suffered
recurring losses from operations and has a stockholders' deficit at June 30,
2006 that raise substantial doubt about its ability to continue as a going
concern.  Management's plans in regard to these matters are also described in
Note 1.  The consolidated financial statements do not include any adjustments
that might result from the outcome of this uncertainty.



/s/ GHP Horwath, P.C.

Denver, Colorado
September 18, 2006




                                     F-1




             BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
                            CONSOLIDATED BALANCE SHEET
                                  JUNE 30, 2006

                                     ASSETS

Current assets:
  Cash and cash equivalents                              $   1,152,199
  Prepaid services                                             103,513
   Other assets                                                  6,107
                                                         -------------
     Total current assets                                    1,261,819
                                                         -------------

Property and equipment, net                                      7,473
                                                         -------------
     Total assets                                        $   1,269,292
                                                         =============

                 LIABILITIES AND STOCKHOLDERS' EQUITY DEFICIT

Current liabilities:
  Accounts payable and accrued expenses                  $     454,193
  Accrued payable - affiliate                                   41,647
  Convertible debt                                              30,437
  Subscribed promissory notes                                  155,000
  Deferred compensation                                        581,344
                                                         -------------
     Total current liabilities                               1,262,621

Deferred compensation                                          412,500
Convertible notes - affiliates                               2,871,698
                                                         -------------
     Total liabilities                                       4,546,819
                                                         -------------
Stockholders' equity deficit:
  Preferred stock, $.01 par value, 10,000 shares
    authorized, no shares issued and outstanding                  -
  Common stock, no par value, 100,000,000 shares
    authorized, 8,625,996 shares issued, 7,932,197
    outstanding                                                   -
  Additional paid-in capital                                66,736,874
  Accumulated deficit                                      (70,014,401)
                                                         -------------
     Total stockholders' equity deficit                     (3,277,527)
                                                         -------------
     Total liabilities and stockholders' deficit         $   1,269,292
                                                         =============






                                     F-2



            BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
                    CONSOLIDATED STATEMENTS OF OPERATIONS
                      YEARS ENDED JUNE 30, 2006 AND 2005

                                                   Year Ended June 30,
                                                   2006           2005
                                               -----------    ------------

Revenue                                        $      -       $      -

Operating expenses:
  General and administrative                     1,343,431        640,965
  Research and development                       3,809,716      1,212,531
                                               -----------    -----------
                                                 5,153,147      1,853,496
                                               -----------    -----------

Loss from operations                            (5,153,147)    (1,853,496)
                                               -----------    -----------

Other (income) and expense:
  Interest expense                                 134,540        289,948
  Interest income                                  (21,514)          (531)
  Other, net                                       (92,879)       (27,581)
                                               -----------    -----------
                                                    20,147        261,836
                                               -----------    -----------
Net loss                                       $(5,173,294)   $(2,115,332)
                                               ===========    ===========

Net loss per common share, basic and diluted   $     (0.70)   $     (0.50)
                                               ===========    ===========

Weighted-average number of common shares
  outstanding, basic and diluted                 7,353,914      4,231,126
                                               ==+========    ===========
















                     See notes to financial statements.

                                     F-3



            BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
       CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY DEFICIT
                        YEARS ENDED JUNE 30, 2006 AND 2005





                                 Common Stock      Additional                      Total
                              ------------------    paid-in       Accumulated   stockholders'
                               Shares     Amount    capital         deficit     equity deficit
                              ---------   ------   -----------   ------------   --------------
                                                                 
Balances, July 1, 2004        4,206,194   $  -     $59,768,602   $(62,638,722)   $(2,870,120)
 Conversion of deferred
  compensation to common
  stock                          50,000      -          55,000           -            55,000
 Issuance of warrants in
  exchange for deferred
  compensation                     -         -         132,500           -           132,500
 Sale of warrants                  -         -          13,000           -            13,000
 Vesting of options for
  services                         -         -          20,860           -            20,860
 Net loss                          -         -            -        (2,115,332)    (2,115,332)
                              ---------   ------   -----------   ------------    -----------
Balances, June 30, 2005       4,256,194      -      59,989,962    (64,754,054)    (4,764,092)
 Conversion of debt to
  equity                      4,077,642      -       4,651,207           -         4,651,207
 Retirement of common stock     (83,340)     -            -           (87,053)       (87,053)
 Conversion of deferred
  compensation to common
  stock                          30,000                 60,000                        60,000
 Sale of common stock           295,500      -       1,136,500           -         1,136,500
 Issuance of common stock
  for services                   50,000      -         100,000           -           100,000
 Sale of warrants                  -         -          32,500           -            32,500
 Issuance of warrants for
  services                         -         -           5,000           -             5,000
 Issuance of options for
  services                         -         -          34,918           -            34,918
 Vesting of options for
  services                         -         -         726,787           -           726,787
 Net loss                          -         -            -        (5,173,294)    (5,173,294)
                              ---------   ------   -----------   ------------    -----------
Balances, June 30, 2006       8,625,996   $  -     $66,736,874   $(70,014,401)   $(3,277,527)
                              =========   ======   ===========   ============    ===========














                See notes to consolidated financial statements.

                                     F-4



             BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
                    CONSOLIDATED STATEMENTS OF CASH FLOWS
                      YEARS ENDED JUNE 30, 2006 AND 2005

                                                      Year Ended June 30,
                                                      2006           2005
                                                  -----------    -----------
CASH FLOWS FROM OPERATING ACTIVITIES
  Net loss                                        $(5,173,294)   $(2,115,332)
  Adjustments to reconcile net loss
   to net cash used in operating activities:
    Depreciation expense                               77,971        142,269
    Stock-based compensation                          866,705         20,860
    Increase in intrinsic value of convertible
     notes                                          1,974,292           -
    (Increase) decrease prepaid services               (4,508)        46,677
    (Increase) decrease other assets                   (6,107)        14,841
    Increase (decrease) accounts payable and
     accrued expenses                                (465,037)       271,008
    Deferred compensation and accrued interest        689,270        338,685
                                                  -----------    -----------
     Net cash used in operating activities         (2,040,708)    (1,280,992)
                                                  -----------    -----------
CASH FLOWS FROM INVESTING ACTIVITIES
 Purchase of property and equipment                    (9,166)          -
                                                  -----------    -----------
     Net cash used in investing activities             (9,166)          -
                                                  -----------    -----------
CASH FLOWS FROM FINANCING ACTIVITIES
 Net proceeds from sale of convertible debt         1,870,821        419,516
 Net proceeds from sale of common stock             1,136,500           -
 Increase in subscribed promissory notes              155,000           -
 Proceeds from sale of warrants                        32,500         13,000
                                                  -----------    -----------
     Net cash provided by financing activities      3,194,821        432,516
                                                  -----------    -----------
Net increase (decrease) in cash and cash
 equivalents                                        1,144,947       (848,476)
Cash and cash equivalents at beginning of year          7,252        855,728
                                                  -----------    -----------
Cash and cash equivalents at end of year          $ 1,152,199    $     7,252
                                                  ===========    ===========
Supplemental disclosure of cash flow
information:
 Cash paid for interest and income taxes          $      -       $      -
Non-cash investing and financing transactions:
 Conversion of debt to equity                     $ 4,610,832    $      -
 Conversion of deferred compensation to warrants         -           132,500
 Conversion of deferred compensation to
  common stock                                         60,000         55,000
 Conversion of accounts payable into
  convertible debt                                       -            30,437

                 See notes to consolidated financial statements.

                                      F-5




            BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                      YEARS ENDED JUNE 30, 2006 AND 2005

1.   ORGANIZATION, NATURE OF BUSINESS, GOING CONCERN AND MANAGEMENT'S
     PLANS:

Organization and business:

Bion Environmental Technologies, Inc. ("Bion" or the "Company") was
incorporated in 1987 in the State of Colorado.

Bion's patented and proprietary technology provides solutions for
environmentally sound clean-up of the waste streams of large-scale animal
farming operations ("confined animal feeding operations" or "CAFO's") (dairy,
cattle feedlot, hogs and poultry) and creates economic opportunities for
integration of alternative, renewable energy production, ethanol production,
sustainable animal husbandry and organic soil/fertilizer and feed production.
Bion's technology also potentially allows direct integration with dairy end-
users (bottling operations, cheese and ice cream plants, etc.) that can
potentially increase the profitability and quality control of each
participant while mitigating the environmental impact of the entire
integrated complex. The Company is in the process of finalizing engineering,
design and economic modeling for applications and integrated projects based
on its second-generation technology.

Bion is currently evaluating sites in multiple states and anticipates
selecting a site for its initial integrated project during its 2007 fiscal
year. Bion is presently establishing its implementation management team with
the intention of commencing development and construction of the initial
project during fiscal 2007. In addition, Bion intends to site additional
projects during 2007 and 2008 to create a pipeline of projects that will
insure significant market share and profitability within 3-5 years (both
regionally and nationally).  Each project is to include: a) Bion waste
treatment system, b) processing the CAFO waste stream from the equivalent of
approximately 20-40,000 dairy cows, c) while producing renewable energy for
on-site use, d) solids to be marketed as feed and/or fertilizer e) which is
integrated with a 20-40+M gallon/year ethanol plant (though some smaller
projects may be undertaken in appropriate situations). At the end of the 5-
year period, Bion hopes to have numerous projects in various stages of
development ranging from full operation to early construction stage.

Through 2001 the Company was primarily an environmental service company
focused on the needs of CAFOs. Thereafter, Bion elected to cease sales of its
first generation systems and focused its activities on development of its
second-generation technology.

Going concern and management's plans:

The consolidated financial statements have been prepared assuming the Company
will continue as a going concern. The Company has incurred net losses of
approximately $5,173,000 and $2,115,000 during the years ended June 30, 2006
and 2005, respectively.  At June 30, 2006, the Company has a working capital
deficiency and a stockholders' deficit of approximately $1,000 and
$3,278,000, respectively.  These factors raise substantial doubt about the
Company's ability to continue as a going concern. The accompanying
consolidated financial statements do not include any adjustments relating to
the recoverability or classification of assets or the amounts and
classification of liabilities that may result should the Company be unable to
continue as a going concern.  The following paragraphs describe management's
plans with regard to these conditions.

                                     F-6



            BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
            NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                      YEARS ENDED JUNE 30, 2006 AND 2005

1.   ORGANIZATION, NATURE OF BUSINESS, GOING CONCERN AND MANAGEMENT'S
     PLANS (CONTINUED):

Going concern and management's plans (continued):

Bion suffered from severe financial difficulties from late 2002 through the
closing of its operating subsidiary Bion Dairy Corporation's ("Dairy") Series
C Note offering on September 30, 2005.  These financial difficulties resulted
in the resignation of nearly all of the Company's officers and directors
during February and March of 2003, and the termination of most Company
employees. New management was able to retain core technical staff, but the
Company drastically curtailed business activities to include only those
activities that were directly needed to complete development and testing of
the second-generation technology.  On September 30, 2005, the Company,
through Dairy, completed a placement of convertible debt, raising net
proceeds of $1,871,000, all of which has been converted to common stock as of
June 30, 2006 (Note 10).

The Company completed a private placement of restricted common stock in
December 2005, raising net proceeds of $1,136,500 (Note 10).  During
September 2006, the Company completed a convertible note offering, raising
$700,000 (Note 6).  The Company continues to explore sources of additional
financing to satisfy its current operating requirements.

While the Company currently does not face a severe working capital shortage,
it is not currently generating any revenues. The Company will need to obtain
additional capital to fund its operations and technology development, and to
satisfy existing creditors. There is no assurance the Company will be able to
obtain the funds that it needs to stay in business, complete its technology
development or to successfully develop its business.

There can be no assurance that sufficient funds required during the next
twelve months or thereafter will be generated from operations or those funds
will be available from external sources such as debt or equity financings or
other potential sources. The lack of additional capital resulting from the
inability to generate cash flow from operations or to raise capital from
external sources would force the Company to substantially curtail or cease
operations and would, therefore, have a material adverse effect on its
business. Further, there can be no assurance that any such required funds, if
available, will be available on attractive terms or that they will not have a
significantly dilutive effect on the Company's existing shareholders.

2.   SIGNIFICANT ACCOUNTING POLICIES:

Principles of consolidation:

The consolidated financial statements include the accounts of the Company and
its wholly-owned subsidiaries, Bion Technologies, Inc., BionSoil, Inc. and
Bion Dairy Corporation and its 57.7% owned subsidiary, Centerpoint
Corporation ("Centerpoint").  All significant intercompany accounts and
transactions have been eliminated in consolidation.

Property and equipment:

Property and equipment are stated at cost and are depreciated using the
straight-line method over the estimated useful lives of the related assets,
generally three to ten years.  The Company reviews its property and equipment
for impairment whenever events or changes in circumstances indicate that the
carrying amount of an asset may not be recoverable.

                                    F-7



            BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
            NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                      YEARS ENDED JUNE 30, 2006 AND 2005

2.   SIGNIFICANT ACCOUNTING POLICIES (CONTINUED):

Income taxes:

The Company recognizes deferred tax assets and liabilities for the future tax
consequences attributable to differences between the financial statement
carrying amounts of existing assets and liabilities and their tax bases, as
well as net operating losses.

Deferred tax assets and liabilities are measured using enacted tax rates
expected to apply to taxable income in the years in which those temporary
differences are expected to be recovered or settled.  The effect on deferred
tax assets or liabilities of a change in tax rates is recognized in the
period in which the tax change occurs.  A valuation allowance is provided to
reduce the deferred tax assets to a level, that more likely than not, will be
realized.

Cash and cash equivalents:

The Company considers all highly liquid investments purchased with an
original maturity of three months or less to be cash equivalents.

Loss per share:

Basic loss per share amounts are calculated using the weighted average number
of shares of common stock outstanding during the period.  Diluted earnings
(loss) per share assumes the conversion, exercise or issuance of all
potential common stock instruments, such as options or warrants, unless the
effect is to reduce the loss or increase earnings per share.  During each of
the years ended June 30, 2006 and 2005, the effect of outstanding options and
warrants would have been anti-dilutive.

Fair value of financial instruments:

The fair values of cash and cash equivalents, convertible debt, subscribed
promissory notes and accounts payable approximate their carrying amounts due
to their short-term maturities. It is not practicable to estimate the fair
value of the accounts payable-affiliate, convertible notes-affiliates and
deferred compensation liability due to the related party nature of the
underlying transactions.

Use of estimates:

In preparing financial statements in conformity with accounting principles
generally accepted in the United States of America, management is required to
make estimates and assumptions that affect the reported amounts of assets and
liabilities and the disclosure of contingent assets and liabilities at the
date of the financial statements and the reported amounts of revenues and
expenses during the reporting period.  Actual results could differ from those
estimates.

Concentrations of credit risk:

The Company's financial instruments that are exposed to concentrations of
credit risk consist of cash and cash equivalents.  The Company's cash and
cash equivalents are in demand deposit accounts placed with federally insured
financial institutions and selected brokerage accounts. Such deposit accounts
at times may exceed federally insured limits.  The Company has not
experienced any losses on such accounts.

                                     F-8


            BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
            NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                      YEARS ENDED JUNE 30, 2006 AND 2005


2.   SIGNIFICANT ACCOUNTING POLICIES (CONTINUED):

Stock-based compensation:

SFAS No. 123, Accounting for Stock-Based Compensation ("SFAS No. 123"),
establishes financial accounting and reporting standards for stock-based
employee compensation plans.  SFAS No. 123 encourages entities to adopt a
fair-value-based method of accounting for stock compensation plans.  However,
SFAS No. 123 also permits entities to continue to measure compensation cost
under Accounting Principles Board Opinion No. 25 ("APB 25") with the
requirement that pro forma disclosures of net income (loss) and earnings
(loss) per share be included in the notes to the financial statements.   The
Company has elected to measure compensation cost under APB 25; accordingly,
the Company uses the intrinsic value method to account for its stock-based
employee compensation plans.  Had compensation cost for these plans been
determined consistent with the fair value method prescribed by SFAS No. 123,
the Company's pro forma net loss and loss per share would have been as
follows:

                                           June 30, 2006     June 30, 2005
                                           -------------     -------------
Net loss:
 As reported                               $ (5,173,000)     $ (2,115,000)
 Less: Stock-based compensation expense
       determined under fair value method      (464,000)         (184,000)
                                           ------------      ------------
Pro forma                                  $ (5,637,000)     $ (2,299,000)
                                           ============      ============
Basic and diluted net loss per share:
 As reported                                     ($0.70)           ($0.50)
                                           ============      ============
 Pro forma                                       ($0.77)           ($0.54)
                                           ============      ============

The fair value of each option grant is estimated on the date of grant using
the Black-Scholes option-pricing model with the following weighted-average
assumptions for the grants in each of the following years:

   Options granted   Expected    Expected     Risk-Free      Expected
     year ended      dividend   volatility   interest rate     term
   ---------------   --------   ----------   -------------   --------

    June 30, 2004       nil         177          2.87%       4 years
    June 30, 2005       nil         196          3.90%       5 years
    June 30, 2006       nil         195          4.75%       3.5 years


Comprehensive income (loss):

SFAS No. 130, Reporting Comprehensive Income establishes standards for
reporting and display of comprehensive income (loss), its components, and
accumulated balances.  For the years ended June 30, 2006 and 2005, there was
no difference between net loss and comprehensive loss.



                                     F-9


            BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
            NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                      YEARS ENDED JUNE 30, 2006 AND 2005

2.   SIGNIFICANT ACCOUNTING POLICIES (CONTINUED):

Revenue recognition:

While the Company has not reported any revenues for the years ended June 30,
2006 and 2005, the Company anticipates that future revenues will be generated
from product sales and technology license fees.  The Company expects to
recognize revenue from product sales when there is persuasive evidence that
an arrangement exits, when title has passed, the price is fixed or
determinable, and collection is reasonably assured.  The Company expects that
technology license fees will be generated from the licensing of Bion's
integrated system.  The Company anticipates that it will charge its customers
a non-refundable up-front technology license fee, which will be recognized
over the estimated life of the customer relationship.  In addition, any on-
going technology license fees will be recognized as earned based upon the
performance requirements of the agreement.

Recent accounting pronouncements:

In December 2004, the Financial Accounting Standards Board ("FASB") issued
SFAS No. 123(R) Share Based Payment, which addresses the accounting for
share-based payment transactions.  SFAS No. 123(R) eliminates the ability to
account for share-based compensation transactions using APB No. 25, and
generally requires instead that such transactions be accounted and recognized
in the statement of income based on their fair values.  SFAS No. 123(R) will
be effective for the Company beginning on July 1, 2006.  Depending upon the
number and terms of options that may be granted in future periods, management
believes that the implementation of this standard could have a material
impact on the Company's financial statements.  As of June 30, 2006, the
estimated fair value of non-vested employee stock options was approximately
$130,000.

3.   MINORITY INTEREST OF CENTERPOINT CORPORATION:

In January 2002, Bion purchased a 57.7% majority interest in Centerpoint from
a third party.  For the years ended June 30, 2006 and 2005, the losses
applicable to the minority interest in Centerpoint exceeded the minority
interest in the equity capital of Centerpoint, therefore the losses
attributable to the minority interest have been charged against the Company's
earnings as there is no obligation of the minority interest to make good on
such losses.  If Centerpoint has future earnings, the Company shall be
credited to the extent of the minority interest losses previously absorbed.

4.   PREPAID SERVICES:

The Company has issued options to purchase shares of the Company's common
stock in exchange for services.  As of June 30, 2006, non-employee options
represented 630,833 of the 1,410,833 options outstanding under the Company's
2006 Consolidated Incentive Plan (Note 10).  Of the 630,833 non-employee
options outstanding, 260,833 were fully vested and contained no service
conditions as of June 30, 2006. These non-employee options were valued using
the Black-Scholes option-pricing model.  Prepaid services of approximately
$43,000 at June 30, 2006 in connection with the fully vested options are
being amortized on the straight-line method through June 30, 2007.  The
Company also issued shares of common stock to a consultant in exchange for
services to be performed through June 30, 2007, of which $60,000 is deferred
as of June 30, 2006.

                                    F-10



            BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
            NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                      YEARS ENDED JUNE 30, 2006 AND 2005

4.   PREPAID SERVICES (CONTINUED):

The remaining 370,000 non-employee options outstanding include service
conditions and have graded vesting schedules through May 1, 2009.  As of June
30, 2006, 97,500 of these options were fully vested.  Generally for these
agreements, the measurement date of the services occurs when the options
vest.  In accordance with Emerging Issues Task Force ("EITF") Issue No. 96-
18, recognition of compensation cost for reporting periods prior to the
measurement date is based on the then current fair value of the options.
Any subsequent changes in fair value is recorded on the measurement date.
The fair value of these options were determined using the Black-Scholes
option-pricing model, using the following assumptions as of June 30, 2006;  a
dividend yield of zero,  volatility of 182%, risk-free interest rate of
5.15%, and an expected life of 8.83 years.  Compensation cost in connection
with options that are not fully vested as of June 30, 2006 is being
recognized on a straight-line basis over the requisite service period for the
entire award.  Compensation expense of $726,787 and $20,860 was recorded
during the years ended June 30, 2006 and 2005, respectively.

5.   PROPERTY AND EQUIPMENT:

Property and equipment consists of the following as of June 30, 2006:

     Research and development equipment     $     305,266
     Computers and office equipment                13,189
                                            -------------
                                                  318,455
     Less accumulated depreciation               (310,982)
                                            -------------
                                            $       7,473
                                            =============

Depreciation expense was $77,971 and $142,269 for the years ended June 30,
2006 and 2005, respectively.

6.   SUBSCRIBED PROMISSORY NOTES:

In June 2006, the Company commenced an offering of its 2006 Series A
Convertible Promissory Notes (the "Notes"), with a minimum of $500,000 and
maximum of $3,000,000 in Notes to be issued.  The holders of the Notes are to
earn interest on the unpaid principal balance of the Notes at 6%, payable on
May 31, 2008, the maturity date of the Notes.  All of the principal and
accrued interest under the Notes shall be converted into common shares of the
Company at the conversion rate of one share for each $6.00 that is owed under
the terms of the Notes if the following conditions are met:

     A)    The closing market price of the Company's shares has been at or
           above $7.20 per share for 10 consecutive trading days, and

     B)   The earliest of the following events:

          1)   An effective registration allowing public resale of the shares
               to be received by the Note holders upon conversion, or
          2)   One year after the initial closing date of the offering, and
          3)   No conversion without an effective registration statement
               shall take place until the Company has become a "reporting
               company" with the Securities and Exchange Commission pursuant
               to the Securities Exchange Act of 1934, as amended.

                                     F-11



            BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
            NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                      YEARS ENDED JUNE 30, 2006 AND 2005

6.   SUBSCRIBED PROMISSORY NOTES (CONTINUED):

The Notes may also be convertible, in whole or in part, into the Company's
common shares at any time at the election of the Note holders at a conversion
rate of $6.00 per share. As of June 30, 2006, the Company had received signed
subscription agreements and proceeds totaling $155,000, and through September
13, 2006, the date the offering closed, $700,000 was received.

7.   CONVERTIBLE DEBT:

In June 2005, the Company and a vendor signed an agreement whereby $30,437 of
unpaid consulting fees due to the vendor are to be convertible into common
stock of the Company at a conversion price of $2.50 per share at the vendor's
option until May 1, 2007.  If the vendor does not elect to convert the debt
prior to May 1, 2007, the debt will be paid by the Company on that date.  The
market value of the shares at the time of the agreement was approximately
$1.25 per share.  Therefore, no beneficial conversion features resulted from
the agreement.

8.   CONVERTIBLE NOTES - AFFILIATES:

On April 4, 2006 convertible deferred compensation due to the Company's
president, Mark A. Smith, pursuant to an April 2003 deferred compensation
agreement, was exchanged for a promissory note and conversion agreement.  The
promissory note and conversion agreement have the same terms and conversion
features as the April 2003 deferred compensation agreement.  Under the
agreements, the president earns compensation of $150,000 annually, all of
which has been deferred to date.  Sums accrued through March 31, 2006, accrue
interest at 6% per annum, and are convertible into the Company's common stock
at the lower of the current market value at the time of conversion, or $2.00
per share.  Through July 1, 2007, conversions may occur by mutual agreement
between the Company and Mr. Smith. The Company may convert the deferred
compensation, in whole or in part, at any date after July 1, 2007 and the
convertible deferred compensation owed the president is mandatorily converted
to common stock of the Company on July 1, 2009.  The Company is accounting
for this employee stock-based agreement under APB 25.  At June 30, 2006, the
note balance (principal and accrued interest) due to Mr. Smith was $378,981,
and the market price of the Company's common stock was $6.40 per share.
Therefore the Company has recorded the intrinsic value of the deferred
compensation agreement at $1,212,739 as of June 30, 2006.  Had the Company
been accounting for this employee stock-based agreement under SFAS 123, the
fair value of the deferred compensation agreement as of June 30, 2006 would
be approximately $1,500,000.  Sums accrued after April 1, 2006, ($37,500
through June 30, 2006), are non-interest bearing and are non-convertible.

On December 31, 2005, convertible deferred compensation payable to Bright
Capital, Ltd. ("Brightcap") for services provided to the Company by Dominic
Bassani, the general manager of Dairy, between April 1, 2003 and September
30, 2005 was exchanged for a promissory note and conversion agreement with
the same terms and features as the deferred compensation agreement.
Effective March 31, 2005, Brightcap entered into an agreement to continue to
provide Mr. Bassani's services to the Company through March 31, 2009 and
Brightcap earns compensation of $300,000 annually with payment deferred.
Sums accrued through September 30, 2005, accrue interest at 6% per annum and
are convertible into the Company's common stock at the lower of the current
market value at the time of conversion or $2.00 per share. Through January 1,
2007 conversions may occur by mutual agreement between the Company and
Brightcap.  The Company may convert the deferred compensation, in whole or in
part, at any date after January 1, 2007 and, on July 1, 2009, the Company's
obligation owed Brightcap is mandatorily convertible to common stock of the
Company. The Company is accounting for this employee stock-based agreement
under APB 25.  At June 30, 2006, compensation due to Brightcap was $518,425
and the market price of the Company's common stock was $6.40 per share.

                                     F-12



            BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
            NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                      YEARS ENDED JUNE 30, 2006 AND 2005

8.   CONVERTIBLE NOTES - AFFILIATES (CONTINUED):

Therefore the Company has recorded the intrinsic value of the deferred
compensation agreement at $1,658,959 as of June 30, 2006.  Had the Company
been accounting for this employee stock-based agreement under SFAS 123, the
fair value of the deferred compensation agreement as of June 30, 2006 would
be approximately $2,000,000.  Sums accrued after October 1, 2005, ($225,000
through June 30, 2006), are non-interest bearing and are non-convertible.

9.   DEFERRED COMPENSATION:

Prior to March 31, 2003, the Company incurred management fees under various
management agreements with the D2 LLC Deferred Compensation Trust ("Trust")
for management and consulting services. These fees totaled $581,344 including
interest at 6%, as of June 30, 2006.  The services were provided in part by
Dominic Bassani, who beneficially owns 50% of the Trust.  In March 2003, the
Trust agreed to accept payment on March 31, 2007, by conversion of the
deferred compensation into common stock of the Company at the higher of the
average price of the Company's common stock during the ten trading days
ending March 27, 2007, or $4.00 per share.

The Company has also recorded deferred compensation liabilities of $412,500
for three officers of the Company consisting of $37,500 to Mark A. Smith
(Note 8), $225,000 to Brightcap Capital Ltd. (Note 8), and $150,000 to
Salvatore Zizza, a former officer and director of the Company, who assumed
the position of Chairman and director of Dairy with an annual salary of
$300,000.  This deferred compensation does not accrue interest and is non-
convertible. Payment is to be made at the earliest date that the Company has
in excess of $2,000,000 in cash and cash equivalents or as decided by the
Board of Directors or December 31, 2007.

10.  STOCKHOLDERS' EQUITY:

Common stock:

Holders of common stock are entitled to one vote per share on all matters to
be voted on by common stockholders.  In the event of liquidation, dissolution
or winding up of the Company, the holders of common stock are entitled to
share in all assets remaining after liabilities have been paid in full or set
aside. Common stock has no preemptive, redemption or conversion rights.  The
rights of holders of common stock are subject to, and may be adversely
affected by, the rights of the holders of any other series of preferred stock
the Company may designate in the future.

On December 31, 2004, the president of the Company converted $55,000 of
deferred compensation into 50,000 shares of common stock. The conversion rate
of $1.10 per share was based on the deferred compensation agreement with the
president and the market price of the common stock of the Company on the date
of conversion (see Note 8).

In May 2005, Brightcap converted deferred compensation of $60,000 into
600,000 warrants and Salvatore Zizza was issued 600,000 warrants valued at
$60,000 in lieu of payment for services rendered to the Company.  Also in May
2005, Mark Smith was granted a $12,500 bonus and purchased 125,000 warrants
of the Company for $12,500.  The price per warrant of $0.10 was based on the
price received for concurrent and subsequent sales of warrants for cash.

In June 2005, Mark Smith and Jeff Kapell purchased 30,000 and 100,000
warrants of the Company at $.10 per warrant for $3,000 and $10,000,
respectively.

                                    F-13



            BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
            NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                      YEARS ENDED JUNE 30, 2006 AND 2005

10.  STOCKHOLDERS' EQUITY (CONTINUED):

Common stock (continued):

On September 30, 2005, the Company completed a $1,917,500 (net proceeds
$1,870,821) placement of Series C notes of Dairy, which triggered the
conversion of the Dairy's Series A, B and C notes ($5,239,489 in aggregate)
into 3,847,217 shares of the Company's common stock, including 693,799 shares
issued to Centerpoint and 83,340 shares issued to Bion.

In conjunction with the conversion, the Company retired the 83,340 shares of
common stock issued to the Company.  The shares issued to Bion and
Centerpoint were recorded at $87,053 and $807,045, being the carrying value
of the debt that was converted.

As a result of dividends declared in July 2004, Centerpoint holds the shares
for the benefit of its shareholders without any beneficial interest.  The
Company is accounting for the shares issued to Centerpoint as treasury stock.
The Company issued 20,428 shares of common stock as commissions in connection
with the placement of the C Notes of Dairy.

On December 31, 2005, the president of the Company converted, with similar
terms as the Dairy A, B and C notes, promissory notes of the Company totaling
$265,440 in principal and interest for 209,997 shares of common stock and
also converted $60,000 of deferred compensation into 30,000 shares of common
stock.  The conversion rate of $2.00 per share was based on the deferred
compensation agreement with the President (see Note 8).

In December 2005, the Company completed a private financing of 291,750 shares
of common stock priced at $4.00 per share.  Net proceeds to the Company were
$1,136,500 and the Company also issued 3,750 shares of common stock as
commissions in connection with the financing.

During the year ended June 30, 2006, the Company issued 50,000 shares of
common stock to a consultant for services valued at $100,000.  The number of
shares issued were based upon the market price of the common shares at the
time the service agreement was entered into.

Warrants:

As of June 30, 2006 the Company had the following common stock warrants
outstanding:

                  Number of     Exercise
                   Shares        Price        Expiration Date
                  ---------     --------     -----------------
Class J/SLAV         10,573     $   6.00     August 31, 2006
Class SVDB 1-6      800,000     $   3.00     July 31, 2013
Class SVDM-1        387,343     $   5.00     July 31, 2008
Class DB-1          600,000     $   1.00     January 31, 2014
Class A 1-3         600,000     $   2.50     May 14, 2015
Class SVMAS-1        67,500     $   3.50     May 31, 2009
Class SVMAS-1A       40,000     $   3.50     October 11, 2009
Class SVMAS-2        32,500     $   2.50     September 30, 2009
Class SVMAS-3        40,000     $   2.50     September 30, 2015
Class SVB 1-3        50,000     $   2.50     April 30, 2015
Class SVB-4          75,000     $   2.50     April 30, 2015
Class SVC 1-5       125,000     $   4.25     December 31, 2012
Class SV-SEI 1-2     41,667     $   1.50     June 30, 2009
Class C, D, E       725,000     $   2.50     April 30, 2015
Class O             100,000     $   3.00     December 31, 2008
                  ---------
                  3,694,583
                  =========
                                     F-14




            BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
            NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                      YEARS ENDED JUNE 30, 2006 AND 2005

10.  STOCKHOLDERS' EQUITY (CONTINUED):

Warrants (continued):

The weighted average exercise for the outstanding warrants is $2.73 and the
weighted average life as of June 30, 2006 is 7 years.

During the year ended June 30, 2006, the president of the Company purchased
80,000 warrants in two separate transactions of 40,000 warrants each at $.25
per warrant, totaling $20,000.  The president also purchased 125,000 warrants
at $.10 per warrant for $12,500.

The Company issued 25,000 warrants priced at $.20 per warrant to a consultant
during the year ended June 30, 2006 for services valued at $5,000.

Stock options:

Prior to June 2006, the Company had various incentive plans (the "Plans")
that provided for incentive stock options to be granted to selected employees
and directors of the Company, and selected non-employee advisors to the
Company.   Effective June 2006, the Company approved the 2006 Consolidated
Incentive Plan (the "2006 Plan"), which consolidated previously reserved
incentive stock options under the Plans into the 2006 Plan.  The Company has
reserved 3,200,000 shares, the maximum number of shares of the common stock
of the Company issuable pursuant to the 2006 Plan. Terms of exercise and
expiration of options granted under the 2006 Plan may be established at the
discretion of the Board of Directors, but no option may be exercisable for
more than ten years.

During the year ended June 30, 2006, the Company granted options to purchase
17,000 shares of common stock at $3.00 to $6.00 per share to non-employees.
The fair value of the options, using the Black-Scholes option pricing model,
is $34,918, of which options totaling $32,738 vested immediately and were
recognized as non-cash stock compensation expense.  The remaining $2,180 of
options vest over a year and $1,163 was amortized on a straight line basis in
the year ended June 30, 2006 as non-cash stock compensation.

The Company granted options to purchase 77,500 shares of common stock to
employees and directors for the year ended June 30, 2006.  The options have
an exercise price of $4.25 to $5.50 per share and are fully vested.  The
Company applies APB Opinion 25 and related interpretations in accounting for
equity instruments issued to employees. Accordingly, no compensation cost has
been recognized for its employee stock options as all options had an exercise
price equal to or greater than the market value of the Company's common stock
at the date of grant.

As of June 30, 2006, options outstanding under the 2006 Plan are summarized
as follows:









                                     F-15



            BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
            NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                      YEARS ENDED JUNE 30, 2006 AND 2005

10.  STOCKHOLDERS' EQUITY (CONTINUED):

Stock options (continued):

                                                 Outstanding Options
                                         Number of          Weighted Average
                                           Shares            Exercise Price
                                         ---------          ----------------
     Balance, July 1, 2004                 651,333             $     3.14
       Options granted                     665,000             $     2.50
       Options exercised                      -                       -
       Options cancelled                      -                       -
                                         ---------             ----------
     Balance, June 30, 2005              1,316,333             $     2.82
       Options granted                      94,500             $     4.69
       Options exercised                      -                       -
       Options cancelled                      -                       -
                                         ---------             ----------
     Balance, June 30, 2006              1,410,833             $     3.15

There were 956,667 options exercisable as of June 30, 2006.

The following table presents information relating to stock options
outstanding and exercisable as of June 30, 2006:





                                         Weighted-     Weighted-
                                         Average       Average                     Weighted-
                                         Remaining     Outstanding                 Average
                           Outstanding   Contractual   Exercise      Exercisable   Exercise
Range of Exercise Prices   Shares        Life-         Price-        Shares        Price
------------------------   -----------   -----------   -----------   -----------   ---------
                                                                    
     $2.00 - $2.50            812,500       7.7          $ 2.41        363,334      $ 2.30
     $3.00 - $3.50            420,333       2.1          $ 3.00        415,333      $ 3.00
     $4.00 - $4.75             40,000       4.4          $ 4.28         40,000      $ 4.28
     $5.00 - $7.50            138,000       2.7          $ 5.53        138,000      $ 5.53
    ---------------         ---------      -----         ------        -------      ------
                            1,410,833       5.5          $ 2.94        956,667      $ 3.15
                            =========      =====         ======        =======      ======





The Company, after giving consideration for the contingent deferred stock
bonuses (Note 12) and employee stock bonuses in 2002 and previously exercised
options of 75,440 shares, had 1,023,727 shares reserved for future issuance
under the 2006 Plan as of June 30, 2006.

11.  INCOME TAXES:

The Company has net operating loss carry-forwards ("NOLs") for tax purposes
of approximately $36,100,000 as of June 30, 2006.  These NOLs expire on
various dates from 2009 to 2027.

The utilization of the NOLs may be limited under Section 382 of the Internal
Revenue Code.


                                     F-16



            BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
            NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                      YEARS ENDED JUNE 30, 2006 AND 2005

11.  INCOME TAXES (CONTINUED):

The Company's deferred tax assets as of June 30, 2006, are estimated as
follows:

               NOLs                        $  13,700,000
               Deferred compensation           1,500,000
                                           -------------
                                              15,200,000
               Valuation allowance           (15,200,000)
                                           -------------
               Net deferred tax assets     $       -
                                           =============

Deferred income taxes reflect the net tax effects of temporary differences
between the carrying amounts of assets and liabilities for financial
reporting purposes and the amounts used for income tax purposes.

The Company has provided a valuation allowance of 100% of its net deferred
tax asset due to the uncertainty of generating future profits that would
allow for the realization of such deferred tax assets.

The expected tax benefit for each of the years ended June 30, 2006 and 2005,
based on a federal tax rate of 34%, is approximately $1,759,000 and $719,000,
respectively.  The difference between the expected tax benefit and non-
recognition of a tax benefit during 2006 and 2005 is primarily the result of
a valuation allowance applied to the deferred tax assets.

12.  COMMITMENTS AND CONTINGENCIES:

Employment and consulting agreements:

The Company has an employment agreement with its president, Mark A. Smith,
through March 31, 2007 providing $150,000 per year compensation.

Effective March 31, 2005, an agreement with Brightcap, through which the
services of the general manager of Dairy, Dominic Bassani, are provided, was
extended through March 31, 2009.  Under the terms of the agreement, Brightcap
will be paid $300,000 annually for Mr. Bassani's services.

Effective May 1, 2005, the Company entered into a four-year consulting/
employment agreement with a former officer and director of the Company,
Salvatore Zizza.  As of January 1, 2006, the former officer and director
assumed the position of Chairman and director of Dairy, with an annual salary
of $300,000 (Note 8).

Effective May 1, 2005, the Company entered into a four-year consulting/
employment agreement with Jeff Kapell.  Under the terms of the agreement, Mr.
Kapell provided part-time services to the Company through March 2006.  In
April 2006, Mr. Kapell was appointed Dairy's Vice President-Renewables at a
salary of $120,000 per year.

In May 2005 the Company declared contingent deferred stock bonuses of 690,000
shares to its key employees and consultants.  The stock bonuses of 492,500
and 197,500 shares are contingent upon the Company's stock price exceeding
$10.00 and $20.00 per share, respectively, and the grantees still being
employed by or providing services to the Company at the time the target
prices are reached.

                                     F-17



            BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
            NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                      YEARS ENDED JUNE 30, 2006 AND 2005

12.  COMMITMENTS AND CONTINGENCIES (CONTINUED):

Employment and consulting agreements (continued):

During February and March of 2003, four members of the Company's core
technical staff who had previously been terminated, returned to the Company
to work for reduced compensation.  While the Company does not have a legal
obligation to pay the difference between the original compensation and the
reduced compensation, if and when the Company has sufficient financial
resources, it is the Company's intention to provide bonuses, over a one to
two-year period, to compensate for the reduced wages.  As of June 30, 2006,
the amount of reduced compensation amounted to approximately $130,000.

Joint venture agreement:

In June 2006, the Company entered into a joint venture agreement with Fair
Oaks Dairy Farm ("FODF") to construct a long term Bion research facility at
FODF ("Stage I System").  The Stage I System will initially be used to
complete testing necessary for the development of design criteria for
permitting and construction of the integrated, full-scale Stage II
installation at FODF.  The estimated cost of Stage I, including system
construction and testing operations in support of Stage II permitting, is
$750,000 which the Company and FODF have agreed to split equally net of any
grants.  Bion has also agreed that FODF funding shall be convertible into the
Company's common shares under the same terms as the 2006 Series A Convertible
Promissory Notes.  Dr. Michael McCloskey and Mr. Timothy den Dulk, co-owners
of FODR, are both consultants to Dairy and have each received 175,000 options
with service conditions and graded vesting schedules through May 1, 2009.
The Company is accounting for its investment in the joint venture using the
equity method.  Through June 30, 2006, neither the Company nor FODF have
contributed any amounts to the joint venture.

Claims contingency:

In May 2002, Arab Commerce Bank Ltd. ("ACB"), an unaffiliated party, filed a
complaint against the Company in the Supreme Court of the State of New York
regarding $100,000 of the Company's convertible bridge notes ("Bridge Notes")
that were issued to ACB in March 2000.  The complaint includes a breach of
contract claim asserting that the Company owes ACB approximately $285,000
plus interest of $121,028 plus interest based on ACB"s interpretation of the
terms of the Bridge Notes and subsequent amendments.  Effective June 30,
2001, the Company issued ACB 5,034 shares of common stock in full
satisfaction of the Bridge Notes based on the Company's interpretation of the
Bridge Notes, as amended. The Company has filed an answer to the complaint
denying the allegations. No activity has taken place on this lawsuit since
early 2002.  The Company believes that the ultimate resolution of this
litigation will not have a material adverse effect on the Company, its
operations or its financial condition.

The Company, together with the former controlling persons of Centerpoint, and
the Company's president are defendants in a class action derivative action
lawsuit in Delaware Chancery Court (TCMP#3 Partners, LLP, et al v. Trident
Rowan Group, Inc. et al, Civil Action No. 170-N).  The claims against the
Company primarily relate to a January 2002 financing transaction with
Centerpoint, in which it is claimed the Company breached its fiduciary duties
to Centerpoint and its shareholders and/or aided and abetted others in
breaching their duties.  Litigation is in the early stages of discovery and
motion practice.  Settlement discussions are under way, and the parties have

                                     F-18



            BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
            NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                      YEARS ENDED JUNE 30, 2006 AND 2005

12.  COMMITMENTS AND CONTINGENCIES (CONTINUED):

Claims contingency (continued):

participated in voluntary, non-binding mediation to attempt to resolve the
disputed matters, which has led to a contingent settlement agreement. This
agreement is contingent on settlement of a complaint to be filed by the
Company against the former controlling shareholders of Centerpoint.
Management believes the claims against the Company are without merit and
intends to defend the claims if a settlement is not reached.

13.  RELATED PARTY TRANSACTIONS:

The Company has an accrued payable of $41,647 to a company controlled by
Salvatore Zizza for rental of office space in 2003.

14.  SUBSEQUENT EVENTS:

Effective August 28, 2006, pursuant to terms agreed upon on December 15,
2005, the Company entered into a four year employment agreement with Jeremy
Rowland.  As of September 18, 2006, Mr. Rowland will assume the position of
Chief Operating Officer of Dairy with an annual salary of $150,000.  In
addition, 150,000 options were issued which are exercisable at $4.00 per
share through December 2015 and vest 25% at the start date of his employment,
and 25% at each of the next 3 anniversaries of his start date.

The Company signed a non-cancellable operating lease commitment for office
space, in New York, effective August 1, 2006 and expiring November 30, 2013.
The average monthly rental under the terms of the lease is $15,820.  The
Company is currently negotiating sublease agreements to unrelated third
parties.




















                                     F-19










           BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES

                      CONSOLIDATED FINANCIAL STATEMENTS

                      NINE MONTHS ENDED MARCH 31, 2007
                                 (UNAUDITED)




                                  CONTENTS

                                                                 Page
                                                                 ----
Consolidated financial statements:

   Balance sheet .............................................   F-21

   Statements of operations ..................................   F-22

   Statements of changes in stockholders' equity deficit .....   F-23

   Statements of cash flows ..................................   F-24

   Notes to consolidated financial statements ................   F-25 - F-38



















                                   F-20


             BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
                          CONSOLIDATED BALANCE SHEET
                                MARCH 31, 2007
                                  (UNAUDITED)

                                    ASSETS

Current assets:
   Cash and cash equivalents                                   $   843,264
   Prepaid services and rent                                        24,448
   Deposits and other receivables                                    3,049
                                                               -----------
         Total current assets                                      870,761
                                                               -----------
Restricted cash                                                    171,945
Property and equipment, net                                         79,531
                                                               -----------
         Total assets                                          $ 1,122,237
                                                               ===========

                     LIABILITIES AND STOCKHOLDERS' DEFICIT

Current liabilities
   Accounts payable and accrued expenses                       $   653,044
   Accrued payable - affiliate                                      41,647
   Convertible debt                                                 30,437
   2006 Series A convertible promissory notes                      727,243
                                                               -----------
         Total current liabilities                               1,452,371

   Deferred rent                                                    72,097
   2007 Series A convertible promissory notes                      700,000
   2007 Series A convertible promissory notes - affiliates         986,521
   Convertible notes - affiliates                                2,063,123
                                                               -----------
         Total liabilities                                       5,274,112

Stockholders' deficit:
   Preferred stock, $.01 par value, 10,000,000 shares
     authorized, no shares issued and outstanding                     -
   Common stock, no par value, 100,000,000 shares
     authorized, 8,757,904 shares issued, 8,064,105
     outstanding                                                      -
   Additional paid-in capital                                   67,746,763
   Accumulated deficit                                         (71,898,638)
                                                               -----------
         Total stockholders' deficit                            (4,151,875)
                                                               -----------
Total liabilities and stockholders' deficit                    $ 1,122,237
                                                               ===========


See notes to unaudited consolidated financial statements.

                                     F-21


             BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
                       CONSOLIDATED STATEMENTS OF OPERATIONS
              THREE AND NINE MONTHS ENDED MARCH 31, 2007 AND 2006
                                   (UNAUDITED)





                                      Three Months Ended March 31,  Nine Months Ended March 31,
                                          2007          2006            2007          2006
                                      -----------   -----------     -----------    -----------
                                                                       
Revenue                               $     -       $      -        $      -       $      -
                                      -----------   -----------     -----------    -----------
Operating expenses:
 General and administrative
  (including the remeasurement
  of convertible deferred com-
  pensation of $(339,000), $234,000,
  $(667,000), and $514,000,
  respectively)                           (58,910)      348,051         (58,874)       873,199
 Research and development (in-
  cluding the remeasurement of
  convertible deferred compensa-
  tion of $(463,000), $206,000,
  $(913,000), and $702,000,
  respectively)                           104,233     1,020,923       1,134,950      2,680,814
                                      -----------   -----------     -----------    -----------
                                           45,323     1,368,974       1,076,076      3,554,013
                                      -----------   -----------     -----------    -----------
Loss from operations                      (45,323)   (1,368,974)     (1,076,076)    (3,554,013)
                                      -----------   -----------     -----------    -----------
Other (income) and expense:
 Interest expense                          44,321        20,884         105,427        113,136
 Interest income                           (5,351)       (9,700)        (28,652)       (10,627)
 Other, net                                  -             (817)           -           (91,614)
                                      -----------   -----------     -----------    -----------
                                           38,970        10,367          76,775         10,895
                                      -----------   -----------     -----------    -----------
Loss before cumulative effect of
 change in accounting principle           (84,293)   (1,379,341)     (1,152,851)    (3,564,908)

Cumulative effect of change in
 accounting principle                        -             -            731,386           -
                                      -----------   -----------     -----------    -----------
Net loss                              $   (84,293)  $(1,379,341)    $(1,884,237)   $(3,564,908)
                                      ===========   ===========     ===========    ===========
Net loss per common share, basic
and diluted:
 Before cumulative effect
  of change in accounting principle   $     (0.01)   $    (0.16)    $     (0.14)   $     (0.43)
 Cumulative effect of change in
  accounting principle                       -              -             (0.08)          -
                                      -----------   -----------     -----------    -----------
Net loss                              $     (0.01)  $     (0.16)    $     (0.22)   $     (0.43)
                                      ===========   ===========     ===========    ===========
Weighted-average number of common
 shares outstanding, basic and
 diluted                                8,607,684     8,615,163       8,617,645      8,218,961
                                      ===========   ===========      ==========    ===========



See notes to unaudited consolidated financial statements.

                                      F-22


           BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
     CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)
                      FOR NINE MONTHS ENDED MARCH 31, 2007
                                 (UNAUDITED)





                                                                                     Total
                             Common Stock         Additional     Accumulated     stockholders'
                          Shares      Amount   paid-in capital     deficit      equity (deficit)
                        ----------    ------   ---------------   ------------   ----------------
                                                                 

Balances, July 1, 2006   8,625,996    $  -       $66,736,874     $(70,014,401)    $(3,277,527)
 Vesting of options for
  services                    -          -           442,260             -            442,260
 Return of shares
  previously issued for
  services                 (20,000)                  (40,000)                         (40,000)
 Conversion of note        151,908                   607,629                          607,629
 Net loss                     -          -              -          (1,884,237)     (1,884,237)
                        ----------    ------     -----------     ------------     -----------
Balances, March 31,
 2007                    8,757,904    $  -       $67,746,763     $(71,898,638)    $(4,151,875)
                        ==========    ======     ===========     ============     ===========































See notes to unaudited consolidated financial statements.

                                      F-23


          BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
                   CONSOLIDATED STATEMENTS OF CASH FLOWS
                 NINE MONTHS ENDED MARCH 31, 2007 AND 2006
                                (UNAUDITED)


                                                                2007         2006
                                                            -----------   -----------
                                                                    
CASH FLOWS FROM OPERATING ACTIVITIES
 Net loss                                                   $(1,884,237)  $(3,564,908)
 Adjustments to reconcile net loss to net cash used
  in operating activities:
   Cumulative effect of change in accounting principle          731,386          -
   Depreciation expense                                           6,565        63,670
   Accrued interest on convertible notes                        105,427       123,362
   Stock-based compensation                                     442,260       661,020
   Decrease in fair value of convertible notes               (1,580,338)         -
   Increase in intrinsic value of convertible notes                -        1,215,944
   Decrease (increase) in prepaid services                       39,065       (16,286)
   Decrease (increase) in other assets                            3,058        (2,217)
   Increase (decrease) in accounts payable and accrued
    expenses                                                    198,850      (509,076)
   Increase in deferred rent                                     72,097          -
   Increase in deferred compensation                            562,500       356,604
                                                            -----------   -----------
     Net cash used in operating activities                   (1,303,367)   (1,671,887)

CASH FLOWS FROM INVESTING ACTIVITIES
 Increase in restricted cash                                   (171,945)         -
 Purchase of property and equipment                             (78,623)       (9,166)
                                                            -----------   -----------
     Net cash used in investing activities                     (250,568)       (9,166)

CASH FLOWS FROM FINANCING ACTIVITIES
 Net proceeds from sale of common stock                            -        1,136,500
 Net proceeds from sale of convertible debt                   1,245,000     1,870,821
 Proceeds from sale of warrants                                    -           32,500
                                                            -----------   -----------
     Net cash provided by financing activities                1,245,000     3,039,821
                                                            -----------   -----------
Net (decrease) increase in cash and cash equivalents           (308,935)    1,358,768
Cash and cash equivalents at beginning of period              1,152,199         7,252
                                                            -----------   -----------
Cash and cash equivalents at end of period                  $   843,264   $ 1,366,020
                                                            ===========   ===========
Non-cash investing and financing transactions:
 Conversion of debt to equity                               $   607,629   $ 4,610,832
 Conversion of deferred compensation to common stock               -           60,000
 Return of common stock for unearned services                    40,000          -




See notes to unaudited consolidated financial statements.

                                      F-24


            BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
                 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                 THREE AND NINE MONTHS ENDED MARCH 31, 2007
                                  (UNAUDITED)

1.   ORGANIZATION, NATURE OF BUSINESS, GOING CONCERN AND MANAGEMENT'S PLANS:

Organization and business:

Bion Environmental Technologies, Inc. ("Bion" or the "Company") was
incorporated in 1987 in the State of Colorado.

Bion's patented and proprietary technology provides solutions for
environmentally sound clean-up of the waste streams of large-scale animal
farming operations ("confined animal feeding operations" or "CAFO's") (dairy,
cattle feedlot, hogs and poultry) and creates economic opportunities for
development of integrated complexes including alternative, renewable energy
production, ethanol production, sustainable animal husbandry and organic
soil/fertilizer and feed production ("Projects" or "Integrated Projects").
Bion's technology also potentially allows direct integration with dairy end-
users (bottling operations, cheese and ice cream plants, etc.) and the end-
users of other CAFO's that can potentially increase the profitability and
quality control of each participant while mitigating the environmental impact
of the entire integrated complex. The Company is in the process of finalizing
engineering, design and economic modeling for dairy and beef applications and
Integrated Projects based on its second-generation technology.

Bion is currently evaluating sites in multiple states and anticipates
selecting a site for its initial Integrated Project during 2007. Bion is
presently establishing its implementation management team with the intention
of commencing development and construction of the initial Project during
2007. In addition, Bion will seek to site additional Projects during 2008 and
2009 to create a pipeline of Projects that will ensure significant market
share and profitability within 3-5 years (both regionally and nationally).
Each Project is to include: a) Bion waste treatment modules, b) processing
the CAFO waste stream from the equivalent of approximately 20-40,000 (or
more) dairy cows (or beef cattle equivalent), c) while producing renewable
energy to replace natural gas or other energy use within the Project modules,
d) solids to be marketed as feed and/or fertilizer e) which is integrated
with a 40+M gallon/year ethanol plant (though some smaller projects may be
undertaken in appropriate situations). At the end of the 5-year period, Bion
hopes to have numerous Projects in various stages of development ranging from
full operation to early construction stage.

Through 2001 the Company was primarily an environmental service company
focused on the needs of CAFOs. Thereafter, Bion elected to cease sales of its
first generation systems and focused its activity on development of its
second-generation technology.





                                      F-25


          BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
          NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                THREE AND NINE MONTHS ENDED MARCH 31, 2007
                                 (UNAUDITED)

1.   ORGANIZATION, NATURE OF BUSINESS, GOING CONCERN AND MANAGEMENT'S PLANS
     (CONTINUED):

Going concern and management's plans:

The consolidated financial statements have been prepared assuming the Company
will continue as a going concern. The Company has incurred net losses of
approximately $5,173,000 and $2,115,000 during the years ended June 30, 2006
and 2005, respectively and net losses of approximately $84,000 and $1,884,000
for the three month and nine months ended March 31, 2007, respectively.  At
March 31, 2007, the Company has a working capital deficiency and a
stockholders' deficit of approximately $581,000 and $4,151,000, respectively.
These factors raise substantial doubt about the Company's ability to continue
as a going concern. The accompanying consolidated financial statements do not
include any adjustments relating to the recoverability or classification of
assets or the amounts and classification of liabilities that may result
should the Company be unable to continue as a going concern.  The following
paragraphs describe management's plans with regard to these conditions.

During September 2006, the Company completed a convertible note offering,
raising $700,000 (Note 6).

During March 2007, the Company raised $700,000 in cash proceeds by sale of
its 2007 Series A Convertible Notes ("2007 Notes") (Note 6).

The Company continues to explore sources of additional financing to satisfy
its current operating requirements.

While the Company currently does not face a severe working capital shortage,
it is not currently generating any revenues. The Company will need to obtain
additional capital to fund its operations and technology development, and to
satisfy existing creditors. There is no assurance the Company will be able to
obtain the funds that it needs to stay in business, complete its technology
development or to successfully develop its business.

There can be no assurance that funds required during the next twelve months
or thereafter will be generated from operations or that those funds will be
available from external sources such as debt or equity financings or other
potential sources. The lack of additional capital resulting from the
inability to generate cash flow from operations or to raise capital from
external sources would force the Company to substantially curtail or cease
operations and would, therefore, have a material adverse effect on its
business. Further, there can be no assurance that any such required funds, if
available, will be available on attractive terms or that they will not have a
significantly dilutive effect on the Company's existing shareholders.



                                     F-26


          BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
          NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                THREE AND NINE MONTHS ENDED MARCH 31, 2007
                                 (UNAUDITED)

2.   SIGNIFICANT ACCOUNTING POLICIES:

Principles of consolidation:

The consolidated financial statements include the accounts of the Company and
its wholly-owned subsidiaries, Bion Technologies, Inc., BionSoil, Inc. and
Bion Dairy Corporation and its 57.7% owned subsidiary, Centerpoint
Corporation ("Centerpoint").  All significant intercompany accounts and
transactions have been eliminated in consolidation.

The accompanying consolidated financial statements have been prepared without
audit pursuant to the rules and regulations of the Securities and Exchange
Commission.  The consolidated financial statements reflect all adjustments
(consisting of only normal recurring entries) that, in the opinion of
management, are necessary to present fairly the financial position at March
31, 2007 and the results of operations and cash flows of the Company for the
three and nine months ended March 31, 2007 and 2006.  Operating results for
the three and nine months ended March 31, 2007 are not necessarily indicative
of the results that may be expected for the year ending June 30, 2007.

The unaudited consolidated financial statements should be read in conjunction
with the Company's audited financial statements and footnotes thereto for the
years ended June 30, 2006 and 2005.

3.   MINORITY INTEREST OF CENTERPOINT CORPORATION:

In January 2002, Bion purchased a 57.7% majority interest in Centerpoint from
a third party.  For the three and nine months ended March 31, 2007 and 2006,
the losses applicable to the minority interest in Centerpoint exceeded the
minority interest in the equity capital of Centerpoint, therefore the losses
attributable to the minority interest have been charged against the Company's
earnings as there is no obligation of the minority interest to make good on
such losses.  If Centerpoint has future earnings, the Company shall be
credited to the extent of the minority interest losses previously absorbed.

4.   PREPAID SERVICES AND RENT:

The Company has issued options to purchase shares of the Company's common
stock in exchange for services.  As of March 31, 2007, non-employee options
represented 630,833 of the 1,745,833 options outstanding under the Company's
2006 Consolidated Incentive Plan.  Of the 630,833 non-employee options
outstanding, 260,833 were fully vested and contained no service conditions as
of March 31, 2007. These non-employee options were valued using the Black-
Scholes option-pricing model.  Prepaid services of $8,420 at March 31, 2007
in connection with the fully vested options are being amortized on the
straight-line method through June 30, 2007.



                                     F-27


          BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
          NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                THREE AND NINE MONTHS ENDED MARCH 31, 2007
                                 (UNAUDITED)

4.   PREPAID SERVICES AND RENT (CONTINUED):

The remaining 370,000 non-employee options outstanding include service
conditions and have graded vesting schedules through May 1, 2009.  As of
March 31, 2007, 97,500 of these options were fully vested.  Generally for
these agreements, the measurement date of the services occurs when the
options vest.  In accordance with Emerging Issues Task Force ("EITF") Issue
No. 96-18, recognition of compensation cost for reporting periods prior to
the measurement date is based on the then current fair value of the options
based on market price of the Company's common shares as of reporting date.
Any subsequent change in fair value is recorded on the measurement date.
The fair value of these options were determined using the Black-Scholes
option-pricing model, using the following assumptions at March 31, 2007; a
dividend yield of zero, a risk-free interest rate of 4.65%, volatility of
190% and an expected life of 8.08 years.  Consulting cost in connection with
options that are not fully vested as of March 31, 2007 is being recognized on
a straight-line basis over the requisite service period for the entire award.
(Credits) or charges to consulting expense of ($211,111) and $834 were
recorded as research and development expenses during the three and nine
months ended March 31, 2007, respectively, and $168,972 and $415,127 during
the three and nine months ended March 31, 2006, respectively.

5.   PROPERTY AND EQUIPMENT:

Property and equipment consists of the following as of March 31, 2007:

     Research and development equipment     $ 305,266
     Leasehold improvements                    36,595
     Furniture                                 28,932
     Computers and office equipment            26,286
                                            ---------
                                              397,079
     Less accumulated depreciation           (317,548)
                                            ---------
                                            $  79,531
                                            =========

Depreciation expense was $3,482 and $58,904 for the three months ended March
31, 2007 and 2006, respectively, and $6,565 and $63,670 for the nine months
ended March 31, 2007 and 2006, respectively.








                                     F-28


          BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
          NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                THREE AND NINE MONTHS ENDED MARCH 31, 2007
                                 (UNAUDITED)

6.   CONVERTIBLE PROMISSORY NOTES:

2006 Series A Convertible Promissory Notes:

On September 13, 2006, the Company closed the offering of its 2006 Series A
Convertible Promissory Notes (the "Notes"), by issuing Notes totaling
$700,000.  The holders of the Notes earn interest on the unpaid principal
balance of the Notes at 6%, payable on May 31, 2008, the maturity date of the
Notes.  All of the principal and accrued interest under the Notes shall be
converted into common shares of the Company at the conversion rate of one
share for each $6.00 that is owed under the terms of the Notes if the
following conditions are met:

     A) The closing market price of the Company's shares has been at or above
$7.20 per share for 10 consecutive trading days, and

     B) The earliest of the following events:

     1)   An effective registration allowing public resale of the shares to
be received by the Note holders upon conversion, or

     2)   One year after the initial closing date of the offering, and

     3)   No conversion without an effective registration statement shall
take place until the Company has become a "reporting company" with the
Securities and Exchange Commission pursuant to the Securities Exchange Act of
1934, as amended, which occurred on January 13, 2007.

The Notes may also be convertible, in whole or in part, into the Company's
common shares at any time at the election of the Note holders at a conversion
rate of $6.00 per share, which was above the approximate market price of the
Company's common shares at the commitment date of the offering.   For the
three and nine months ended March 31, 2007 the notes accrued interest of
$10,489 and $27,243, respectively.

2007 Series A Convertible Promissory Notes:

On March 31, 2007, the Company sold $700,000 of its 2007 Series A Convertible
Notes (the "2007 Notes"). In addition the Company issued 2007 Notes totaling
$986,521 in exchange for promissory notes with convertible features and
deferred compensation (Note 9).  The 2007 Notes are convertible into shares
of the Company's common stock at $4.00 per share until maturity on July 1,
2008, at the election of the 2007 Note holder, and will accrue interest at 6%
per annum.  The note holders will have the option to exchange the 2007 Notes,
plus interest, into securities substantially identical to securities the





                                     F-29


          BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
          NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                THREE AND NINE MONTHS ENDED MARCH 31, 2007
                                 (UNAUDITED)

6.   CONVERTIBLE PROMISSORY NOTES (CONTINUED):

2007 Series A Promissory Notes (Continued):

Company sells in any subsequent offering of up to $3,000,000.  The Company
has the right to require the 2007 Notes (principal plus interest) to be
converted into its common shares at the lesser of $4.00 per share or the
price of an offering in which the Company raises $3,000,000 or more.  The
conversion price of the 2007 Notes of $4.00 per share was above the
approximate market price of the Company's common shares at the commitment
date of the offering.

7.   CONVERTIBLE DEBT:

In June 2005, the Company and a vendor signed an agreement whereby $30,437 of
unpaid consulting fees due to the vendor are to be convertible into common
stock of the Company at a conversion price of $2.50 per share at the vendor's
option until May 1, 2007.  If the vendor does not elect to convert the debt
prior to May 1, 2007, the debt will be repaid by the Company on that date.
The market value of the shares at the time of the agreement was approximately
$1.25 per share.  Therefore no beneficial conversion feature resulted from
the agreement.

8.   CONVERTIBLE NOTES - AFFILIATES:

On April 4, 2006 convertible deferred compensation due to the Company's
president, Mark A. Smith, pursuant to an April 2003 deferred compensation
agreement, was exchanged for a promissory note and conversion agreement.  The
promissory note and conversion agreement have the same terms and conversion
features as the April 2003 deferred compensation agreement.  Under the
agreements, the president earned compensation of $150,000 annually, all of
which has been deferred to date.  Sums accrued through March 31, 2006, accrue
interest at 6% per annum, and are convertible into the Company's common stock
at the lower of the current market value at the time of conversion, or $2.00
per share.  Through July 1, 2007, conversions may occur by mutual agreement
between the Company and Mr. Smith. The Company may convert the deferred
compensation, in whole or in part, at any date after July 1, 2007 and the
convertible deferred compensation owed the president is mandatorily converted
to common stock of the Company on July 1, 2009.  Through June 30, 2006, the
Company accounted for this employee stock-based compensation agreement under
Accounting Principles Board Opinion No. 25 ("APB 25") and recorded the
intrinsic value of the deferred compensation agreement at each reporting
date.  On July 1, 2006, the Company adopted the provisions of Statement of
Financial Accounting Standards ("SFAS") No. 123 (Revised), "Share-Based
Payment" ("SFAS 123(R)"), which supersedes APB 25.  In accordance with SFAS
123(R), outstanding instruments previously classified as liabilities and
measured at intrinsic values, are to be measured initially at fair value with


                                    F-30


          BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
          NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                THREE AND NINE MONTHS ENDED MARCH 31, 2007
                                 (UNAUDITED)

8.   CONVERTIBLE NOTES - AFFILIATES (CONTINUED):

differences to be recorded as the cumulative effect of a change in accounting
principle.  The fair value of deferred compensation owed to Mark A. Smith on
July 1, 2006 was $1,521,609, and the cumulative effect of the change in
accounting principle of $308,870 was recorded.  Fair value at July 1, 2006
was calculated using a Black-Scholes option pricing model with the following
assumptions: a dividend yield of zero, a risk-free interest rate of 5.13%,
volatility of 181%, a remaining contractual life of 3 years and a stock price
of $6.40.  At March 31, 2007 the fair value of deferred compensation owed to
Mark A. Smith was re-measured as $871,405 and resulted in credits to earnings
of $338,634 and $667,315 for the three and nine months ended March 31, 2007,
respectively.  Fair value at March 31, 2007 was calculated utilizing the
following assumptions: a dividend yield of zero, a risk-free interest rate of
4.58%, volatility of 66%, a remaining contractual life of 2.25 years and a
stock price of $3.90.

On December 31, 2005, convertible deferred compensation payable to Bright
Capital, Ltd. ("Brightcap") for services provided to the Company by Dominic
Bassani, the former general manager of Dairy, between April 1, 2003 and
September 30, 2005 was exchanged for a promissory note and conversion
agreement with the same terms and features as the deferred compensation
agreement.  Effective March 31, 2005, Brightcap entered into an agreement to
continue to provide Mr. Bassani's services to the Company through March 31,
2009 and Brightcap earns compensation of $300,000 annually with payment
deferred.  Sums accrued through September 30, 2005, accrue interest at 6% per
annum and are convertible into the Company's common stock at the lower of the
current market value at the time of conversion or $2.00 per share. Through
January 1, 2007 conversions may occur by mutual agreement between the Company
and Brightcap.  The Company may convert the deferred compensation, in whole
or in part, at any date after January 1, 2007 and, on July 1, 2009, the
Company's obligation owed Brightcap is mandatorily convertible to common
stock of the Company. Through June 30, 2006, the Company accounted for this
employee stock-based compensation agreement under APB 25 and recorded the
intrinsic value of the deferred compensation agreement at each reporting
date.  On July 1, 2006, the Company adopted the provisions of SFAS 123(R),
which supersedes APB 25.  The fair value of deferred compensation owed to
Brightcap on July 1, 2006 was $2,081,475, and the cumulative effect of the
change in accounting principle of $422,516 was recorded.  Fair value at July
1, 2006 was calculated using a Black-Scholes option pricing model with the
following assumptions: a dividend yield of zero, a risk-free interest rate of
5.13%, volatility of 181%, a remaining contractual life of 3 years and a
stock price of $6.40.  At March 31, 2007 the fair value of deferred
compensation owed to Brightcap was re-measured as $1,191,717 and resulted in
a credit to earnings of $463,110 and $913,023 for the three and nine months
ended March 31, 2007, respectively.  Fair value at March 31, 2007 was
calculated utilizing the following assumptions: a dividend yield of zero, a
risk-free interest rate of 4.58%, volatility of 66%, a remaining contractual
life of 2.25 years and a stock price of $3.90.

                                     F-31


          BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
          NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                THREE AND NINE MONTHS ENDED MARCH 31, 2007
                                 (UNAUDITED)

8.   CONVERTIBLE NOTES - AFFILIATES (CONTINUED):

Since September 30, 2006, Mr. Bassani no longer serves in the capacity of
general manager of Dairy.  However, he continues to provide services through
Brightcap as per the agreement above.

9.   DEFERRED COMPENSATION:

Prior to March 31, 2003, the Company incurred management fees under various
management agreements with the D2 LLC Deferred Compensation Trust ("Trust")
for management and consulting services. These fees totaled $607,629 including
interest at 6%, as of March 31, 2007.  The services were provided in part by
Dominic Bassani, who beneficially owns 50% of the Trust.  In March 2003, the
Trust agreed to accept payment on March 31, 2007, by conversion of the
deferred compensation into common stock of the Company at the higher of the
average price of the Company's common stock during the ten trading days
ending March 27, 2007, or $4.00 per share.  As of March 31, 2007, this
obligation was converted at $4.00 per share and the Company issued 151,908
common shares to satisfy its obligation.

Through December 31, 2006, the Company had also recorded deferred
compensation liabilities of $787,500 for three officers of the Company
consisting of $112,500 to Mark A. Smith, $375,000 to Brightcap Capital Ltd.,
and $300,000 to Salvatore Zizza, a former officer and director of the
Company, who assumed the position of Chairman and director of Dairy with an
annual salary of $300,000.  Effective January 1, 2007, the Company entered
into agreements converting deferred compensation amounts owed as of December
31, 2006 into promissory notes with conversion agreements.  The notes accrue
interest at 6% per annum, with principal and interest due and payable on
January 1, 2009, if not previously paid.  The conversion agreements allow for
the conversion of the notes into shares of the Company's common stock at the
equivalent price of the Company's next private financing in excess of
$2,000,000 as follows: a) by the holder at any time after July 1, 2007; b) by
the Company any time after there has been an effective registration including
the shares underlying conversion of the notes for six months; c) by the
holder and the Company by mutual agreement at any time prior to payment by
the Company of outstanding principal and interest.  During the three months
ended March 31, 2007, the Company recorded deferred compensation of $37,500
to Mark A. Smith, $75,000 to Brightcap, and $75,000 to Salvatore Zizza which
was non-interest bearing and non-convertible.  As of March 31, 2007 the
accrued principal and interest owed under the promissory notes with
conversion agreements of $787,500 and $11,521, respectively, together with
the deferred compensation owed for the three months ended March 31, 2007 was
converted to 2007 Series A Promissory Notes (Note 6). As the conversion price
of the 2007 Notes of $4.00 per share was above the approximate market price
of the Company's common shares at the date of the conversion of the
promissory notes and deferred compensation, no beneficial conversion feature
resulted from the transaction.


                                      F-32


          BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
          NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                THREE AND NINE MONTHS ENDED MARCH 31, 2007
                                 (UNAUDITED)

10.  STOCKHOLDERS' EQUITY:

Common stock:

In November 2006, the Company entered into a mutual release and agreement
with a consultant to whom the Company had issued 50,000 shares of common
stock valued at $100,000 during the year ended June 30, 2006.  Under the
terms of the mutual release and agreement, 20,000 shares valued at $40,000
were returned by the consultant and cancelled by the Company.

On March 31, 2007, the Company issued 151,908 share of its common stock upon
conversion of deferred compensation owed to the Trust of $607,629 (Note 9).

Warrants:

As of March 31, 2007 the Company had the following common stock warrants
outstanding:

                          Number of     Exercise
                           Shares        Price        Expiration Date
                          ---------     ---------     ---------------
  Class SVDB 1-6           800,000      $    3.00     July 31, 2013
  Class SVDM-1             387,343      $    5.00     July 31, 2008
  Class DB-1               600,000      $    1.00     January 31, 2014
  Class A 1-3              600,000      $    2.50     May 14, 2015
  Class SVMAS-1             67,500      $    3.50     May 31, 2009
  Class SVMAS-1A            40,000      $    3.50     October 11, 2009
  Class SVMAS-2             32,500      $    2.50     September 30, 2009
  Class SVMAS-3             40,000      $    2.50     September 30, 2015
  Class SVB 1-3             50,000      $    2.50     April 30, 2015
  Class SVB-4               75,000      $    2.50     April 30, 2015
  Class SVC 1-5            125,000      $    4.25     December 31, 2012
  Class SV-SEI 1-2          41,667      $    1.50     June 30, 2009
  Class C, D, E            725,000      $    2.50     April 30, 2015
  Class O                  100,000      $    3.00     December 31, 2008
                         ---------
                         3,684,010
                         =========










                                      F-33


          BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
          NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                THREE AND NINE MONTHS ENDED MARCH 31, 2007
                                 (UNAUDITED)

10.  STOCKHOLDERS' EQUITY (CONTINUED):

During the nine months ended March 31, 2007, 10,573 warrants with an exercise
price of $6 expired.  The weighted average exercise price for the outstanding
warrants is $2.72 and the weighted average life as of March 31, 2007 is 6.3
years.

Stock options:

Prior to June 2006, the Company had various incentive plans (the "Plans")
that provided for incentive stock options to be granted to selected employees
and directors of the Company, and selected non-employee advisors to the
Company.  Effective June 2006, the Company approved the 2006 Consolidated
Incentive Plan (the "2006 Plan"), which consolidated previously reserved
incentive stock options under the Plans into the 2006 Plan.  The Company has
reserved 3,200,000 shares, the maximum number of shares of the common stock
of the Company issuable pursuant to the 2006 Plan. Terms of exercise and
expiration of options granted under the 2006 Plan may be established at the
discretion of the Board of Directors, but no option may be exercisable for
more than ten years.

During the year ended June 30, 2006, the Company granted options to purchase
17,000 shares of common stock at $3.00 to $6.00 per share to non-employees.
The fair value of the options, using the Black-Scholes option pricing model,
was $34,918, of which options totaling $32,738 vested immediately and were
recognized as non-cash stock compensation expense.  The remaining $2,180 of
options vest over a year and $145 and $1,017 was amortized on a straight line
basis in the three and nine months ended March 31, 2007, respectively, as
non-cash stock compensation.

Effective July 1, 2006, the Company adopted SFAS No. 123(R), using the
modified prospective method.  SFAS 123(R) requires the recognition of the
cost of employee services received in exchange for an award of equity
instruments in the financial statements and is measured based on the grant
date fair value of the award.  SFAS 123(R) also requires stock option
compensation expense to be recognized over the period during which an
employee is required to provide service in exchange for the award (the
vesting period).  Prior to the adoption of SFAS 123(R), the Company accounted
for stock-based compensation awards under APB 25. Under APB 25, generally no
compensation expense is recorded when the terms of the award are fixed and
the exercise price of the employee stock option equals or exceeds the fair
value of the underlying stock on the date of grant.

During the three and nine months ended March 31, 2007, the Company recorded
compensation expense related to stock options of $141,170 and $441,426,
respectively, and granted 335,000 options during the nine months ended March
31, 2007.  The fair value of the options granted during the nine months ended
March 31, 2007 is estimated on the grant date using the Black-Scholes option-
pricing model with the following weighted average assumptions:


                                     F-34


          BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
          NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                THREE AND NINE MONTHS ENDED MARCH 31, 2007
                                 (UNAUDITED)

10.  STOCKHOLDERS' EQUITY (CONTINUED):

Stock options (continued):


          Volatility                   124%
          Dividend yield                 0%
          Risk-free interest rate     4.74%
          Expected life (years)        3.3

As of March 31, 2007, options outstanding under the 2006 Plan are summarized
as follows:

                                                Outstanding Options
                                          Number of      Weighted Average
                                           Shares         Exercise Price
                                          ----------     ----------------

     Balance, July 1, 2006                 1,410,833        $  2.94
       Options granted                       335,000        $  4.33
       Options exercised                        -              -
       Options cancelled                        -              -
                                           ---------        -------
     Balance, March 31, 2007               1,745,833        $  3.23
                                           =========        =======

There were 1,072,500 options exercisable as of March 31, 2007.

The following table presents information relating to stock options
outstanding and exercisable as of March 31, 2007:





                                        Weighted-    Weighted-
                                        Average      Average                   Weighted-
                                        Remaining    Outstanding               Average
                           Outstanding  Contractual  Exercise     Exercisable  Exercise
Range of Exercise Prices   Shares       Life         Price        Shares       Price
------------------------   -----------  -----------  -----------  -----------  ---------
                                                                
     $2.00 - $2.50             812,500      7.0        $  2.41        436,667   $  2.32
     $3.00 - $3.50             420,333      1.4        $  3.00        420,333   $  3.00
     $4.00 - $4.75             290,000      6.5        $  4.12         77,500   $  4.15
     $5.00 - $7.50             223,000      3.1        $  5.52        138,000   $  5.53
                             ---------      ---        -------      ---------   -------
                             1,745,833      5.0        $  3.23      1,072,500   $  3.14
                             =========      ===        =======      =========   =======



                                         F-35


          BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
          NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                THREE AND NINE MONTHS ENDED MARCH 31, 2007
                                 (UNAUDITED)

10.  STOCKHOLDERS' EQUITY (CONTINUED):

Stock Options (continued):

The total fair value of stock options that vested during the three and nine
months ended March 31, 2007 and 2006 was $7,533 and $201,408, and $24,686 and
$201,466, respectively.  The intrinsic value of stock options exercised
during both the three and nine months ended March 31, 2007 and 2006 was $0 as
there were no options exercised during these periods.  As of March 31, 2007
the Company had $799,358 of unrecognized compensation cost related to stock
options that will be recorded over a weighted average period of approximately
3 years.

Prior to July 1, 2006, the Company accounted for stock-based compensation
awards under APB 25 and had adopted the disclosure-only provision of SFAS No.
123, "Accounting for Stock-Based Compensation" ("SFAS 123").  Had
compensation expense for stock option grants been determined based on the
fair value at grant dates consistent with the method prescribed by SFAS 123,
the loss attributable to common shareholders and loss per common share would
have been adjusted to the pro forma amounts for the three and nine months
ended March 31, 2006 as follows:

                                            Three months     Nine months
                                               ended            ended
                                           March 31, 2006   March 31, 2006
                                           --------------   --------------
Net loss:
 As reported                                 $(1,379,000)     $(3,565,000)
 Less: Stock-based compensation
  expense determined under fair value
  method                                         (38,000)        (252,000)
                                             -----------      -----------
Pro forma                                    $(1,417,000)     $(3,817,000)
                                             ===========      ===========
Basic and diluted net loss per share:
 As reported                                      ($0.16)          ($0.43)
                                             ===========      ===========
  Pro forma                                       ($0.16)          ($0.46)
                                             ===========      ===========







                                      F-36


          BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
          NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                THREE AND NINE MONTHS ENDED MARCH 31, 2007
                                 (UNAUDITED)


11.  OPERATING LEASE:

The Company entered into a non-cancellable operating lease commitment for
office space in New York, effective August 1, 2006 and expiring November 30,
2013.  In conjunction with the signing of the lease, the Company provided the
lessor with a secured letter of credit in the amount of $171,945, which is
reflected as restricted cash as of March 31, 2007.  The Company's obligations
under the lease are partially guaranteed by Salvatore Zizza, chairman of Bion
Dairy.  The Company has entered into two separate agreements to sub-lease
approximately 32% of the Company's lease obligation and the tenants have also
agreed to reimburse the Company for leasehold improvements and furnishings.
As of March 31, 2007, the Company has outstanding receivables from its
tenants of approximately $2,000.    The Company is recognizing rent expense
relating to the lease under the straight-line method.  The average monthly
rent expense for the 88-month lease is $15,820.  The Company is also
recognizing the sub-lease rental income from its tenants under the straight-
line method, with a monthly average of $5,252.  The difference between the
straight-line method, and the actual lease payments have resulted in a
deferred rent liability of $63,120 as of March 31, 2007.  As of March 31,
2007, the Company also has deferred rent of $8,977 relating to a tenant's
three-month rent prepayment.

As of March 31, 2007 the Company had prepaid rent relating to its operating
leases of $16,028.

At March 31, 2007, future minimum rental payments due under non-cancelable
leases and future minimum rental payments to be received under non-cancelable
subleases were:

Fiscal year:                     Operating lease   Sublease   Net operating
                                 payments          rentals    lease payments
                                 ---------------   --------   --------------
Three months ended June 30, 2007   $   42,986      $ 13,756      $ 29,230
2008                                  177,829        56,905       120,924
2009                                  184,484        59,035       125,449
2010                                  191,405        61,249       130,156
2011                                  198,602        63,553       135,049
2012                                  212,775        68,088       144,687
Thereafter                            322,975       103,352       219,623
                                   ----------      --------      --------
Total                               1,331,056       425,938       905,118








                                      F-37


          BION ENVIRONMENTAL TECHNOLOGIES, INC. AND SUBSIDIARIES
          NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                THREE AND NINE MONTHS ENDED MARCH 31, 2007
                                 (UNAUDITED)


12.  COMMITMENTS:

Joint venture agreement:

In June 2006, the Company entered into an agreement with Fair Oaks Dairy Farm
("FODF") to construct a Bion facility ("Stage I System") at FODF.  Bion has
been working with FODF since May 2005 for the purpose of installing a waste
treatment facility at FODF that could become the basis for a future
Integrated Project.  The June 2006 agreement contemplates expansion beyond
the initial waste treatment facility.    The Stage I System will initially be
used for testing necessary for: a) finalization of design criteria for
permitting and construction of, and b) optimization of renewable energy
production and utilization for the full scale Integrated Projects.  The
Company is currently in negotiations toward an amended agreement with FODF
pursuant to which: a) the Company will construct a commercial scale Bion
System designed to handle the waste stream from approximately 3,500-6,200
milking cows ("Initial System") at existing FODF facilities in Indiana which
will incorporate and expand the scope of the Stage I System; and b) when the
Initial System has completed start-up phase and demonstrated environmental
results consistent with the published results achieved at Bion's DeVries
research facility, the Initial System will become the basis of expansion into
an Integrated Project at FODF through development stages including dairy
expansion, construction of additional Bion System modules, including
renewable energy production, solids processing facilities, and construction
of an ethanol plant.  It is anticipated that the amended agreement will be
executed during fiscal year 2007.  Preliminary engineering, design and site
work at FODF has begun pursuant to the existing agreement and the Company
anticipates completion of development of this Integrated Project during 2008
and 2009.  FOFD is owned and controlled by Michael McCloskey and Timothy Den
Dulk who have served as consultants to the Company since May 2005.

13.  RELATED PARTY TRANSACTIONS:

The Company has an accrued payable of $41,647 to a company controlled by
Salvatore Zizza for rental of office space in 2003.

14.  SUBSEQUENT EVENTS:

On April 19, 2007 the Company sold an additional $100,000 of its 2007 Series
A Convertible Notes.








                                      F-38